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ABSTRACT 
Neisseria meningitidis is a major cause of sepsis and meningitis worldwide but is also 
a common commensal, present in the nasopharynx of between 8 to 20% of healthy 
individuals. During carriage, bacteria are found on both the surface of the 
nasopharyngeal epithelium and in deeper tissues. The development of 
meningococcal disease requires spread of the bacterium across the respiratory 
epithelium into the systemic circulation. Therefore investigating the pathway of 
epithelial traversal by N. meningitidis is crucial for understanding carriage and 
disease, but has been hindered by the lack of appropriate model systems. Work in 
this thesis established a physiologically relevant cell culture model of the upper 
respiratory epithelial cell barrier to investigate the mechanisms responsible for the 
traversal of N. meningitidis. We demonstrate the applicability of Calu-3 human 
respiratory epithelial cells for studying the meningococcus, and also grow the cells on 
permeable cell culture membranes to form polarised monolayers. Intracellular 
bacteria were present in the monolayers and transcellular traversal of the layers 
occurred without disrupting barrier function. Host and bacterial factors involved in 
successful traversal were also determined. The potential of the Calu-3 monolayer for 
investigating other aspects of meningococcal infection was demonstrated by 
investigating the role of type IV pili and CD46 during adhesion. Understanding the 
early phases of infection, before the meningococcus reaches the blood, is essential 
for our understanding of pathogenesis and could enable the development of 
interventions, such as prophylactic vaccines, to prevent this important human 
infection. 
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1. INTRODUCTION 
1.1. Neisseria meningitidis, meningococcal septicaemia and 
meningitis 
1.1.1. History 
The science of microbiology is widely considered to have been founded by Antonie 
van Leeuwenhoek (Waller, 2002). Leeuwenhoek was originally a draper from Delft 
who became interested in microscopy after acquiring his first microscope in 1653 
(Waller, 2002). He discovered a novel method for creating small, high quality lenses 
which he used to make improvements in the light microscope. In 1676, he became 
the first person to observe and describe single celled organisms which he called 
animalcules (Waller, 2002). Bacterial meningitis was first described over 100 years 
later, in 1805, by the Swiss physician Vieusseux during an outbreak in Geneva 
(Vieusseux, 1805; de Souza and Seguro, 2008). At the time the causative agent was 
unknown and germ theory was in its infancy. However, by the late 19^ ^ century the 
role of microscopic organisms in disease had become well established through the 
work a number of scientists, but perhaps most famously by Ignaz Semmelweis, Louis 
Pasteur and Robert Koch (Waller, 2002). In 1847, the Hungarian obstetrician 
Semmelweis proposed that puerperal fever was a contagious disease caused by poor 
hygiene among doctors and medical students (Herba, 1847). In the early 1860s 
French chemist and microbiologist Louis Pasteur demonstrated that fermentation 
was caused by micro-organisms and in 1879 that puerperal sepsis was usually caused 
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by Streptococcus (Waller, 2002). In 1890 Robert Koch formalised the germ theory of 
disease with the publication of Koch's Postulates, a series of proofs required to verify 
that a specific micro-organism is the causative agent of a disease (Waller, 2002). In 
1887 Diplococcus intracellularis meningitidis was identified by Anton Weischselbaum 
as the causative agent of 'epidemic cerebrospinal meningitis' (Weichselbaum, 1887). 
The micro-organism was later renamed Neisseria meningitidis by Albert Neisser after 
characterization of the related pathogen. Neisseria gonorrhoeae (Kampmeier, 1978). 
1.1.2. N. meningitidis and symptoms of disease 
N. meningitidis is a Gram-negative diplococcus with a genome of approximately 2.2 
million bases, encoding approximately 2000 genes (Parkhill et al., 2000; Tettelin et 
ai., 2000). Humans are the sole natural host for N. meningitidis and the nasopharynx 
the only known reservoir of infection (Stephens, 1985; Caugant et al., 1994). The 
bacterium is transmitted from person-to-person by direct contact with oral or 
nasopharyngeal secretions, or through respiratory droplets (Tzeng and Stephens, 
2000; Stuart et al., 2001). Whilst the human nasopharynx is the primary site of 
meningococcal infection, the pathogen has also occasionally been found colonising 
the mucous membranes of other sites including the endocervix (Fiorito et al., 2001), 
anus (Judson et al., 1978), urethra (Faur et al., 1975) and conjunctiva (Barquet et al., 
1990). 
In the majority of cases infection results in asymptomatic carriage lasting for a matter 
of days, through to weeks or months in some cases (Greenfield et al., 1971). When it 
does occur, the onset of disease is usually 1 to 14 days after exposure of a susceptible 
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individual to a pathogenic strain (Stephens, 2007). Based on studies with N. 
gonorrhoeae, an inoculum size of approxinnately 10^ to lO'^  bacteria is thought to be 
required for infection with N. meningitidis (Cohen et al., 1994; Stephens, 2007). 
Meningococcal disease is often mistaken for viral infection because the initial 
symptoms, including fever and headaches, are similar (van Deuren et al., 2000). This 
error can lead to potentially fatal delays in diagnosis as the mild symptoms can 
progress, within a few hours, to life-threatening disease, manifest as septicaemia 
and/or meningitis. Serious meningococcal disease is typified by a purpuric skin rash, 
neck stiffness, photophobia and signs of sepsis (van Deuren et al., 2000; Thompson et 
al., 2006). The rapid progression of the illness, and non specific nature of the early 
symptoms make case fatality rates high as there is only a narrow time window to 
establish a diagnosis and initiate treatment (van Deuren et al., 2000; Thompson et a!., 
2006; de Souza and Seguro, 2008). Other forms of the disease are rarer and include 
pericarditis, conjunctivitis, otitis, sinusitis, arthritis and urethritis (Tzeng and 
Stephens, 2000). 
1.1.3. Phylogeny 
Traditionally, strains have been characterised by their reactivity with antibodies 
against surface-exposed epitopes on the outer membrane or capsule. This technique 
has defined 13 serogroups (identifying capsular antigens), 20 serotypes [identifying 
class 2/3 outer membrane protein (OlViP) antigens], and 10 sero-subtypes (identifying 
class 1 OMPs) (Frasch et a!., 1985). Further phenotypic characterisation of strains has 
been achieved using the antigenic properties of lipopolysaccharide (LPS), 
19 
immunoglobulin A1 (IgAl) proteases and pili (Stephens etai, 1985; van Deuren eta!., 
2000). The 13 serogroups of N. meningitidis (based on structural differences in the 
capsule) are A, B, C, E-29, H, I, K, L, M, W-135, X, Y and Z. Of these, the most clinically 
important are serogroups A, B, C, Y, W-135 and more recently X which has emerged 
as a problem in certain geographic locations such as Niger (Djibo et al., 2003; Boisier 
et al., 2007). 
Serotyping based on exposed surface molecules is helpful for design of vaccination 
strategies as it allows evaluation of the antigenic variation between strains. 
However, while this kind of phenotypic characterisation of surface structures may 
reveal genetic relatedness this is not always the case and phenotypically similar 
strains may have major genetic differences. For this reason, serotyping lacks the 
detail required for modern epidemiological studies (Caugant, 1998). Furthermore, 
many carriage isolates do not express a polysaccharide capsule making it impossible 
to place them into serogroups. Establishing, accurate phylogeny requires an 
understanding of the genetic relatedness of different strains/species (Caugant, 1998). 
For N. nneningitidis this has been achieved predominantly using multilocus enzyme 
electrophoresis (MLEE) and multilocus sequence typing (IVILST), which identify 
naturally occurring allelic variation in multiple housekeeping genes. MLEE and MLST 
identify variation in protein sequence (Selander et al., 1986) and nucleotide sequence 
respectively, and allow strains to be assigned to electrophoretic types (ET) (for MLEE) 
or sequence types (ST) (for MLST). This has provided insights into the evolution of 
the pathogen and improved understanding of the epidemiology of commensal and 
disease-causing N. meningitidis strains (Selander et ai, 1986; Fox et al., 1991; 
20 
Bjorvatn et al., 1992). Notable insights gained from these methods include the 
appreciation that carrier strains are more diverse than invasive strains (Yazdankhah 
and Caugant, 2004), and that disease causing strains from different serogroups can 
be grouped into 'clonal complexes' based on their genetic relatedness. For example, 
in strains isolated from patients with meningococcal disease the ET-37 (ST-11) 
complex is overrepresented compared to carriage strains (Caugant et al., 1988). The 
ET-37 complex contains strains of various serogroups including B, C and W-135 (Wang 
et al., 1993; MacLennan et al., 2000). 
1.1.4. Epidemiology 
N. meningitidis is the leading worldwide cause of rapidly fatal sepsis and meningitis 
(Stephens, 2007). According to World Health Organisation estimates, half a million 
new cases of meningococcal disease occur every year, resulting in 50,000 deaths (van 
Deuren et al., 2000; Brandtzaeg and van Deuren, 2002). However, the bacterium is 
also a common commensal, colonising the nasopharynx of between 8 and 20 % of 
healthy humans, though higher rates of carriage are seen in epidemic situations and 
in those living in shared accommodation (e.g. military recruits or university students) 
(Greenfield etai, 1971; Caugant etal., 1994; Stephens, 1999; Caugant et al., 2007). 
The incidence and case fatality of meningococcal disease varies with age, serogroup 
and geographical area (Tzeng and Stephens, 2000; Stephens, 2007). There are peaks 
in the rates of meningococcal disease in infants [before protective immunity develops 
and after protection from maternal antibodies wanes (Pollard and Levin, 2000)], and 
in adolescents and young adults (as close social contact increases). There are also 
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environmental risk factors that contribute to susceptibility to meningococcal disease 
including smoking (Stuart et al., 1989; Fischer et ai, 1997) and recent infection with 
influenza viruses (Cartwright etal., 1991; Harrison etal., 1991). 
Serogroup A N. meningitidis is linked to the highest incidence of disease (over 1000 
cases per 100,000 population), during large epidemics in sub-Saharan Africa 
(Stephens, 2007). In this region epidemics of meningococcal disease occur every 5 to 
10 years and can cause in excess of 200,000 cases in a single year (Tzeng and 
Stephens, 2000). This pattern is not seen in other regions and the reasons for this are 
not known, though environmental factors such as low humidity have been implicated 
(Molesworth et al., 2003). Serogroup B strains generally cause sporadic or endemic 
disease (Stephens, 2007). However, over long periods morbidity and mortality can be 
significant as in Europe [where serogroup B strains cause over 63 % of meningococcal 
disease (Cartwright et al., 2001)], the US, Chile and most recently New Zealand 
(Tzeng and Stephens, 2000). Serogroup C is widespread and responsible for both 
major epidemics (e.g. Brazil and sub-Saharan Africa) and local outbreaks (e.g. within 
North America and Western Europe) (Tzeng and Stephens, 2000). Serogroup W-135 
caused worldwide outbreaks associated with the Hajj pilgrimage between the years 
2000-2002, and also significant disease across sub-Saharan Africa (Stephens, 2007). 
Serogroup Y isolates have become more frequent in the US and Israel, while 
serogroup X has recently caused localised outbreaks in Niger and other areas of sub-
Saharan Africa [reviewed in (Stephens, 2007)]. 
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1.1.5. Treatment and vaccines against N. meningitidis 
In the absence of treatment, the mortality rate for systemic meningococcal infection 
is between 70 and 90 % (Flexner, 1913), although with modern antibiotic treatment 
and healthcare this has been reduced to around 10 % (Stephens, 2007). p-lactams are 
the antibiotic of choice for treatment, particularly penicillin G, ceftriaxone and 
cefotaxime. However, when prophylactic treatment is required, for example in 
healthcare workers or close contacts of patients, rifampicin and ciprofloxacin are 
used (Rosenstein et ai, 2001). 
From a public health perspective the prevention of meningococcal disease by 
vaccination is far more effective for preventing epidemics than treatment due to the 
rapid onset and spread of the disease, and difficulties with early diagnosis. The 
majority of available vaccines against N. meningitidis target the capsule. The first 
anti-capsular vaccines against serogroup A and C strains were licensed almost 40 
years ago in response to epidemics among US military recruits (Gotschlich et a!., 
1969; Artenstein et al., 1970; Devine et ai., 1970; Gold et ai., 1975). These vaccines 
are safe and reasonably effective in children older than two years and adults. 
However, the duration of immunity is limited to 3 to 5 years, and the vaccines do not 
significantly reduce carriage or induce immunological memory (Hassan-King et al., 
1988). Despite these limitations, polysaccharide vaccines against N. meningitidis 
have been used to control epidemics in sub-Saharan Africa. Although there as been 
concern that they are usually deployed too late to have a maximum effect on an 
epidemic, there is no doubt that polysaccharide vaccines have saved lives (Stephens, 
2007). 
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A major breakthrough in vaccinology was the discovery that vaccines directed against 
the capsule of Haemophilus influenzae type b (Hib) were more effective when the 
capsular antigen was conjugated to a carrier protein (Booy et ai, 1994). A similar 
method was applied to design vaccines against N. meningitidis using diphtheria or 
tetanus toxoid as a carrier protein. The meningococcal serogroup C conjugate vaccine 
(MCC vaccine) was introduced in the UK in 1999, and led to a reduction in the 
incidence of invasive group C disease by 93 % (Trotter et al., 2004). This decrease 
included a 70 % reduction in the number of cases in unvaccinated individuals due to 
herd immunity (Ramsay et al., 2003). 
The main drawback with this approach is that the vaccines are serogroup specific, so 
capsular antigens from different serogroups must be combined to create multivalent 
conjugate vaccines covering different serogroups. Several multivalent vaccines, such 
as the tetravalent polysaccharide meningococcal conjugate vaccine (MCV4, Sanofi-
Pasteur) incorporating polysaccharide from serogroups A, C, W-135 and Y conjugated 
to diphtheria toxin, have been developed and licensed (Kieny and La Force, 2007; 
Smith, 2008). 
However, despite its remarkable efficacy, MCV4 remains unaffordable for use in 
developing countries and is therefore inappropriate for the control of epidemic 
meningitis in Africa, a major WHO target (Okoko et al., 2009). This problem led to 
the inception of the Meningitis Vaccine Project in 1996 (Girard et al., 2006; La Force et 
al., 2007). This project, funded by the Bill and Melinda Gates foundation, has now 
developed an affordable ($ 0.50 per dose) serogroup A conjugate vaccine for use in 
the developing world, predominately in the African meningitis belt (Girard et al., 
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2006; Okoko et al., 2009). Named MenAfriVac, this vaccine is manufactured by the 
Serum Institute of India Limited (SIIL) and has proven highly effective, eliciting 
significantly higher bactericidal antibody titres than the polysaccharide vaccines used 
presently (Kshirsagar et al., 2007). The vaccine is in the final stages of licensure and 
by the end of 2009 is expected to be introduced into selected African countries 
(Okoko et al., 2009). 
Unfortunately, the capsule of serogroup B N. meningitidis consists of a homopolymer 
of a2-8-linked sialic acid which is identical to a modification on a neural cell adhesion 
molecule, NCAM-1 (Finne et oi, 1983; Finne et al., 1987). This has meant that anti-
capsular vaccines against serogroup B are generally considered unfeasible because of 
the risk of eliciting auto-antibodies (Jodar et al., 2002). Therefore most approaches 
have been directed at identifying immunogenic sub-capsular antigens. 
Neisseria spp. shed blebs of outer membrane called outer membrane vesicles (OMVs) 
during both in vitro and in vivo growth (Devoe and Gilchrist, 1973; Pettit and Judd, 
1992; Namork and Brandtzaeg, 2002). OMVs contain numerous Neisseria OMPs with 
the exact protein profile dependent on the composition of the outer membrane of 
the strain from which they are derived. OMV-based vaccines have been used in 
response to serogroup B epidemics in Norway and Cuba, though their efficacy was 
limited, particularly in young infants, and induced immunity that did not extend to 
heterologous strains (Bjune et al., 1991; Sierra et al., 1991; Jodar et al., 2002) 
Universal vaccines against serogroup B are currently being evaluated by Novartis 
Vaccines (Giuliani et al., 2006) and Wyeth Vaccines (Fletcher et al., 2004). The Wyeth 
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vaccine is based solely on the meningococcal factor H binding protein (fHbp) while 
the Novartis vaccine includes five OMRs, one of which is fHbp. Both vaccines elicit 
bactericidal antibodies and coverage is good, with Giuliani and co-workers reporting 
bactericidal activity against up to 98 % of serogroup B isolates (Giuliani etal., 2006). 
1.2. Anatomy of the human nasopharyngeal epithelium 
The human nasopharynx is the primary site for infection by N. meningitidis (Stephens, 
1985; Caugant et ol., 1994). It is lined by a pseudostratified columnar epithelium 
which is the first cellular barrier encountered by the meningococcus following 
acquisition of the bacterium. This cell layer consists of differentiated, polarised, 
respiratory epithelial cells whose surface is covered with airway secretions reaching a 
depth of some 10 to 12 |im (Reznik, 1990). Adjacent cells in the epithelium are joined 
by tight junctions which form a barrier excluding mucosal pathogens. The majority of 
cells in the layer are ciliated, resulting in a brush border, although areas of un-ciliated 
cells are also present along with mucus secreting goblet cells (Drettner and Aust, 
1977; Reznik, 1990). 
1.3. Pathogenesis of N. meningitidis 
N. meningitidis colonises the epithelial surface of the human nasopharynx, though 
bacteria are not confined solely to this region during asymptomatic carriage, and are 
also found in clusters beneath the epithelial cell layer in tonsillar tissue (Sim et al., 
2000). Other micro-organisms, both pathogenic and exclusively commensal, are also 
present in the nasopharynx and may influence colonisation by N. meningitidis. For 
26 
instance, colonisation with the related species Neisseria lactamica is thought to elicit 
cross reactive immunity that protects against meningococcal disease (Troncoso et al., 
2000; Li et ai., 2006c;). Interestingly, in a study of two other colonisers of the 
nasopharynx Streptococcus pyogenes and Neisseria subflava, it was shown that co-
culture of the species doubled the growth rate of S. pyogenes probably due to 
production of vitamin B2 by N. subfiava (Abbaszadegan et al., 1997). This 
demonstrates that the surface of the nasopharynx is a complex ecosystem, colonised 
by a number of different bacteria including N. meningitidis, competing for nutrients, 
and surviving in the face of the host immune system. To cause disease the 
meningococcus must spread from the nasopharynx, penetrate the respiratory 
epithelium and enter the systemic circulation. Septicaemia results from the 
multiplication of the pathogen in the circulation and a further step of blood brain 
barrier traversal is required to cause meningitis. 
1.3.1. Adhesion and Colonisation 
Work in the organ culture model indicates that meningococcal attachment is limited 
to the non-cilliated cells of the respiratory epithelium (Stephens et al., 1983). In 
encapsulated bacteria, this interaction is mediated by bacterial surface associated 
filaments called Type IV pili (Tfp) (see 1.4.1.1) (Stephens and McGee, 1981; Nassif et 
al., 1994; Merz et al., 1996; Pujol et al., 1997). These proteinaceous extensions 
project 1-2 |im beyond the bacterial surface and promote adherence to epithelial 
cells (Virji et al., 1992; Pujol et al., 1997; Nassif et al., 1999). The host receptor 
recognised by the pilus has been proposed to be CD46 (Kallstrom et al., 1997) 
although there is evidence for and against this (see section 1.4.1.1). 
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Meningococci attach to epithelial cells during the early stages of infection and form 
small microcolonies. The microvilli on infected cells appear to be elongated and 
interweave through the microcolonies (Stephens et al., 1983; Pujol et al., 1999). In 
addition, re-arrangement of the host cell actin cytoskeleton beneath the site of 
attachment can be seen (Pujol et al., 1997). Work in a dynamic flow model of the 
blood brain barrier suggests that rearrangement of the host cell surface prevents 
bacterial dislodgement by the shear stress created by blood flow in the vascular 
system (Mairey et ol., 2006). Rearrangements seen on epithelial cells may have a 
similar role during nasopharyngeal colonisation, preventing bacteria from being 
dislodged by the movement of air and mucus across the nasopharynx. 
Between 6 and 18 hours after adhesion bacteria spread across the cells in a Tfp-
dependent manner (Pujol et al., 1997). Following dispersal, pili retract, capsule 
expression is down regulated (Deghmane et al., 2002) and bacteria become tightly 
associated with the host plasma membrane in a process described as intimate 
attachment (Stephens et al., 1983; Pujol et al., 1997). The molecular signal 
recognised by the bacteria upon contact with viable cells is not known. However, it 
has been shown that cell contact upregulates genes with an upstream CREN (contact 
regulatory element of Neisseria) sequence (Deghmane et al., 2002). There are a 
number of genes of unknown function preceded by CREN sequences (Deghmane et 
al., 2003; Deghmane et al., 2000). The LysR type transcriptional regulator CrgA, and 
pilus component PilCl are two of the characterised genes with upstream CREN 
sequences (Deghmane et al., 2000). Both are upregulated following cell contact. 
CrgA is responsible for the regulation of a number of genes, but importantly is 
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thought to repress expression of the capsule biosynthesis operon, as well as the pilus 
components PilE and PilCl and thereby cause downregulation of both capsule and 
pilus expression {Deghmane et a!., 2000; Deghmane et al., 2002). However, more 
recent studies contradict some of this work, showing that pilus mediated adhesion, 
and regulation of siaD and pilE are independent of CrgA (Morelle et al., 2003; leva et 
al., 2005). Once intimate adherence has taken place the bacteria may be internalised 
(Stephens et al., 1983; Pujol et al., 1997; Eugene et al., 2002; Spinosa et al, 2007). 
The early interactions between host and pathogen are important because they can 
dictate the outcome of infection. Most cases of meningococcal sepsis occur within 
days or a few weeks of exposure to a virulent strain (Greenwood et al., 1978; Cooke 
et ol., 1989). Furthermore there is a direct correlation between the ability of a strain 
to penetrate nasopharyngeal tissue and its propensity to cause systemic disease 
(Townsend etol., 2002). 
1.3.2. Traversal of the nasopharyngeal epithelium by /V. meningitidis 
and the intracellular lifestyle 
After adhesion, the bacterium traverses through the epithelial cell barrier to reach 
the sub-epithelial compartment (Sim et al., 2000), although how this occurs and the 
factors responsible are largely unknown. Studies using semi-confluent cultured cells 
show that following intimate adhesion to the host cell plasma membrane the 
bacteria may be internalised, although compared to the number of bacteria attached 
to the apical surface this is a rare event. Intracellular bacteria have been observed in 
numerous studies (Stephens et al., 1983; Stephens et al., 1993; Pujol et al., 1997; Lin 
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et oi., 1997; Nikulin et a!., 2006; Tala et al., 2008). Studies with human brain 
microvascular endothelial cells (HBMEC) coined the term Neisseria containing 
vacuole (NCV) to describe the intracellular compartment occupied by the 
meningococcus (Nikulin et al., 2006). Immuno-fluorescence microscopy suggests that 
the NCV interacts with the endocytic pathway and acquires the early endosomal 
marker protein, the transferrin receptor (TfR), and the late endosomal/lysosomal 
marker protein, LAMP-1 (Nikulin et al., 2006). However, other attempts to 
characterise the nature of this compartment have been unsuccessful. Recent work 
has also provided electron microscopic evidence that intracellular bacteria escape the 
NCV and enter the cytoplasm (Tala et al., 2008), although this is contentious. An 
earlier study using transmission electron microscopy (TEM) showed that wild-type 
bacteria were clearly enclosed within a vacuole, while only unencapsulated bacteria 
appeared to be cytoplasmic (Stephens etal., 1993). 
Experimental evidence suggests that bacteria replicate in the intracellular 
compartment of epithelial and endothelial cells and that the capsule is important for 
this process (Nikulin et al., 2006). However, the nutrient sources utilised by the 
intracellular bacteria are not known. Posession of a polysaccharide capsule has been 
shown to be important for intracellular survival in semi-confluent HeLa epithelial 
cells, possibly by protecting the bacteria from cationic antimicrobial peptides 
(CAMPS) (Spinosa et al., 2007). 
Pathogens can cross epithelial barriers by several routes. The most obvious 
distinction is between transcellular traversal (through cells) and paracellular traversal 
(between cells) (Fig. 1.1) (Kumagai et al., 2005; Soriani et al., 2006; Russell et al., 
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2007). Three studies have investigated the interaction of N. meningitidis with 
polarised cultured cells and both paracellular and transcellular routes of traversal 
have been identified. One study used a bi-layer of endometrial epithelial cells and 
microvascular endothelial cells (Birkness et al., 1995); w/here columns of bacteria 
were seen between cells, as well as in vacuoles within cells. Of note, the epithelial 
cells in this model do not become polarised. This may affect the distribution of 
surface receptors and therefore the mechanism of bacterial adherence and route of 
traversal. Addition of cytochalasin D to the bi-layer reduced meningococcal traversal 
providing some evidence that the transcellular route is the primary route for 
traversal. However, given the importance of actin in junctional structures and 
disruption of tight junctions caused by cytochalasin D (Madara et a!., 1986), it is 
possible that the treatment would also have disrupted paracellular traversal in this 
experiment. 
Both the other studies (Merz et al., 1996; Pujol et al., 1997) used polarised 
monolayers of T84 intestinal epithelial cells and report that barrier function is 
maintained during traversal. On this basis the authors suggest that the transcellular 
route is more likely, though neither study focuses specifically on this question. 
Therefore current knowledge of how the meningococcus traverses the host 
respiratory epithelial barrier and how it behaves within cells is rudimentary and 
controversial. 
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Figure 1.1 Routes of traversal utilised by pathogens to cross epithelia 
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1.3.3. Stages of infection following epithelial penetration 
Meningococci entering the bloodstream may be cleared by humoral and, to a lesser 
extent, cellular immune defences (Brandtzaeg et al., 1992; Tzeng and Stephens, 
2000). However, if bacteria avoid immune killing, they can multiply within the 
endovascular compartment, causing the release of cytokines such as TNFa, IL-1 and 
IL-6 that play a major part in inflammation and meningitis (Brandtzaeg et al., 1992). 
Meningitis is thought to arise following bloodstream dissemination although, 
interestingly up to one third of patients with meningococcal disease present with 
meningitis without signs of sepsis. The reasons for this are unclear (Stephens, 2007). 
The pathway used by the meningococcus to cross the blood-brain barrier into the CSF 
is ambiguous. Studies have shown that bacteria have the ability to invade and 
survive within microvascular endothelial cells (Eugene et al., 2002; Nikulin et al., 
2006). A recent study demonstrated that the meningococcus recruits the 
Par3/Par6/PKC( polarity complex in a Tfp dependent manner (Coureuil et al., 2009). 
In monolayers of brain endothelial cells, mislocalisation of these proteins away from 
the adherens junction increases the permeability of the monolayers which is thought 
to provide a route for paracellular traversal (Coureuil et al., 2009). 
1.4. Virulence determinants of N. meningitidis important for 
colonisation and disease 
N. meningitidis possesses a number of virulence determinants important for 
colonisation and disease, although in almost all cases their role in traversal has not 
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been studied. Host-pathogen interactions occur primarily at the bacterial surface, 
where a number of virulence determinants are present. The major surface structures 
of N. meningitidis are shown in Fig. 1.2. 
1.4.1. Adhesins 
The first stage of epithelial traversal is the adhesion of the pathogen to the epithelial 
monolayer. The Tfp is primarily responsible for meningococcal adhesion (Rude! et ol., 
1992; Nassif et a!., 1994) but there are also other minor adhesins. 
1.4.1.1. Type IV pili 
Pili are filamentous structures that extend from the surface of bacteria. They are 
composed of different protein subunits which assemble to form the final structure, 
with one subunit, termed the pilin, found in greatest abundance (Soto and Hultgren, 
1999). Pili are classified into different types based on their amino acid sequence, 
the morphology of the assembled pilus, and more recently on the mechanisms of 
assembly (Pelicic, 2008). 
Tfp are the most widespread type of pilus, and are found in different species from 
diverse genera. They are present in many Gram-positive [e.g. Clostridium perfringens 
(Varga et al., 2006)] and Gram-negative bacteria [Escherichia coli (Giron et al., 1991)] 
from the Proteobacteria, but also in other phyla such as Cyanobacteria and 
Firmicutes (Pelicic, 2008). Tfp were originally identified using electron microscopy 
(EM), and appear as long (1-2 |-im), thin (5-8 nm) structures, which form bundles. 
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The identification of Tfp by ElVI in numerous species has now been confirmed through 
identification of the genes necessary for Tfp biogenesis in these species. Sequencing 
has shown that different species share stril<ing sequence similarity in the Tfp 
encoding loci and structural similarities in the protein subunits (Craig et ol., 2004; 
Pelicic, 2008). 
The pilins (PilE in N. meningitidis) of Tfp are synthesised as a precursor (pre-pilin) 
which is cleaved by a leader peptidase (PilD in N. meningitidis) at a glycine residue, 
releasing the mature pilin and the hydrophilic leader peptide. Despite sequence 
diversity, mature pilins always possess a consensus N-terminal motif (Pugsley, 1993), 
with the fifth residue usually a glutamate and residues 20-25 tending to be 
hydrophobic (Craig et ai., 2004; Pelicic, 2008). Structural studies show that filaments 
are formed from pilins arranged in a helical structure, with the conserved N-terminal 
domains buried in the centre of the fibre, forming the major pilin-pilin interaction 
(Parge et a!., 1995; Craig et al., 2004). Assembly requires a number of proteins 
including a traffic ATPase to provide energy (PilF in N. meningitidis), the specific 
peptidase to cleave the pre-pilin (PilD in N. meningitidis) and integral inner and outer 
membrane proteins required for successful emergence of the pilus (PilM, N, 0, P, Q in 
N. meningitidis) (Fig. 1.3) (Pelicic, 2008). 
Tfp are important for bacterial attachment to, and colonisation of, a broad range of 
substrates including host species and abiotic surfaces (Pelicic, 2008). The Tfp is the 
primary meningococcal adhesin (Rudel etoi., 1992; Nassif eta/., 1994). 
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Figure 1.3 Proposed Structure of the Type IV pilus 
Model of the Tfp structure showing major components. The leader 
sequence is cleaved from the major pilin (PilE) on the IM by the leader 
peptidase (PilD). The structure of assembly machinery is not fully 
understood, though energy is provided by the PilF ATPase. Retraction of 
the pilus is controlled by Pi IT. The pilus crosses the OM through a pore 
consisting of PilQ. PilC was originally proposed as the tip adhesin but is 
now thought to be involved in regulation of retraction, and located on the 
bacterial surface. 
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When human cells are infected with N. meningitidis mutants lacking Tfp, only low 
levels of adhesion are seen (Virji et al., 1992; Nassif et ai., 1993; Nassif et a!., 1994; 
Pujol et al., 1997; Nassif et al., 1999). In addition, strains recovered from patients are 
consistently piliated further indicating the importance of Tfp in pathogenicity 
(Stephens and McGee, 1981). Meningococcal Tfp are also required for 
deoxyribonucleic acid (DNA) uptake (Wolfgang et al., 1998), twitching motility (Merz 
et al., 2000) and bacterial aggregation (Helaine etal., 2005). 
Interestingly, expression of the meningococcal Tfp is subject to both sequence 
variation and phase variation during invasive disease (Rytkonen et al., 2004). In N. 
meningitidis the 18.22 kDa major pilin is encoded by the pilE gene (Jonsson et al., 
1994). Intragenomic alteration in the pilE sequence occurs through RecA-dependent 
gene conversion between the pilE (expression) locus, and multiple, non-expressed 
pilS (silent) copies clustered nearby in the genome (Hamrick et al., 2001). Phase 
variation occurs as a result of on/off switching of pilC expression by frameshift 
mutations in a poly-G tract within the coding region (Jonsson et al., 1991). 
The 110 kDa PilC protein has a major role in meningococcal Tfp function (Jonsson et 
al., 1991). Two alleles (pilCl and pilC2) were first identified in the gonococcus but are 
also present in the meningococcus. In N. meningitidis, only PilCl is required for 
adhesion. PilC2, which is expressed independently of PilCl, fails to promote adhesion 
despite identical functions in pilus expression and transformation competence 
(Morand et al., 2004; Nassif et al., 1994). Initial studies suggested that PilC was the 
tip adhesin for the pilus (Rudel et al., 1995). However, it has also been shown that 
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Pile localises to the bacterial surface (Rahman et a!., 1997). PilC is clearly important 
for host cell adhesion as mutation of pUCl impairs adhesion, although loss of pilCZ 
does not (Nassif et al., 1994). Purified PilC binds to host cells and can block pilus-
mediated adhesion of the meningococcus (Scheuerpflug et al., 1999; Kirchner and 
Meyer, 2005). Reporter fusions with both genes showed that pilCl expression is 
upregulated following host cell infection while pilC2 is not. Upregulation is important 
for adhesion to human endothelial cells (Taha et al., 1998), and is also detected in the 
CSF and choroid plexus suggesting the protein has a role in the development of 
meningitis (Pron et al., 1997). Moreover PilC may not just be involved in adhesion 
directly, but also through the regulation of pilus retraction (Morand et al., 2004). 
PilT is another component of the meningococcal Tfp machinery with a role in host cell 
colonisation and invasion. Originally identified in the gonococcus with roles in 
twitching motility and competence (Wolfgang etal., 1998), PilT has since been shown 
to be required for pilus retraction. Addition of pilins to the Tfp causes pilus 
extension, while removal of subunits causes retraction. The dynamic nature of Tfp is 
integral to their function, allowing the force generating interactions required for 
motility. PilT dependent retraction is important in the latter stages of meningococcal 
adhesion where it provides the motive force that allows intimate adhesion (Pujol et 
al., 1999; Merz et al., 2000). 
CD46 also known as membrane cofactor protein (MCP) has been proposed as the 
receptor for Tfp (Kallstrom et al., 1997). CD46 is a member of a family of proteins 
involved in the regulation of complement activation (RCA family). There are four 
major isoforms of CD46: BCl, BC2, CI and C2 (Fig. 1.4) (Kim and Song, 2006). 
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Figure 1.4 Domain structure of the four isoforms of CD46 
The N-terminal regions of all four isoforms are identical, consisting of four 
short consensus repeats (SCRs) involved in complement control (1-4, ovals). 
Alternative splicing occurs to produce the serine-threonine-proline rich 
(STP) region (triangles) in BC or C form. Alternative splicing in the C-
terminus, produces either Cyt-1 (16 amino acids) or Cyt-2 (23 amino acids). 
Deletion mutagenesis of the BCl isoform has identified a number of regions 
important for attachment of Neisseria gonorrhoeae (indicated in pink). 
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All the isoforms are generated by alternative splicing of the same gene (Liszewski et 
al., 1991; Maisner et al., 1996). The N-terminal regions of all four isoforms are 
identical, consisting of four short consensus repeats (SCRs) involved in complement 
control. Alternative splicing occurs to produce the serine-threonine-proline rich (STP) 
region. All isoforms use the C region whereas the B exon is alternatively spliced 
resulting in BC or C STP domains. Alternative splicing in the C-terminus, produces 
either Cyt-1 (16 amino acids) or Cyt-2 (23 amino acids). Both contain a casein kinase 
II phosphorylation site but Cyt-1 also has a protein kinase C site while Cyt-2 has a src 
kinase site. Both Cyt-1 and Cyt-2 also contain sequences which target CD46 to the 
basolateral membrane of epithelial cells (Maisner et al., 1996). Deletion mutagenesis 
of the BCl isoform has identified a number of regions important for attachment of 
Neisseria gonorrhoeae. 
CD46 isoforms are expressed at the plasma membrane of almost all host cell types 
except erythrocytes (Kim and Song, 2006). These SCR domains bind to activated 
complement components C3b/C4b, and act as a cofactor for factor i-mediated 
inactivation of complement (Liszewski et al., 1991). The crucial role of CD46 in 
complement regulation is highlighted by the occurance of mutations in cd46 in 
patients with haemolytic uraemic syndrome (Noris et al., 2003; Richards et al., 2003). 
Its ubiquity and surface expression make CD46 accessible as a pathogen receptor and 
it is utilised by several viruses including measles (Dorig et al., 1994) and human 
herpes virus 6 (Santoro et al., 1999). 
Evidence for the role of CD46 in meningococcal adhesion includes the binding of 
purified pili to a protein with the same molecular mass as CD46 by western blotting. 
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In addition bacterial adhesion is blocked by a-CD46 antibodies and purified CD46 can 
inhibit adhesion of the meningococcus to M180 cervical carcinoma cells (Kallstrom et 
a!., 1997). Furthermore, piliated meningococci aggregate Staphylococcus aureus 
coated with a CD46 fusion protein while un-piliated meningococci do not (Kallstrom 
et al., 1997). Interestingly, transgenic mice expressing human CD46 are more 
susceptible to nasopharyngeal carriage, although the development of systemic 
meningococcal disease in these animals was independent of the piliation state of 
bacteria (Johansson et al., 2003). However against this evidence, meningococcal 
adhesion to Chinese Hamster Ovary (CHO) cells expressing human CD46 is lower than 
seen with human epithelial and endothelial cells (Kallstrom et al., 1997). There is also 
an inverse correlation between the level of CD46 expressed by cell lines and adhesion 
by N. gonorrhoeae (Tobiason and Seifert, 2001) and down-regulation of CD46 
expression on epithelial cells does not affect adhesion of gonococci (Rahman et al., 
1997; Kirchner et al., 2005). Furthermore, mAbs against CD46 fail to inhibit the 
adherence of N. gonorrhoeae in both a primary human cervical cell model (Edwards 
et al., 2002) and a model using human epithelial cell lines (Gill et al., 2003). 
1.4.1.2. Opacity proteins: Opa and Opc 
Encapsulated meningococci adhere primarily by means of Tfp. However, some 
strains isolated from the nasopharynx are non-piliated and must therefore rely on 
alternative adhesins. Furthermore, after initial, pilus mediated adhesion, Tfp are 
retracted and capsule expression is down-regulated, bringing bacteria into close 
apposition with host cells and allowing intimate attachment (Deghmane et al., 2002). 
Under these conditions Opa and Opc are important in maintaining adhesion (Virji et 
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al., 1993). However, some studies suggest that other proteins might also be involved 
in this process as the absence of Opa and Opc does not affect the development of 
intimate adhesion (Pujol etol., 1997). 
Opas have been extensively studied in the gonococcus but are also expressed by the 
meningococcus (Aho et al., 1991). All members of the Opa multigene family encode 
proteins with eight transmembrane P strands and four surface exposed loops (Virji et 
al., 1993). While the periplasmic and transmembrane domains are conserved, there 
is extensive sequence and structural variation within and between N. meningitidis 
strains in the first three exposed loops (Virji et al., 1993). A single strain may express 
one or several Opas, with phase variation giving distinct patterns of expression in 
different strains (Virji, 2009). In addition, horizontal transfer of opa alleles, as well as 
intragenomic recombination between alleles allows the formation of mosaic genes. 
The result is a large diversity of opa alleles with antigenically variable exposed loops 
(Stern et al., 1986; Hobbs et al., 1998). 
Functionally, different Opas may allow distinct host cell tropism (Makino et al., 1991; 
Virji et al., 1993). In N. meningitidis Opas have been shown to bind a number of host 
cell receptors by targeting negatively charged structures such as heparan sulphate 
proteoglycans (HSPGs) and sialic acids (Chen et al., 1995; van Putten and Paul, 1995; 
Moore et al., 2005). In addition over 90 % of N. meningitidis and N. gonorrhoeae 
isolates tested to date bind to carcinoembryonic antigen-related cellular adhesion 
molecules (CEACAMs) via Opas (Virji et al., 1996; de Vries et ai, 1998). These 
proteins, including CEACAMl, CEA and CEACAM3, are members of the 
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immunoglobulin superfamily and have common motifs, allowing Opas to target 
several distinct CEACAMS (Virji et al., 1996; Muenzner et al., 2000). 
N. meningitidis Opc is encoded by a single gene which is conserved between strains 
(Achtman, 1995; Zhu et al., 1999). Opc shares some physiochemical properties and 
35 % sequence identity (Olyhoek et al., 1991b) with Opas, but is unique to N. 
meningitidis and only expressed by a subset of strains. Interestingly, Opc is absent in 
ET-37 strains {Seiler et al., 1996), which tend to cause severe sepsis but not 
meningitis. In addition, Opc affects internalisation of bacteria into HBMEC by binding 
via fibronectin in serum to integrins on endothelial cells. Thus Opc mediates close 
attachment of the meningococcus with endothelial cells (Sarkari et al., 1994; Unkmeir 
et al., 2002). These data have lead to speculation that Opc might be important for 
penetration of the blood brain barrier (Whalen et al., 1995; Unkmeir et al., 2002). 
The structure and genetic control of Opc also differs from Opas (Olyhoek et al., 
1991a; Sarkari et al., 1994), with expression of Opc protein regulated by alterations in 
the length of a homopoiymeric tract in the promoter region. 
1.4.1.3. Other adhesins 
A number of other adhesins have been described recently although their roles have 
not been fully characterised. Neisseria Hia homologue A (NhhA) is a homologue of 
the H. influenzae autotransporter protein Hsf (Peak et al., 2000; Scarselli et al., 2006). 
In N. meningitidis, it mediates low level adherence to laminin and HSPGs (Scarselli et 
al., 2006), but is absent from N. gonorrhoeae (Peak et al., 2000). 
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The adhesion penetration protein (App) is present in all sequenced Neisseria strains 
(Serruto at at., 2003). App resembles an H. influenzae autotransporter Hap and is 
suggested to have a role in Neisserial adhesion. When expressed in E. coli, App is 
exported to the bacterial surface and mediates adhesion to Chang conjunctival cells. 
The role of autocleavage and secretion is unclear but it may affect bacterial 
detachment from cells and spread (Serruto et al., 2003). 
The haemagglutinin/haemolysin-related protein A (HrpA)-HrpB system is a two 
partner secretion system recently found in N. meningitidis (Schmitt et al., 2007; Tala 
et al., 2008). HrpA is the proposed effector protein with HrpB the putative 
transporter. The proteins have been implicated in several roles including adhesion 
(Schmitt et al., 2007), intracellular survival and escape from intracellular vacuoles 
(Tala et al., 2008). 
Neisserial adhesion A protein (NadA) (Comanducci et al., 2002) and meningococcal 
serine protease A (MspA) (Turner et al., 2006) were discovered as vaccine candidates 
because they can elicit bactericidal antibodies, although both have also been 
implicated in adhesion. Alleles encoding NadA are found in three of the four known 
hypervirulent lineages of N. meningitidis but are absent from carriage strains and N. 
gonorrhoeae (Comanducci et al., 2002). In vitro experiments with a mutant lacking 
nadA showed it had reduced adhesion to epithelial cells (Capecchi et al., 2005). 
Several, but not all, virulent strains of N. meningitidis express MspA which is reported 
to mediate binding to both epithelial and endothelial cells when expressed in E. coli 
(Turner et al., 2006). 
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1.4.2. Nutrient acquisition 
Nutrient acquisition is critical once bacteria enter host cells. To date, almost nothing 
is known about the nutrient sources used by intracellular meningococci. Typical 
nutrients that are essential for pathogens and can limit growth during infections are 
iron and the carbon energy source which are studied in this thesis. 
1.4.2.1. Iron acquisition 
Although iron is one of the most abundant elements, it is scarcely available in 
physiological conditions because of its rapid oxidation from ferrous (Fe^ )^ to ferric 
(Fe^^) form which is insoluble and cytotoxic (Dunn et al., 2007). Therefore, iron is 
sequestered in the human host, intracellularly by ferritin and haemoproteins 
(Harrison and Arosio, 1996; Harrison et al., 1996; Knutson et al., 2003), and in the 
extracellular compartment by lactoferrin and transferrin (Baker et al., 2002). Gram-
negative pathogenic bacteria consequently express multiple outer membrane 
receptors to scavenge iron and siderophores. Many of these belong to the TonB 
dependent receptor (TBDRs) family. 
TBDRs rely on the inner membrane protein TonB to provide energy for the transport 
of ligands such as iron across the outer membrane (Wandersman and Delepelaire, 
2004). In pathogenic Neisseria spp. iron acquisition systems include a number of 
TBDRs for the host iron binding proteins transferrin (TbpA and TbpB) (Schryvers and 
Morris, 1988a; Gray-Owen and Schryvers, 1996) and lactoferrin (LbpA and LbpB) 
(Schryvers and Morris, 1988b; Bonnah and Schryvers, 1998). Haem, haemoglobin 
(Hb) and haptoglobin-haemoglobin (Hp-Hb) are utilised via two other distinct surface 
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receptors. HmbR is responsible for acquisition of haem and Mb, but not Hp-Hb 
(Stojiljl<ovic et al., 1996). The other receptor consists of an outer membrane protein 
HpuA and a lipoprotein HpuB that are essential for acquiring iron from Hb and Hp-Hb 
{Lewis et al., 1997). Until recently no pathogen had been demonstrated to use 
ferritin as an iron source. Larsson and colleagues have shown that N. meningitidis 
triggers the rapid redistribution and degradation of cytosolic ferritin within infected 
epithelial cells as a response to iron starvation although they did not show utilisation 
of this iron source (Larson et al., 2004), 
Some bacteria synthesise and secrete small molecules called siderophores. These 
chelate extracellular iron, which is then delivered to the cytoplasm via a surface 
located, cognate siderophore receptor, usually a TBDR. Interestingly, the 
meningococcus is unable to synthesise siderophores (West and Sparling, 1985) but, it 
can use siderophores secreted by other organisms occupying the same niche within 
the host. Both N. meningitidis and N. gonorrhoeae posess fetA, a homologue of the 
E. coli receptor FepA which binds ferric enterochelin, a siderophore. FetA is 
functional in N. gonorrhoeae (Carson et al., 1999), although the binding constant of 
FetA for enterochelin is significantly lower than for other enterochelin receptors. 
This suggests that an alternative, but structurally similar siderophore, or other human 
iron binding protein might be the true ligand of FetA (Carson et al., 1999). 
A recent screen of 576 mutants of N. meningitidis for genes necessary for 
colonisation of human nasopharyngeal tissue identified several genes including those 
involved in Tfp biogenesis, and a putative TBDR, NMB1829 (Exiey et al., 2009). TonB 
is necessary for the replication of N. meningitidis in epithelial cells (Larson et al., 
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2002) but nothing else is known of the contribution of individual TBDRs to the 
intracellular lifestyle of N. meningitidis in epithelial cells. 
1.4.2.2. Carbon metabolism 
Various studies have emphasised the importance of carbon metabolism in the 
survival of bacterial pathogens in vivo. For instance, enzymes required for reactions 
in the Entner-Doudoroff pathway (which catabolises glucose to pyruvate) are 
essential for the colonisation of E. coli in the gastrointestinal tract (Chang et al., 
2004). Furthermore the expression of isocitrate lyase, an enzyme in the glyoxylate 
cycle (which replenishes the TCA cycle), is upregulated by Mycobacterium 
tuberculosis in macrophages (McKinney et a!., 2000), and is necessary for survival in 
these cells (McKinney et a!., 2000). However, the glyoxylate cycle is not present in 
pathogenic Neisseria (www.genome.jp/kegg). 
With regard to exogenous carbon energy sources, the acquisition of lactate is 
necessary for H. influenzae to cause bacteraemic infection (Herbert et al., 2002) and 
work in our laboratory has shown that the meningococcal lactate permease is 
required for both nasopharyngeal colonisation and disseminated infection with N. 
meningitidis (Exley et al., 2005a; Exley et al., 2005b). Although the acquisition of 
lactate does not contribute to the adhesion of N. meningitidis to epithelial cells, 
nothing is known about its role in intracellular replication and epithelial traversal. 
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1.4.3. Capsule 
The meningococcus is able to survive and replicate in the bloodstream, despite 
exposure to the host immune system (van Deuren et al., 2000). Almost all bacterial 
strains isolated from the bloodstream express a polysaccharide capsule, while those 
recovered from the nasopharynx of carriers are frequently not encapsulated (Vogel 
and Frosch, 1999). The capsule of serogroup strains B, C, W-135 and Y consist largely 
of sialic acid (Liu et al., 1971b), while serogroup A strains have a capsule composed of 
mannosamine phosphate (Liu et al., 1971a). The capsule is required for prevention of 
complement-mediated bacteriolysis. Strains that do not express capsule are highly 
sensitive to complement (Mackinnon et al., 1993; Vogel and Frosch, 1999). 
Capsule is also important at earlier stages in pathogenesis and is required for survival 
and replication in epithelial cells (Nikulin et al., 2006; Spinosa et al., 2007) possibly by 
conferring resistance to CAMPs (Spinosa et al., 2007). It is also interesting that the 
capsule is antiphagocytic, with lower levels of adhesion seen for capsulated strains 
than unencapsulated strains (Stephens et al., 1993; Hammerschmidt et al., 1996a; 
Virji et al., 1996). 
1.4.4. LPS 
LPS is composed of a hydrophobic region (lipid A) inserted in the outer membrane, 
and a hydrophilic inner core portion composed of carbohydrates. In 
Enterobacteriaceae, the '0-antigen' (consisting of repeating saccharide subunits) is 
attached to the extracellular end of the inner core, but this is lacking in the 
meningococcus (Kahler and Stephens, 1998; Vogel and Frosch, 1999). Instead two 
49 
short carbohydrate chains, the a-and p-chains, extend from the inner core portion of 
meningococcal LPS which includes heptose and ketodeoxyoctonate residues (Kahler 
and Stephens, 1998). The differences in the side chain composition of strains allows 
them to be grouped into immunotypes (Tsai et a!., 1983). 
The LPS of N. meningitidis has multiple roles in virulence including the triggering of 
inflammation and complement evasion. LPS also contributes to colonisation, as LPS-
deficient strains are impaired for adhesion to, and invasion into, epithelial cells 
(Albiger et ol., 2003). Septic shock, the most serious manifestation of meningococcal 
infection, results from an overactivation of host inflammatory responses to bacterial 
components, particularly LPS (Kahler and Stephens, 1998). Meningococcal LPS is 
released during infection from the bacterial surface in blebs, and the lipid A portion is 
a potent trigger of production of pro-inflammatory cytokines and chemokines 
including IL-1, IL-6 and TNFci {Vermont et al., 2002; van der Ley and Steeghs, 2003). 
Plasma concentrations of LPS correlate with disease severity and outcome (van der 
Ley and Steeghs, 2003; Plant et al., 2006). 
1.4.5. Phase variation 
Phase variation is the reversible switching on and off of surface antigens and is 
important for evasion of the host immune response. It primarily occurs through a 
process known as slipped strand mispairing at sites of repetitive nucleotide 
sequences within or upstream of genes, that cause DNA slippage during replication 
(Jennings et al., 1999). A number of virulence factors are subject to phase variation. 
For instance, the antigenic structure of LPS varies as a result of phase variation in the 
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LPS biosynthetic genes (Jennings et al., 1999) while Tfp are phase variable as a result 
of on/off switching of pilC expression (Hamrick et al., 2001), as described in section 
1.4.1.1. The capsule (Hammerschmidt et al., 1996b) and opacity proteins (Stern et 
a!., 1986) are also subject to phase variation. 
1.5. Host cell pathways with potential roles In traversal 
It is likely that during traversal of the respiratory epithelial monolayer, the 
meningococcus will interact with components of the host cells. Indeed some of these 
interactions may be vital to the passage of the bacteria. The use of drugs and 
chemical inhibitors that disrupt host cell pathways should provide insights into the 
route used by the bacteria. Indeed N. gonorrhoeae traversal has been shown to 
involve cytoskeletal components and microtubule motors (Wang et al., 2007). In this 
thesis a number drugs affecting a variety of host cell pathways (including cytoskeletal 
components) were used (Table 1). 
1.5.1. Modulating the microtubule network 
Microtubules consist of polymerised chains of tubulin heterodimers, with each dimer 
consisting of an a and P subunit. When the GTP bound state of tubulin is prevalent, 
these dinners polymerise causing microtubule elongation. However, when the GDP 
bound form is more abundant, microtubules depolymerise. This leads to a 
phenomenon known as dynamic instability where microtubules elongate and retract, 
with rapid transitions between the two states [reviewed in (Erickson and O'Brien, 
1992)]. 
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Table 1. The mode of action and targets of chemical inhibitors used in the study 
Host Target Chemical Inhibitor Basis of Activity 
Actin Cytoskeleton Cytochalasin D Binds and stabilises actin 
filaments 
Latrunculin D Binds and sequesters actin 
monomers 
Microtubule Networl< Colchicine Binds and sequesters tubulin 
dimers 
Nocodazole Stimulates GTPase activity of p-
tubulin, depolymerising 
microtubules 
Taxol Inhibits disassembly of 
microtubules 
Vinblastine De-polymerises microtubules 
Endocytosis Amiloride Inhibits macropinocytosis 
M-D Inhibits clathrin mediated 
endocytosis 
Molecular Motors Sodium orthovanadate Inhibits dynein 
BDM Inhibits the myosin ATPase 
ATP synthesis Sodium azide Inhibits mitochondrial respiration 
via cytochrome C oxidase 
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Nocodazole is a synthetic compound, developed as an anti-cancer drug (Atassi et al., 
1975). At low concentrations it stops polymerisation of tubulin subunits in vitro 
(Hoebeke et al., 1976). In cultured cells nocodazole causes depolymerisation of 
microtubules, and prevents cells progressing through mitosis (De Brabander et al., 
1976). 
Nocodazole stimulates the intrinsic GTPase activity of ^-tubulin increasing the cellular 
pool of GDP bound tubulin dimers and causing depolymerisation of microtubules 
(Vasquez et al., 1997). A major side effect of nocodazole treatment is disruption of 
the Golgi apparatus (Turner and Tartakoff, 1989; Dinter and Berger, 1998). Other 
pleiotropic effects include induction of apoptosis in some cell lines, cell cycle arrest 
and alteration of cell shape (De Brabander et al., 1976). Clearly these side effects 
could have serious consequences for the state of the polarised cell monolayer model. 
Colchicine is a toxic alkaloid originally extracted from plants of the genus Colchicum. 
The drug prevents microtubule polymerisation by binding to the tubulin subunits and 
blocking their polymerisation (Borisy and Taylor, 1967). Similar to nocodazole, 
colchicine affects cell division and potentially cell shape as well. Other drugs that 
affect the microtubule network include taxol, which inhibits the depolymerisation of 
tubulin subunits (Horwitz, 1992), and vinblastine, which depolymerises microtubules 
(Wang et al., 2007). 
1.5.2. Disruption of the actin cytoskeleton 
Actin forms filaments within the cell that are necessary for a huge range of functions 
including phagocytosis, cell motility and maintenance of cell junctions. Cytochalasins 
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are fungal toxins that bind to actin filaments and block their polymerisation and 
depolymerisation (Cooper, 1987). There are numerous cytochalasins of which 
cytochalasin D is the most widely used. It binds to the barbed end of the actin 
filament where actin polymerisation occurs. This binding irreversibly caps the end of 
the filament preventing further polymerisation or depolymerisation (Flanagan and 
Lin, 1980; Morris and Tannenbaum, 1980; Brown and Spudich, 1981; Detmers et al., 
1983). A single cytochalasin D molecule can cap an actin filament (Cooper, 1987). 
Latrunculin A is purified from Latrunculia magnificans, a Red Sea sponge that exudes 
a noxious, red fluid that can kill fish within minutes. Two related compounds, 
latrunculin A and latrunculin B, can be isolated from this fluid. In contrast to 
cytochalasin D, latrunculins depolymerise actin structures both in vitro and in vivo 
(Kashman et al., 1980; Spector et al., 1983; Coue et al., 1987). Latrunculin only binds 
to monomeric actin preventing polymerisation (Morton et al., 2000). 
Although the ability of cytochalasin D to disrupt tight junctions has been studied 
(Madara et al., 1986), recent study found that both cytochalasin D and latrunculin A 
had no effects on the integrity of a T84 cell monolayer (Wang et al., 2007). 
1.5.3. Inhibitors of endocytosis 
The form of endocytosis known as macropinocytosis refers to the formation of larger 
scale endocytic vesicles of irregular size and shape, generated by actin-driven 
invagination of the plasma membrane (Swanson and Watts, 1995; Amyere et al., 
2002). It is usually accompanied by cell surface ruffling (Swanson and Watts, 1995; 
Conner and Schmid, 2003) which relies on outward-directed actin polymerization 
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creating membrane protrusions that surround the phagocytic target. The entry of a 
number of intracellular pathogens such as Salmonella spp and Shigella flexineri 
closely resembles macropinocytosis. Entry of Neisseria also bears some resemblance 
to this process with recruitment of ezrin, cortical actin and cortactin to the site of 
invasion (Nassif et ai, 2002). Amiloride specifically blocks macropinocytosis (West et 
al., 1989). This compound is an inhibitor of the Na^/H^ exchange protein in the 
plasma membrane. It is not clear why it specifically inhibits macropinocytosis. 
Clathrin-mediated endocytosis (CME) is the best characterised endocytic pathway 
(Lamaze and Schmid, 1995; Takei and Haucke, 2001). CME occurs constitutively in all 
mammalian cells and is responsible for the continuous uptake of essential nutrients, 
antigens, growth factors, and pathogens (Takei and Haucke, 2001). Monomers of the 
18 kDa clathrin protein interact to assemble into a polyhedral lattice that encloses 
cytosolic vesicles (Pearse, 1976). Internalisation through CME involves binding of 
ligands to specific cell surface receptors (e.g. transferrin receptor [Tfr]) and 
recruitment of a clathrin lattice by adaptor proteins (e.g. Adaptor protein-2 [AP2]) 
that bind the cytosolic domains of the receptors (Takei and Haucke, 2001; Conner 
and Schmid, 2003; Doherty and McMahon, 2009). This is followed by invagination 
and pinching off of the coated pits from the plasma membrane, to form intracellular 
clathrin-coated vesicles. The clathrin and adaptor proteins are then recycled. Mono-
dansycadaverine (M-D) blocks the endocytosis via CME (Davies et ol., 1980). 
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1.5.4. Inhibition of mitochondrial respiration 
Sodium azide inhibits mitochondrial respiration by reducing the activity of respiratory 
chain complex IV (cytochrome C oxidase) (Bennett et al., 1996). The drug has been 
used along with other energy poisons to investigate the metabolic requirements for 
repair of the gastric mucosa in bullfrogs (Cheng et al., 2001). In this situation, sodium 
azide had no affect on the ability of cells to polarise and form tight junctions. 
1.5.5. inhibitors of molecular motors 
Motor proteins bind to elements of the host cell cytoskeleton and are responsible for 
active trafficking of cargo, including large vesicles, along the cytoskeleton. Vacuoles 
containing meningococci may utilise these motors to traverse the intracellular milieu. 
The actin cytoskeleton is bound by myosin motors. Inhibition of the myosin ATPase 
by 2,3 butane-dione monoxime (BDM) should prevent of force generating 
actin/myosin interactions without disruption of cell morphology (Simpson and 
Armstrong, 1999). 
Microtubules are bound by the motor proteins kinesin and dynein. The phosphatase 
inhibitor sodium orthovanadate (Na3V04) inhibits dynein although it also has a 
number of other effects on the cell, although its non specific inhibition of 
phosphatases (Swarup et al., 1982). There is a notable lack of inhibitors of kinesin. 
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1.6. Experimental models to Investigate meningococcal passage 
across the nasopharyngeal epithelium 
Traversal of the respiratory epithelium in the nasopharynx by the meningococcus is 
an important stage in the development of this potentially fatal disease. Paradoxically 
it is also one of the least studied and poorly understood stages of infection. The main 
reason for this is the shortcomings w/ith the current experimental models. 
Infection of semi-confluent cells grown on solid substrates has provided much 
information on the processes of bacterial adherence, invasion and intracellular 
survival, but is of little use in the understanding of traversal. The lack of apical-basal 
differentiation may fundamentally affect the way in which the bacteria interact with 
cells and obviously there is no route for basolateral escape. To study traversal, there 
must be a route for basal exit of bacteria. Ideally, cells should be of respiratory 
origin, and organised into a differentiated, polarised monolayer, linked by tight 
junctions, to mimic the epithelial barrier properties encountered by the pathogen in 
the nasopharynx (Reznik, 1990). 
Unfortunately, the human specific nature of the meningococcus also precludes the 
use of animal models to examine nasopharyngeal traversal, although studies using 
explanted human nasopharyngeal and tonsillar tissue have been performed 
successfully (Stephens et al., 1983; Stephens et al., 1993; Rayner et al., 1995; Read et 
al., 1995; Townsend et al., 2002). However, the use of surgically resected tissue from 
different individuals necessarily introduces variation due to host-to-host differences. 
Furthermore removed tissue is likely to be abnormal by its nature. Organ culture is 
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technically demanding, expensive and the short supply of appropriate tissue means 
that experiments can be time consuming and small scale, making quantitation of 
host-pathogen interactions problematic (Merz et al., 1996). The organ culture model 
is well suited to analysing the interaction of bacteria with host tissue. However, the 
complexity of the tissue makes it difficult to define specific pathways of traversal. 
These problems can be avoided by growing cells on permeable membranes in cell 
culture inserts where they form a differentiated monolayer with a basolateral route 
of escape (Fig. 1.5). As mentioned above, experiments involving infection of layers of 
cultured cells with N. meningitidis have been performed in three studies. Two used 
polarised monolayers of T84 human intestinal epithelial cells (Merz et al., 1996; Pujol 
et al., 1997) while the other used a using a bi-layer of cells separated by a permeable 
culture insert (Birkness et al., 1995). Hec-l-B endometrial epithelial cells and HMEC 
endothelial cells were grown on the apical and basolateral surfaces of the membrane 
respectively (Birkness et al., 1995), however, the epithelial cells in this model do not 
become polarised. These experiments provide the only attempts to directly study 
meningococcal traversal of epithelial cells and are limited by the origin of the cell 
lines used. To date no experiments have been performed on a differentiated 
monolayer of respiratory epithelial cells, which would be the model of choice when 
the natural route of infection of the pathogen is considered. 
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Figure 1.5 Growth of differentiated cell monolayers 
Calu-3 cells were seeded at a density of 4 x 10^ on cell culture in inserts in 
12 well plates. Cells were left for five days with the media changed every 
other day. 
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1.7. Calu-3 cells and modelling the airway epithelial barrier 
Calu-3 human bronchial epithelial cells are one of the few respiratory cell lines that 
can be grown on porous membranes and differentiated to form tight junctions, 
allowing it to be used as a model of the respiratory epithelial barrier (Shen et al., 
1994; Foster et al., 2000; Ehrhardt et al., 2002; Florea et al., 2003). The cell line 
exhibits morphological features of differentiated, functional human airway epithelial 
cells (Shen et al., 1994; Grainger et al., 2006) summarised in Fig. 1.6. Studies have 
also shown that Calu-3 cells provide a model of airway transport and metabolism 
(Florea et al., 2003). For example, monolayers show cAMP dependent chloride (CI) 
secretion, and express the cystic fibrosis transmembrane conductance regulator 
(CFTR) (Shen eto/., 1994). 
These features have led to the Calu-3 cell line becoming the principal cell line for in 
vitro research into tracheobronchial epithelial permeability and they have been used 
extensively in studies of drug delivery and toxicity (Cavet et al., 1997; Ehrhardt et al., 
2002; Pezron et al., 2002; Fiegel et al., 2003; Cooney et al., 2004; Li et al., 2006a). 
Furthermore the expression of CFTR has allowed its use for cystic fibrosis (CF) 
research (Li et al., 2006b) and with the CF-associated pathogens Pseudomonas 
aeruginosa (Hogardt et al., 2007) and Burkholderia cepacia (Duff et al., 2006). Calu-3 
monolayers have also been used to study several viral respiratory infections including 
the Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) (Sims et al., 2007). 
Although this cell line is derived from the bronchial epithelium, it is relevant for 
studying the biology of the meningococcus as the respiratory tract is lined by a 
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pseudostratified columnar epithelium from the posterior nares down to the distal 
bronchioles (Drettner and Aust, 1977; Reznik, 1990). Growing Calu-3 cells on porous 
membranes and allowing them time to differentiate and polarise provides N. 
meningitidis with both a basolateral route for escape and an respiratory epithelial cell 
barrier very similar to that encountered in the nasopharynx. 
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1.8. Aims 
The overall aim of this thesis was to investigate the traversal of the nasopharyngeal 
epithelium by N. meningitidis. This involved developing a physiologically relevant cell 
culture model of the upper airway using Calu-3 cells and using it to investigate the 
interactions of N. meningitidis with a polarised, differentiated, respiratory 
epithelium. Specifically, the model would allow the route of meningococcal traversal 
to be defined, and enable identification of the bacterial and host factors involved. 
Such a model would be a valuable tool for investigating other aspects of early 
infection such as colonisation and adhesion. Understanding of the important early 
phases of infection, before the meningococcus reaches the blood, is essential for our 
knowledge of pathogenesis and could lead to the development of interventions, such 
as prophylactic vaccines, to prevent this important human infection. 
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2. MATERIALS AND METHODS 
2.1. Bacterial strains and growth conditions 
Neisseria strains were cultured in Brain Heart Infusion broth (BHI, Oxoid, 37 g 
dissolved in 1 L dHzO with 1 g soluble starch, BDH, Merck) or on BHI agar (1 % wt/vol) 
supplemented with Levinthai's base [500 ml defibrinated horse blood (Sigma, UK) 
autoclaved with 1 L BHI broth]. Meningococci were grown on solid media at 37 °C 
with 5 % CO2 for 16-18 hours. E. coli and Solmonello enterica serovar typhimurium (S. 
typhimurium) were grown in Luria-Bertani broth (20 g LB medium, Gibco, BRL 
dissolved in 1 L distilled dH20) at 37 °C with shaking, or on LB agar (1.5 % wt/vol. Agar 
No.l, Oxoid). Bacteria were stored in media containing 15 % glycerol at -80 °C. The 
strains used in this work are shown in Table 2. 
Table 2. - Strains used in the study 
Species Strain Description Antibiotic 
resistance 
Origin/references 
N. meningitidis MC58 
Serogroup B clinical 
isolate. ET-5 
Opa+/Opc+ 
Isolated in the UK 
in 1989 
(Virji et al., 1993) 
MC58eGFP MC58 strain carrying 
plasmid pEG2 
Ery (Christodoulides 
et al., 2000) 
MC58Anmbl882 Tn5 inserted in 
nmbl882 
Kan R. Exiey, 
unpublished 
MC58Anmbl829 Deletion mutant of 
nmbl829. 
Tet (ExIey et a!., 
2009) 
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Species Strain Description 
MC58Mmbl829 Anmbl829 mutant 
complemented carrying pYHS25 1829 
MC58Ap/7f 
MC58As/aD 
MC58A/ctP 
Transposon inserted 
in pilE. Tfp deficient. 
Deletion of 
polysialyltrasferase. 
Capsule deficient. 
Tn5 inserted in IctP 
Antibiotic Origin/references 
resistance 
Ery (Exley et al., 
2009) 
Kan (Lappann eto/., 
2006) 
Ery (Hammerschmidt 
et al., 1996a) 
Kan (Exley et al., 
2005b) 
E. coli ToplO 
DH5a 
S. typhimurium 12023 pFXR 25.1 Wild type S. 
typhimurium 
expressing GFP 
Invitrogen 
Invitrogen 
National Type 
Culture Collection 
2.2. Antibiotics 
A list showing the antibiotics and the concentrations used for N. meningitidis and E. 
coli is shown in Table 3. 
Table 3. - Antibiotics and the concentrations used in this study 
Antibiotic Solvent N. meningitidis E. coli 
Kanamycin HzO 100 |ig/ml 50 ng/ml 
Tetracycline H2O 15 ng/ml 2.5 |ig/ml 
Carbenicillin H2O - 50 ng/ml 
Erythromycin Ethanol 2 |ig/ml 200 ng/ml 
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2.3. Molecular biology 
2.3.1. Agarose gel electrophoresis and DNA purification 
DNA was combined with gel loading buffer (0.25 % bromophenol blue, 0.25 % xylene 
cyanol, 30 % glycerol) and seperated on 0.8-1 % agarose (Gibco, BRL) gels in Ix Tris 
acetate ethylenediaminetetraacetic acid (EDTA) buffer (TAE) (0.4 M Tris, 0.01 M 
EDTA-Na2-salt, 0.2M L acetic acid). DNA was visualised using SYBR Safe™ 
(Invitrogen), under ultraviolet (UV) light. Fragments were excised from gels using a 
scalpel and purified using the QIAquick® gel extraction kit (Qiagen) according to the 
protocol provided by the manufacturer. 
2.3.2. Polymerase chain reaction 
Polymerase Chain Reaction (PGR) was carried out using either Taq polymerase 
(Sigma) or Expand PGR High Fidelity Polymerase (Roche). In all cases the reaction 
conditions recommended by the manufacturer were used. When required the PGR 
products were purified using a commercially available PGR purification kit (Qiagen). 
2.3.3. Restriction endonuclease digestion of DNA 
DNA digestion was carried out using restriction endonucleases in reaction conditions 
advised by the manufacturer (New England Biolabs). In general reaction volumes of 
40|il were used. Digestion products visualised as described above and purified using 
the QIAquick® gel extraction kit (Qiagen). 
66 
2.3.4. DNA ligation 
Ligations were performed in two ways. Quick-Stick Ligase (Bioline) was used in the 
first instance, according to the manufacturer's instructions, in a reaction volume of 
10 lil. When this was unsuccessful, ligations were carried out overnight at room 
temperature using T4 DNA ligase (Invitrogen), under recommended reaction 
conditions. 
2.3.5. Transformation 
E. coli was transformed using the heat shock method. DNA was added to 50 \x\ of E. 
co// TOP 10 competent cells (Invitrogen) which were then kept on ice for 30 minutes. 
After a heat shock at 42 °C for 45 seconds, the mixture was left on ice for two 
minutes, then 250 \x\ of SOC medium was added. The cells were incubated at 37 °C 
with continuous shaking (200 rpm) for one hour then plated to the appropriate 
selective media. 
N. meningitidis is naturally competent for transformation. Bacteria were grown 
overnight on solid media. Approximately half a loop of bacteria was harvested from 
plates and resuspended in phosphate buffered saline (PBS). A 10 p.1 drop of the 
bacterial suspension was placed on a fresh agar plate. Once dry, this drop was 
overlain by a 10 pil drop of PBS containing 1-2 |ig of DNA. After a four hour 
incubation the bacteria were transferred to a fresh agar plate containing appropriate 
antibiotics. 
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2.3.6. Isolation of plasmid and genomic DNA 
For preparation of genomic DNA from N. meningitidis bacteria were grown overnight 
on solid media. Approximately half a loop of bacteria was harvested from plates and 
resuspended in 560 p.1 TE (10 mM Tris, pH 7.6, 1 mM EDTA), 30 }il of 10 % SDS 
(wt/vol) and 3 jil of 20 p-g/ml proteinase K (Sigma, UK). The mixture was then 
incubated for one hour at 37°C after which 100 |j.l of 5 M NaCI and 80 p.! of cetyl-
trimethyi-ammonium bromide/NaCI (10 % CTAB, Sigma; 0.7 iVI NaCI, BDH) were 
added. The solution was then incubated at 65 °C for 10 minutes. The aqueous layer 
was transferred to a 1.5 ml tube and one volume of phenol pH 
7.5/chloroform/isoamyl alcohol (25:24:1) (BDH, Merck) was added. The mixture was 
vortexed then centrifuged at 16,000 xg for 20 minutes. The aqueous layer was 
retained and two volumes of 100 % ethanol were used to precipitate the DNA, which 
was pelleted by centrifugation at 16,000 xg for five minutes. The DNA pellet was 
then washed with 70 % ethanol and air-dried before finally being resuspended in TE 
containing RNAse (100 pig/ml, Sigma U.K.). 
For the purification of plasmid DNA from E. coli, the QIAprep Spin Miniprep kit 
(Qiagen) was used following the protocol provided by the manufacturer. A list of 
plasmids used in the study is shown in Table 4. 
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Table 4. - Plasmids used in the Study 
Plasmid Description/Origin 
pEG2 (Christodoulides et ai, 2000) 
pEGFP-Nl CLONETECH laboratories inc. 
pReSI - Puro (Frank et al., 2006) 
pshRNA-Mock (Frank et al., 2006) 
pshCD46 1 This study 
pshCD46 2 This study 
pshCD46 3 This study 
pshCD46 4 This study 
2.3.7. Design of shRNA constructs against CD46 
Candidate 21 base target sequences for shRNA (short hairpin RNA) were identified in 
the coding sequence of human CD46, using recommended rules [(Frank et a!., 2006); 
Frank Scott personal communication], and named shCD46 1-4. Complementary DNA 
oligonucleotides were designed so that shRNAs would be produced when they were 
ligated into a mammalian expression vector. To do this, the sense and antisense 
target sequences were linked by a 15 base stem loop forming sequence and a Pollll 
terminator was added to the 3' end. In addition, restriction sites were added to the 
ends of the oligonucleotides to facilitate cloning. BamhW and HinDlW sites were added 
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to the 5' and 3' ends respectively, and a C/ol site was introduced close to the 3'end to 
allow conformation of ligation at later stages of cloning. The sequences of shRNA 
constructs shCD46 1-4 are shown in Table 5. 
Table 5. - Oligonucleotides used to make shRNA constructs 
Target Name Nucleotide sequence 5' -> 3' 
shRNA CD46-lnc G A T C C C G A G G A G C C A C C A A C A T T T G A A G C C C G G G C C G C C C T C T T C A A A T G T T G G T G G C T C C T C I I L L MGGAAATCGATA 
shCD46 1 shRNAjCD46-lC_ AGCTTATCGATTTCCAAAAAAGAGGAGCCACCAACATTTGAAGAGGGCGGCCCGGGCTTCAAATGTTGGTGGaCCTCGG 
shRNA CD46-2nc: GATCCCGTAATGAGGGTTATTACnAAGCCCGGGCCGCCCTCnAAGTAATAACCCTCATTACTTTTTTGGAAATCGATA 
^ shRNA CD46-2C AGCTTATCGATTTCCAAAAAAGTAATGAGGGTTATTACTTAAGAGGGCGGCCCGGGCTTAAGTAATAACCACATTACGG 
shRNA CD46-3nc: GATCCCGTAAGCCCCCAATATGTGAAAGCCCGGGCCGCCCTCTTTCACATATTGGGGGCTTACTTTTTTGGAAATCGATA 
ShCD46 shRNA CD46-3c: AGCTTATCGAMCCAAAAAAGTAAGCCCCCAATATGTGAAAGAGGGCGGCCCGGGCTTTCACATATTGGGGGCTTACGG 
shRNA CD46-4nc: GATCCCGCTGCCTCCATCTAGTACAAAGCCCGGGCCGCCCTCTTTGTACTAGATGGAGGCAGCTTTTTTGGAAATCGATA 
ShCD46 4 CD46-4C AGCTTATCGATTTCCAAAAAAGCTGCCTCCATCTAGTACAAAGAGGGCGGCCCGGGCTTTGTACTAGATGGAGGCAGCGG 
KEY: Restriction site Sense CD46 sequence Linker Antisense CD46 sequence Pollll terminator sequence 
2.3.8. Annealing single stranded DNA oligonucleotides 
The complementary single stranded DNA oligonucleotides (Sigma) were diluted to 
500 |j.M in dHzO, and 10 p.1 of each complementary oligonucleotide was mixed with 
10 |il of 5x annealing buffer (0.5 M NaCI, 50 mM Tris 7.4) and 20 |al of H2O. The 
mixture was boiled for five minutes in a water-bath and then left to cool to room 
temperature overnight to allow annealing. 
2.4. Human Tissue Culture 
The human bronchial epithelial cell line Calu-3 was kindly provided by Dr Clive 
Robinson (St George's Hostpital, London) and cultured in Dulbecco's Modified Eagle 
Medium: Nutrient Mixture F-12 (DMEM/F12) (Invitrogen). The Chang human 
conjunctival epithelial cell line was cultured in RPMl 1640 media (invitrogen). The 
human epithelial HeLa cell line was maintained in Dulbecco's modified Eagle's 
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medium (DMEM) (Invitrogen). The amphitropic packaging cell line Phoenix was a 
kind gift from Dr Andrew Peden (Dept. Pathology, University of Cambridge) and 
maintained in DMEM. COS-7 cells were cultured in RPMI 1640. All media was 
supplemented with Glutamax™ {Invitrogen), and 10 % foetal calf serum (PAA 
Laboratories). All cells were incubated at 37 °C in 5 % CO;. 
2.4.1. Seeding cells for studies of semi-confluent layers 
Cells were seeded onto round 13mm diameter cover slips (VWR) in 24 well plates and 
grown to semi-confluency overnight. For Calu-3 cells a density of 4 x 10^ cells/well 
was used, while for Chang cells a density of 5 x lO"^  cells/well was used. 
2.4.2. Growth of differentiated respiratory epithelia 
Cell monolayers were grown on 1 p.m pore size BD Falcon™ cell culture inserts (BD 
Bioscience) containing polyethylene terephthalate (PET) membranes in 12 well tissue 
culture companion plates (BD Bioscience) (Fig. 1.5). Membranes had a surface area 
of approximately 1 cm^. Prior to seeding, membranes were coated with a mixture of 
fibronectin (5 [ig per cm^ BD Bioscience) and laminin (10 pg per cm^, BD Bioscience). 
Except where stated, liquid covered culture (LCC) monolayers were used for 
experiments. For LCC, Calu-3 cells were seeded into the apical chamber at a density 
of 4 X 10^ cells per membrane and maintained with 1 ml of culture medium in the 
apical chamber and 1.5 ml in the basal chamber. Cells were allowed to grow and 
differentiate for five days, with the media changed every second day. For air 
interface culture (AlC), cells were seeded in the same way but the apical media was 
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removed after two days; media in the basolateral chamber was changed every 
second day. 
2.4,3. Monitoring monolayer integrity 
The integrity of monolayers was monitored by mearsuring the trans-epithelial 
electrical resistance (TEER) with an EVOM TEER meter attached to STX chopstick 
electrodes (WPI) (Fig. 4.1). Only LCC monolayers with TEER value of over 1400 Q 
were used in experiments. For air interface culture (AlC) monolayers, 1 ml of 
medium was added to the apical chamber immediately before measurement of TEER 
then removed again. 
Texas Red labelled 70,000 MW dextran (final concentration 0.1 |j.M, Invitrogen) was 
added to the apical chamber of cell culture wells. Samples were taken from the 
basolateral chamber at times afterwards, and fluorescence analysed with a 
spectrophotometer (Varian Gary Eclipse). 
2.5. Growth of N. meningitidis for infection of cultured cells 
Meningococci were grown overnight on BHI plates with antibiotics as appropriate. 
Bacteria were harvested from plates with a sterile loop and re-suspended in 400 |il of 
PBS. A 20 |il aliquot of the suspension was added to 980 |il of P2 Lysis Buffer 
(Qiagen). After mixing thoroughly, the ODzeo was measured to calculate the number 
of colony forming units (CFU) (given that 10® CFU/ml gives an OD Aaeo of 1.8). The 
suspension was then diluted to the required multiplicity of infection (MOI) in the 
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appropriate media. All inocula consisted of 1 ml of a bacterial suspension per well 
except for infection of AlC layers where a 200 nl inoculum volume was used. 
2.6. Infection of semi-confluent cells 
Semi-confluent cells were infected at an MO! of 100. Media was removed from cell 
culture wells and replaced with media containing the inoculum. Cells were incubated 
with bacteria for five hours before fixation with 3 % PFA as described in section 
2.12.1. 
2.7. Adhesion to polarised monolayers 
Adhesion assays were performed by challenging polarised monolayers with bacteria 
at an MOI of 40. After three hours, monolayers were rinsed with Hank's buffered 
saline solution (HBSS) (Invitrogen) then treated with 1 % saponin to lyse cells and 
release all cell associated bacteria. The number of bacteria was enumerated by 
plating to solid BHI media. The influence of purified CD46 on adhesion was assessed 
by adding the purified protein to bacteria prior to infection of cells. The inoculum 
was prepared at the required MOI as described in section 2.5 except for the addition 
of 6.25 ng of purified CD46 per 10^ bacteria. Bacteria and CD46 were incubated 
together at 37 °C for 30 minutes, and then added to cells. 
2.8. Recovery of intracellular bacteria 
For recovery of intracellular bacteria, Calu-3 monolayers were challenged with 
bacteria at an MOI of 40. At 8 or 24 hours after inoculation, monolayers were 
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washed three times with PBS on their apical and basolateral surfaces then incubated 
with 200 lig/ml gentamicin for 30 minutes. Cell culture inserts were washed three 
times with PBS, and cells were lysed by treatment with 1 % saponin in PBS for five 
minutes. The number of intracellular bacteria was established by plating serial 
dilutions of the lysate to solid media. 
2.9. Competitive traversal assay 
Caiu-3 monolayers were prepared as described above. Media in the apical and basal 
chambers of monolayers was replaced immediately prior to infection. Inocula were 
prepared, consisting of a 1:1 ratio of mutant and wild type bacteria at a final MO! of 
40. The ratio of strains in inocula was confirmed by plating of serial dilutions to solid 
media with and without antibiotics. 
Media in the apical chamber was replaced with 1 ml of the prepared inoculum. After 
seven hours, the cell culture insert was washed thoroughly with PBS and transferred 
to a new well containing 1.5 ml of sterile culture media. After one hour a sample of 
media was taken from the basolateral chamber and the ratio of strains in this output 
was quantified by serial dilution and plating to solid media with and without 
antibiotics. This procedure was repeated at 23 hours post-challenge. 
A well containing no cells was included in all experiments to monitor the relative 
growth of both strains. The competitive index was calculated by dividing the ratio of 
mutant to wild-type in the output by the ratio in the input, and was expressed 
logarithmically as the LogCI. 
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2.10. Challenge of cells with Salmonella 
Cultured cells were infected with S. typhimurium expressing GFP and grown to 
exponential phase, as previously described (Beuzon et al., 2000). Briefly, bacteria 
were cultured in 5 ml LB broth overnight then sub-cultured into fresh LB and grown 
until the OD Aeoo was between 0.4 and 0.6. Bacteria were enumerated and diluted in 
DIVIEM to give an MO! of 100 then added to the cells and incubated for 15 minutes at 
37 °C in 5 % CO2. Next, samples were washed three times with DMEM and incubated 
in DMEM containing 100 |J,g/ml gentamicin for one hour, after which the media was 
replaced with DMEM containing gentamicin at 20 pg/ml for a further 8 hours 
2.11. Transfection of cultured cells 
For transfection of cells in the well of a 24 well plate, culture media was removed and 
replaced with 400 |il of Optimem (Invitrogen). Plasmid DNA was diluted to the 
required concentration in 50 \i\ of Optimem and mixed thoroughly. In a separate 
tube, 2 \i\ of Lipofectamine 2000 (Invitrogen) was added to 50 \i\ of Optimem, mixed 
thoroughly and left to stand at room temperature for five minutes. The 
DNA/Optimem mix was then added to the Lipofectamine/Optimem mix, and left at 
room temperature for 20 minutes. The mixture was then added drop-wise to the 
cells and the plate swirled briefly to ensure even distribution of the mixture over 
cells. Plates were then incubated at 37 °C with 5 % CO2. After five hours the 
transfection mixture was replaced with the normal culture medium but with 
additional penicillin/streptomycin (100 units/ml and 100 [ig/ml, respectively) 
(Invitrogen). 
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For transfection of cells in a 6 well plate the same protocol was used except culture 
media was replaced with 1500 \i\ of Optimem, the Lipofectamine and DNA dilutions 
were made in 250 pil of Optimem, and 8 pil of Lipofectamine was used per well. 
2.12. Fixation, labelling and staining 
2.12.1. Fixation for immuno-fluorescence 
Samples were washed twice with PBS, fixed for 15 minutes at room temperature in 
500 nl 3 % paraformaldehyde (PFA) in PBS, then washed three times with PBS. 
Methanol was also used to fix when the pAb a-P-tub E7 (see Table 6) was used. In 
this case 500 \i\ of methanol, chilled to -20 °C, was added to samples, which were left 
at -20 °C for five minutes, then rinsed twice with PBS. Cell culture membranes were 
fixed and then excised from the inserts using a scalpel to be immuno-labelled. 
2.12.2. Permeabilisation 
Following fixation, samples were washed three times in PBS then permeablised in 
one of three ways. Usually, samples were exposed for 15 minutes to 0.2 % Triton X-
100 (T X-100), then washed thoroughly with PBS. In some cases, fixed cells were 
permeablised by adding 0 1 % (w/vol) saponin in PBS. 0.1 % saponin was then 
included in all antibody labelling and washing steps except the final dHzO wash prior 
to mounting. Streptolysin 0 (SLO) (Sigma) was also used to permeablise cells. Stocks 
was prepared in PBS and stored at -20 °C. Aliquots were then thawed and activated 
by a 15 minute incubation on ice in 100 mM dithiothreitol (DTT) (Sigma). Activated 
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SLO (250 units) were added to each coverslip and left for 10 minutes on ice. Samples 
were then washed three times in PBS. 
2.12.3. Immuno-labelling and staining for fluorescence microscopy 
Samples were incubated with primary antibodies for one hour at room temperature, 
then washed three times in PBS and incubated with the appropriate, fluorescently 
conjugated, secondary antibodies for 45 minutes at room temperature. Actin was 
stained with fluorescently labelled phalioidin which was added with the secondary 
antibodies. Cholesterol was labelled with filipin (Sigma) which was prepared in 
DMSO at 50 mg/mi under argon or nitrogen, stored at -20°C and protected from 
light. Stocks were diluted 1:250 in PBS and added to fixed cells, for 15 minutes at 
room temperature. 
2.12.4. Differential labelling of intracellular and extracellular bacteria 
To label extracellular bacteria infected cells were incubated for one hour with an a-
LPS 3,7,9 mAb, after which cells were washed twice in PBS then incubated for 
30 minutes with an a-mouse IgG RRX-conjugated secondary antibody. Next samples 
were permeablised by treatment with 0.2 % T X-100 in PBS, and the labelling process 
repeated with a Cy2-conjugated a-mouse IgG secondary antibody to label both 
intracellular and extracellular bacteria. Host cell structures were labelled after 
permeabilisation. In experiments with bacteria expressing GFP, the second labelling 
step was omitted. 
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2.12.5. Mounting and examination of fluorescently labelled samples 
Labelled cells on cover slips were washed twice in PBS, then in dHiO and mounted in 
Prolong Gold (Invitrogen). Usually, labelled membranes were mounted cell side up 
on a glass slide (VWR). Otherwise, to obtain cross sectional images of the monolayer, 
membranes were folded in half, cell side out, and then mounted on the slide. This 
presented the cells along the fold in cross section and allowed XY resolution imaging 
of the Z axis of the layer. Membranes were mounted in Prolong Gold and covered 
with a 22x22 mm coverslip (BDH). Samples were analysed by epifluorescence (BX40; 
Olympus) or confocal laser scanning microscopy (ISM510, Zeiss). Images were 
imported into Adobe Photoshop CS2 for processing. 
2.12.6. Transmission electron microscopy 
For TEM, cells were washed three times on ice with ice cold PBS. Samples were then 
fixed by immersion in EM grade gluteraldehyde (Agar Scientific) diluted to 0.5 % in 
200 mM sodium cacodylate (Agar Scientific) for 30 minutes at room temperature. 
Following fixation the samples were washed three times in 200 mM sodium 
cocodylate buffer and postfixed in 1 % osmium tetroxide-1.5 % potassium 
ferrocyanide (Sigma) at room temperature for one hour. Cells were then washed in 
water, incubated in 0.5 % magnesium uranyl acetate (Sigma) overnight at 4 "C, 
washed again in water, dehydrated in 99 % ethanol, and embedded flat in EPON 
(Sigma). Cross sections were cut through fixed monolayers and placed on EM grids, 
lead citrate was added for contrast and grids were examined using a Biacore 2000 
transmission electron microscope. 
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2.13. Antibodies and stains 
Antibodies used in this work are shown in Table 6. All antibodies were diluted in 10 
% horse serum in PBS. 
Table 6. - Antibodies used in this study 
Name Target Origin Working Dilution Source/Reference 
IF* WB* FACS* 
a-LPS 3,7,9 LPS 3,7,9 (4047) Mouse mAB 1/200 1/200 
- NIBSC ref. 4047 
a-ZO-1 ZO-1 Rabbit pAb 1/30 
- -
Zymed 
a-Occ Occludin Rabbit pAb 1/30 
- -
Zymed 
a-P-tub E7 B-Tubulin Mouse pAb 1/100 1/1000 
-
Developmental Studies 
Hybridoma Bank, Iowa 
a-Tfp S M I Class 1 Tfp Mouse pAb 1/1000 1/1000 
-
Mumtaz Virji, Bristol 
University 
a-CD46 122-2 CD46 Mouse pAb 1/50 - - Santa Cruz Biotechnology 
inc. 
a-CD46 
1.BB.442 
CD46 Mouse pAb 
-
1/200 1/50 Santa Cruz Biotechnology 
inc. 
a-LAIVlPl LAMP-1 Rabbit pAb 1/300 - - Alberto Ramos, UCL 
a-menB 
95/750 
N. meningitidis 
Serogroup B 
Capsule 
Mouse mAb 
- - -
NIBSC 
a-CSA-1 
S. typhimurium 
common 
structural antigens 
Goat pAb 1/200 - -
Kirkegaard and Perry 
Laboratories 
a-M HRP Mouse Ig Goat pAb - 1/1000 - Dako 
a-M Cy2 Mouse Ig Donkey pAb 1/200 - - Jackson 
a-M FITC Mouse Ig Donkey pAb 1/200 - 1/200 Jackson 
a-M RRX Mouse Ig Donkey pAb 1/200 - - Jackson 
a-R Cy5 Rabbit Ig Donkey pAb 1/200 - - Jackson 
a-R RRX Rabbit Ig Donkey pAb 1/200 - - Jackson 
Phalloidin 
Alexa 595 
Actin 1/100 - - Invitrogen 
Phalloidin 
Alexa 647 
Actin 1/100 - - Invitrogen 
* Immuno-fluorescence * Western Blot Fluorescence activated cell sorting 
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2.14. Chemicals and inhibitors 
The chemicals and inhibitors (Sigma) used to inhibit host cell functions in this study 
are shown in Table 7. 
Table 7. - Concentrations of inhibitors used in this study 
Chemical Solvent Concentration 
Cytochalasin D DMSO 0.3 |iM 
Nocodazole DMSO 2 | iM 
Mono-dansylcadaverine DMSO 150 \xM 
Taxol DMSO 2 | iM 
Latrunculin A DMSO l ^ i M 
Vinblastine HzO 10 \jlM 
Sodium azide HzO 3 mM 
Amiloride H2O 3 mM 
Sodium orthovanadate H2O 100 nM 
Colchicine 100 % ethanol 50 |iM 
2,3 Butane-dione 
monoxime 
70 % ethanol 10 mM 
The final concentration of DMSO in culture wells never exceeded 0.1 %. Chemicals 
were added to the cells at the start of experiments except for nocodazole and 
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colchicine which were pre-incubated with the monolayer at 4 °C for one hour. 
Treated monolayers were then returned to 37 °C for a further hour before infection. 
Analysis of the effects of these chemicals on Calu-3 monolayers was performed by 
adding them to Calu-3 cell monolayers then monitoring TEER and permeability to 
fluorescent tracer for 24 hours. Bacterial growth was assessed by inoculating 4 x 10^ 
bacteria into 1ml of DMEM:F12 in the wells of cell culture plates. Plates were then 
incubated at 37 °C with 5 % CO2. Samples were taken from the wells over 24 hours 
and the ODeoo was read using a Biomate 3 UV-Vis spectrophotometer (Biomate). 
2.15. Flow cytometry 
Flow cytometry analysis was carried out on a FACS calibur machine (Becton 
Dickinson). 10,000 or 50,000 events were recorded for eukaryotic or bacterial 
samples respectively. Results were analysed using FlowJo. 
2.15.1. Detection of in vitro interactions between CD46 and N. 
meningitidis 
Bacteria were grown overnight on solid media then suspended in PBS, enumerated, 
and fixed in 3 % PFA. Bacteria were centrifuged at maximum speed for five minutes 
then re-suspended in 15 % glycerol in PBS at a concentration of 2 x 10® CFU/ml. 
Aliquots of fixed bacteria were stored at -20 °C. 
For analysis of CD46 binding, 2 x 10^ fixed bacteria were washed in PBS and then 
pelleted by centrifugation at maximum speed for five minutes. Bacteria were then 
re-suspended in 10 p.1 of PBS containing recombinant CD46, and incubated at 37 °C. 
81 
After one hour, bacteria were washed three times in PBS-Tween 0.1 %. After the 
final wash, bacteria were re-suspended in 50 [i\ of a-CD46 (1.BB.442) diluted 1/100 in 
PBS-Tween 0.1 %. Samples were incubated on ice for 30 minutes with the primary 
antibody then washed in PBS-Tween 0.1 % three times before being incubated for 30 
minutes with an appropriate, FITC-conjugated, secondary antibody. Bacteria were 
then washed three more times in PBS-Tween 0.1 %, resuspended in 1 ml of PBS, and 
transferred to FACS tubes (BD Falcon) for analysis. 
2.15.2. FACS analysis of human cells 
Cells were harvested using a cell scraper (Sarstedt) and re-suspended in FACS buffer 
(5 % FBS, 0.1 % sodium azide in PBS). Cells were washed three times by 
centrifugation at 2500 xg for five minutes and re-suspension in buffer. To measure 
CD46 expression, cells were incubated with the a-CD46 (1.BB.442) mAb on ice. After 
one hour, cells were washed three times in FACS buffer then incubated with an 
appropriate, FITC-conjugated, secondary antibody for 30 minutes on ice. Cells were 
then washed three more times in FACS buffer, re-suspended in 1 ml of FACS buffer, 
then transferred to FACS tubes (BD Falcon) for analysis. 
Where cells were transfected with a plasmid expressing GFP, antibody labelling was 
not necessary. Cells were harvested and washed as above, then analysed directly. 
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2.16. Western blotting 
2.16.1. Preparation of N. meningitidis samples for SDS-PAGE 
Bacteria were grown overnight on BHI agar, harvested and resuspended in 500 [il of 
PBS (Sigma, U.K.) and combined with an equal volume of SDS-PAGE (Sodium dodecyl 
sulphate polyacrylamide gel electrophoresis) sample buffer [10 % glycerol, 62.5 mM 
Tris-HCl (pH 6.8) 2 % SDS, 0.01 mg/ml bromophenol blue, 5 % P-mercaptoethanol]. 
Samples were then boiled for 10 minutes prior to loading. 
2.16.2. Preparation of cultured cell lysates for SDS-PAGE 
Eukaryotic cells were incubated for 10 minutes on ice in 50 pil of lysis buffer [0.5 % 
TX-lOO, 10 mM Tris-HCl (pH 7.6), 5 mM EDTA (pH 8), 150 mM NaCI, complete EDTA 
free protease inhibitor (Roche)]. Next samples were centrifuged at maximum speed 
for 10 minutes and the supernatant was removed and combined with an equal 
volume of 2x SDS-PAGE sample buffer. Samples were then boiled for 10 minutes. 
2.16.3. SDS-PAGE 
SDS-PAGE analysis of proteins was performed according to the method described by 
Sambrook et al. (1989). Polyacrylamide gels were run in SDS running buffer (200 mM 
glycine, 248 mM Tris, 34 mM SDS) at 110 V for 1-2 hrs. The reagents used to prepare 
polyacrylamide gels are shown in Table 8. All blue Precision Plus Protein marker 10-
250 kDa (BIO-RAD) was used to estimate the molecular mass of proteins. 
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Table 8. - Reagents used to prepare polyacrylamide gels 
Running Gel Stacking Gel 
30 % Acrylamide/Bis (Severn Biotech Ltd) 8 ml 0.75 ml 
Tris-HCI (pH 8.8) + 0.3 % SDS 5 ml 1.25 ml 
dH20 (Sigma) 7 ml 3 ml 
10 % ammonium persulfate (APS) (Sigma) 67 lil 50 Hi 
Tetramethylethylenediamine (TEMED) (BDH) 14 \i\ 5 Hi 
2.16.4. Western transfer 
Proteins were transferred to the membrane at 70 V for 60 minutes using the Mini-
PROTEAN 3 system (BIO-RAD). Immobilon P polyvinylidene fluoride (PVDF) 
membranes (Millipore) were pre-wet with 99% methanol then rinsed in cold transfer 
buffer (48 mM Tris, 39 mM glycine, pH 8.3). Two sheets of Whatman paper were cut 
to the size of the gel and placed in transfer buffer. A fibre pad (BIO-RAD) soaked in 
transfer buffer was placed on the anode side of the transfer grill, followed by a sheet 
of Whatman paper, then the polyacrylamide gel, then the PVDF membrane, then 
another sheet of Whatman paper and finally another fibre pad. After transfer, 
membranes were blocked in 5 % skimmed milk powder in PBS at 4 °C overnight, or 
for one hour at room temperature. 
2.16.5. Protein Detection 
Relevant antibodies were diluted in 0.05 % Tween 20 with 0.5 % skimmed milk in PBS 
(PBSTM), and incubated with the PVDF membrane for 1-2 hours. The membrane was 
then washed three times with PBSTM for 10 minutes each. Appropriate IgGs 
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conjugated to horse radish peroxidase (Dakocytomation) was used as the secondary 
antibody. Antibody binding was detected using ECL Western Blotting detection 
reagents (GE Healthcare). 
2.17. Far Western detection of CD46 binding 
Bacterial lysates were prepared, separated and transferred as described for SDS-
PAGE. Following blocking with 5 % milk in PBS, membranes were incubated 
overnight at 4 °C in 2 ml of purified CD46 SCR domains (100 jig/ml) diluted in PBS. 
The membrane was then developed as described for western blotting. 
2.18. Tfp expression in bacteria 
Monolayers were infected with MC58 at an MO! of 40 as described. After 24 hours, 
media from the apical and basal chambers was plated to solid media and incubated 
overnight overnight. 10 apical and 10 basolateral colonies were then picked, re-
streaked to solid media for 16 hours then harvested and resuspended in 0.5 ml PBS. 
Bacterial suspensions were then combined with an equal volume of 2x SDS-PAGE 
sample buffer and boiled for 10 minutes. 100 pi of each samples was then 
transferred to a methanol pretreated PVDF membrane (Millipore), using a IVIINIFOLD 
1 slot blot system (Whatman), and washed twice with transfer buffer. Following 
transfer, membranes were blocked in 5 % milk in PBS for one hour at room 
temperature with gentle shaking. The membrane was then developed as described 
above for western blotting. 
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2.19. Detection of capsule expression by ELISA 
Capsule expression was analysed by ELISA. Suspensions of bacteria were diluted to a 
concentration of 1 x 10® CFU/mi in PBS. Bacteria were then killed by heating at 56 °C 
for one hour and then re-suspended in ELISA coating buffer (Sigma). A 100 pi aliquot 
containing 1 x 10® killed bacteria was added to each well of a 96 well plate and left 
overnight at 4°C. Wells were incubated with coating buffer alone as a control. Plates 
were washed once with water and then incubated for a further two hours with 
blocking buffer (2 % BSA in PBS). Following blocking, plates were washed three times 
with PBS/Tween 0.1 % then incubated with primary antibody (a-menB capsule) 
serially diluted from 1:10 to 1:2560 in blocking buffer for one hour at 37 °C. Plates 
were washed three times in PBS/Tween 0.1 % then incubated with 100 nl of an a-
mouse HRP-conjugated secondary antibody for a further hour at 37 °C. Finally plates 
were washed again in PBS/Tween 0.1 %, then exposed to 100 |il of SIGMAFAST OPD 
substrate (Sigma) for six minutes. The reaction was stopped with 100 nl of 0.3 M HCI. 
Absorbance was read at 492 nm using a Multiskan Ascent machine linked to Ascent 
software (Labsystems). 
2.20. Production of a stably transfected cell line 
Attempts were made to produce a stably transfected cell line using the Phoenix 
retrovirus expression system (Orbigen). Cells of the amphitropic retroviral packaging 
cell line, Phoenix, were seeded at 4 x 10^ cells per well in a 6 well plate and grown 
overnight. Four wells were used per construct. The cells were transfected with 
either the p shCD46 4 or p shRNA-Mock constructs using Lipofectamine 2000 as 
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described in section 2.11. After 24 hours, the media was replaced with 3 ml of fresh 
DMEM/10 % foetal calf serum (FCS). After 48 hours, supernatants containing virus 
were harvested and filtered through a 0.45 iim filter. 
1.5 X 10® Calu-3 cells were seeded in 10 cm dishes and incubated overnight to be 
ready for infection with the fresh virus containing supernatant. 3 ml of viral 
supernatant with 3 |il of polybrene (final concentration 5 ng/p.1, Sigma) was added to 
each dish. Calu-3 cells were infected with virus carrying the shCD46 4 construct or 
the shRNA-Mock construct. Cells were also exposed to polybrene only as a control. 
After 24 hours the virus containing supernatant was removed and replaced with fresh 
DMEM:F12. The following day the media was replaced with DMEM:F12 containing 
2.5 ng/ml puromycin. From then on, media was replaced with fresh DMEM:F12 (with 
puromycin) every second day until all the cells in the dish treated only with polybrene 
were dead. 
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3 . CHARACTERISATION OF THE INTERACTION OF N. MENINGITIDIS WITH 
SEMI-CONFLUENT CALU-3 RESPIRATORY EPITHELIAL CELLS 
3.1. Interactions of N. meningitidis with Calu-3 and Chang cells 
The respiratory epithelium extends from the posterior nares to the distal bronchioles. 
It consists of a pseudostratified epithelium, with both ciliated and non ciliated cells as 
well as mucus producing goblet cells (Drettner and Aust, 1977; Reznik, 1990). 
Previous studies on N. meningitidis with polarised cell monolayers have utilised cell 
lines with little physiological relevance to the route of infection (Birkness et al., 1995; 
Pujol et al., 1997; Merz et al., 1999). One aim of the work in this thesis was to 
determine whether polarised monolayers of Calu-3 respiratory cells could provide a 
physiologically relevant model for the investigation of the early stages of 
pathogenesis of N. meningitidis. Calu-3 cells are of upper bronchial origin and have 
been shown to accurately represent functional human airway epithelial cells when 
grown into polarised monolayers (Florea et al., 2003). They have been widely used 
to investigate the permeability of the respiratory epithelium (Cavet et al., 1997; 
Ehrhardt et al., 2002; Pezron et al., 2002; Fiegel et al., 2003; Cooney et al., 2004; Li et 
al., 2006a) and the pathogenesis of B. cepacia (Duff et al., 2006) and P. aeruginosa, 
(Hogardt et al., 2007) as well as respiratory viruses such as SARS-CoV (Sims et al., 
2007). 
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However, Calu-3 cells have not previously been employed to study N. meningitidis, 
unlike Chang conjunctival cells (Merz et a!., 1999; Capecchi et ai, 2005; Exiey et a!., 
2005a; ExIey et ol., 2009). Therefore the first stage in validating the use of Calu-3 
cells was to compare the interaction of Calu-3 cells with the meningococcus to the 
interactions seen with Chang cells. Cells were grown to semi-confluency then 
challenged with IVIC58, a clinical serogroup B isolate of N. meningitidis, at an MOI of 
100. This MOI was chosen because it has been used in previous studies of Chang cells 
and N. meningitidis (ExIey et al., 2005a; Exley et ai., 2009). It also represents a 
midpoint in a large range of MOIs used to study the interaction of N. meningitidis 
with Chang cells which have varied from 10 (Virji et a!., 1995) to 500 (Capecchi et al., 
2005; Horton et al., 2009). After five hours, cells were fixed and differentially 
labelled pre- and post-permeabilisation to allow extracellular and intracellular 
bacteria to be visualised. 
Confocal microscopy demonstrated that MC58 adhered at similar levels to Calu-3 and 
Chang cells (average no. of adherent bacteria per cell 17.4 and 20 for Chang and Calu-
3 cells, respectively, p> 0.05, Fig. 3.1 A), and that the rates of bacterial invasion into 
the two cell lines were comparable (average no. of internalised bacteria per cell 2.18 
and 2.21 for Chang and Calu-3 cells, respectively, p> 0.05, Fig. 3.1A). The adhesion of 
N. meningitidis to several types of non-phagocytic cells is dependent on Tfp (Virji et 
al., 1992; Pujol etal., 1997; Nassifeta/., 1999). Therefore, we also incubated Calu-3 
cells with MC58 or an isogenic mutant lacking Tfp (MC58Ap;7E) (Lappann et al., 2006) 
at an MOI of 100 for five hours. 
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Figure 3.1 
Interactions of N. meningitidis witli Calu-3 and Chang epithelial cells 
Cells were grown on coverslips and challenged with N. meningitidis MC58 at an MO! 
of 100 for five hours, then fixed and labelled pre- and post-permeabilisation with a-
L3,7,9 mAb to show intracellular (green) and extracellular (green and red) bacteria. 
The number of adherent and intracellular bacteria was counted by confocal 
microscopy of 300 cells. A - The number of adherent and intracellular bacteria was 
similar following challenge of Calu-3 and Chang cells. The adherence of a Tfp" mutant 
strain (MC58Ap/7f) to both cell lines is reduced as expected. Error bars show the 
standard deviation from at least three experiments. Significant differences are 
indicated: * p < 0.05, * * p < 0.01, * * * p < 0.001 (Unpaired T-test). B - Representative 
confocal microscopy images of adherent and intracellular bacteria with Calu-3 cells. 
Pink arrows indicate bacteria shown at higher magnification (inset). Scale bars = 5 
|im. 
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Confocal microscopy demonstrated that adhesion of N. meningitidis to Calu-3 cells is 
pilus dependent (Figs. 3.1 A, B), with an approximately 80 % reduction in the number 
of adherent pilus-deficient mutant per cell compared with the wild-type strain (p < 
0.001). This result is consistent with findings using the other epithelial cell lines 
(Nassif ef o/., 1999). 
3.2. Transmission electron microscopy of meningococcal adhesion 
to, and invasion into semi-confluent Calu-3 cells 
TEM was used to gain further insights into the nature of meningococcal adhesion to, 
and invasion into Calu-3 cells. Semi-confluent Calu-3 cells were challenged at an MOI 
of 100 for five hours then fixed and prepared for TEM. Representative images show 
that the bacteria adhere tightly to the surface of cells (Figs. 3.2A and B). There is also 
extensive remodelling of the Calu-3 cells. Accumulation of actin beneath the 
adherent bacteria results in a band of filamentous grey staining, where other host 
cell components have been excluded (Fig. 3.2A). The Calu-3 cell plasma membrane is 
deformed around and underneath bacteria, with membranous extensions 
surrounding bacteria in some cases (Figs. 3.2A and B). High magnification images of 
intracellular bacteria appear to show that they are enclosed within a vacuole (Figs. 
3.2Cand D). 
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Figure 3.2 
TEM images of N. meningitidis infection of semi-confluent Calu-3 cells 
Calu-3 cells were infected with MC58 at an MO! of 100 for five hours. Samples were 
fixed, processed and sectioned for TEM. A - Meningococci intimately associated with 
Calu-3 cells. Remodelling of Calu-3 cells is evident with the area under adherent 
bacteria enriched with actin (indicated with *). B - In many cases, bacteria are 
associated with rearrangements of the host cell membrane, resulting in pedestal like 
structures and protrusions. Boxed areas are enlarged in panels i) and ii). C and D -
Intracellular bacteria are also present and appear to be enclosed in a membrane-
bound vacuole. 
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3.3. The NCV is resistant to permeabilisation with saponin 
The nature of the intracellular niche occupied by the meningococcus is the subject of 
some controversy. A number of studies have suggested that intracellular bacteria are 
enclosed within a vacuole (know/n as the Neisseria containing vacuole or NCV). 
However, attempts to identify endocytic markers which, consistently co-localise with 
bacteria have been largely unsuccessful. This has lead to the suggestion that the 
bacteria may be free in the cytoplasm during the intracellular stage of its life cycle 
(Tala et at., 2008). In light of our TEM data, which indicated that the meningococci 
are within vacuoles in Calu-3 cells, we attempted to further characterise the NCV. 
Interestingly when fixed Calu-3 cells were permeablised with 0.1 % saponin, with or 
without EDTA, intracellular bacteria could not be detected by immuno-labelling (Fig. 
3.3A). However, when 0.2 % T X-100 was used, intracellular bacteria were seen (Fig. 
3.3A). This result was also found following challenge of HeLa and Chang cells (Fig. 
3.3B). Given that the only difference between these samples was the detergent used 
for permeabilisation, we hypothesised that saponin failed to permeablise the 
intracellular compartment occupied by meningococci and hence intracellular bacteria 
were not immunolabelled. 
To test this hypothesis, Calu-3 cells were inoculated with wild-type MC58 expressing 
eGFP. Samples were permeablised with either 0.2 % T X-100 or 0.1 % saponin, then 
bacteria were immuno-labelled with a red fluorophore. In samples permeablised 
with T X-100, green fluorescent bacteria were also labelled red, indicating that the 
NCV had been successfully permeablised (Fig. 3.4A). 
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Figure 3.3 
Permeabilisation with 0.1 % saponin does not permit immunodetection of 
intracellular bacteria 
A - Calu-3 cells were fixed at five hours post inoculation. Bacteria were labelled with 
an a-L3,7,9 nnAb before and after permeabilisation. RRX-conjugated a-mouse 
secondary antibody (red) was used before permeabilisation, and Cy2-conjugated a-
mouse secondary antibody (green), afterwards. Cells were counterstained with an 
Alexa 647-conjugated phalloidin that binds actin (blue). Only permeabilisation with 
0.2 % T X-100 allowed visualisation of intracellular bacteria (green only) ( ^ ) . B - The 
experiment was repeated with Chang and HeLa cells. The number of intracellular 
bacteria in 50 cells was counted and expressed as a percentage of the total number 
of visible bacteria. The experiment was repeated twice and representative results 
are shown. Scale bars = 5 |j,m. 
96 
Figure 3.3 
a N. meningitidis LPS 
Actin 
(blue) 
Post perm, 
(green) 
Pre perm, 
(red) Merge 
m LU 
B 20 
15 -• i 0) ^ 
1 1 
m o 1 0 -
3 
8 % 
I 5 -
• Chang 
• HeLa 
TX100 Saponin Saponin 
(0.2%) (0.1%) (0.1%) + 2nM 
EDTA 
Permeablisation 
None 
97 
Figure 3.4 
N. meningitidis resides within a saponin resistant vacuole 
A - Calu-3 cells were infected with N. meningitidis expressing GFP, and fixed five 
hours later. The cells were permeablised with either 0.2 % T X-100 or 0.1 % saponin 
and labelled with a murine a-L3,7,9 mAb followed by an RRX-conjugated a-mouse 
secondary antibody (red). Actin was counterstained with Alexa 647-conjugated 
phalloidin (blue). Bacteria visualised just by endogenous GFP expression alone (>-) 
are present only in the saponin permeablised samples. In the T X-100 permeablised 
samples the a-L3,7,9 mAb bound all bacteria. B - Infection and bacterial labelling 
was performed as above but cells were counterstained with an antibody for LAMP-1 
instead of phalloidin (which is membrane permeable) to demonstrate that that 
saponin and T X-100 both permeablise the host cell plasma membrane. Single 
stained bacteria ( ) are only seen in the T X-100 permeablised sample confirming 
that the NCV is resistant to saponin permeabilisation. Scale bars = 5 |im. 
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However, in saponin permeablised samples, single labelled, green fluorescent 
bacteria were seen (Fig. 3.4A). This demonstrates that intracellular bacteria were 
protected within the cell from antibody binding, even after permeabilisation with 
saponin. 
To determine whether it was the NCV or the Calu-3 cell plasma membrane that was 
saponin resistant, we repeated the experiment using an antibody to the late 
endocytic marker LAMP-1 to counterstain the cells, instead of the membrane 
permeable phalloidin used previously. No difference in LAMP-1 labelling was seen 
between saponin and T X-100 permeablised samples (Fig. 3.4B) indicating that the 
plasma membrane was permeablised by both detergents. However, as before, 
intracellular bacteria were only seen when cells were permeablised with T X-100 (Fig. 
3.4B). Taken together, these data demonstrate that the NCV is resistant to saponin. 
3.4. The NCV has a low cholesterol content 
Saponin permeablises cells by forming complexes with cholesterol and so is unable to 
permeablise membranes with a low cholesterol content (Jacob et al., 1991). 
Therefore our results suggests that the membrane of the NCV has a low cholesterol 
content. SLO is a pore forming toxin that also permeablises membranes by forming a 
complex with cholesterol (Bhakdi et al., 1985; Ohno-lwashita et ol., 1991; Sekiya et 
ol., 1993). 
Therefore we infected Calu-3 cells with eGFP expressing N. meningitidis at an MOI of 
100 for five hours. Cells were fixed, permeablised with T X-100 (0.2 %), saponin (0.1 
100 
%) or SLO and then immunolabelled for meningococci and LAMP-1 (Fig. 3.5). As 
before, the NCV was permeablised by T X-100, with antibody accessing all the GFP 
expressing bacteria. However, as with the saponin permeablised cells, we found that 
SLO permeabilisation did not allow antibodies to access intracellular, GFP expressing 
bacteria. In both saponin and SLO permeablised cells, bacteria labelled only by 
endogenous GFP expression were clearly seen; LAIVIP-l labelling demonstrates that 
the plasma membrane had been permeablised. When no permeabilisation was used, 
antibodies were also unable to access intracellular bacteria and the a-LAMP-1 
antibodies were also unable to access the cytoplasm effectively. 
S. typhimurium is known to reside within a cholesterol-rich vacuole, the Salmonella 
containing vacuole (SCV) (Catron et al., 2002; Parwez et a!., 2008). To determine 
whether cholesterol was important for permeabilisation by saponin and SLO, the 
same experiment was repeated in Calu-3 cells infected with S. typhimurium (Fig. 3.6). 
All methods permeablised the SCV, allowing a-Salmonella CSA-1 antibodies to access 
intracellular bacteria. Bacteria labelled only by endogenous GFP expression were 
only detected in unpermeablised cells. As expected, a-LAMP-1 antibodies were also 
able to access the cytoplasm effectively, except in unpermeablised samples (Fig. 3.6). 
LAMP-1 also co-localises with the SCV as previously reported (Ramsden et al., 2007a). 
Filipin is a chemical which is membrane permeable and binds to cholesterol. It is 
fluorescent under UV light so can used to visualise cholesterol in cells by fluorescence 
microscopy. Uninfected Calu-3 cells were treated with filipin and examined by 
epifluorescence and DIC microscopy (Fig. 3.7A). Filipin staining was also performed 
on Calu-3 cells infected with either A/, meningitidis or S. typhimurium. In both cases, 
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GFP expressing bacteria were used and extracellular bacteria were immuno-labelled 
using antibodies. Cholesterol accumulation was never seen around intracellular 
meningococci, in contrast to the high levels of accumulation seen around intracellular 
Salmonella. Taken together, these data indicate that the NCV is a compartment with 
a low cholesterol content. 
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Figure 3.5 
Saponin and SLO fail to permeabiise the N. meningitidis vacuole 
CaIu-3 cells were infected with N. meningitidis expressing GFP, and fixed after five 
hours. Cells were permeablised with either 0.2 % T X-100, 0.1 % saponin or SLO and 
labelled with a murine a-L3,7,9 mAb and a RRX-conjugated a-mouse secondary 
antibody (red). LAMP-1 was labelled to identify permeabilisation of the cell 
membrane. Bacteria labelled by eGFP alone ( ) are present only in samples 
permeablised with saponin or SLO which both target cholesterol. In T X-100 
permeablised cells the mAb accessed and bound all bacteria. In non-permeablised 
samples, intracellular bacteria were not detected by the a-L3,7,9 mAb and the a-
LAMP-1 antibody did not access the cell cytoplasm. Scale bars = 5 jam. 
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Figure 3.6 
Detergents targeting cholesterol permeablise the SCV 
To evaluate the permeabilisation techniques, Calu-3 cells were infected with S. 
typhimurium expressing GFP and fixed after five hours. The cells were permeablised 
with either 0.2 % T X-100, 0.1 % saponin or SLO and labelled with a murine a-
Salmonella CSAl mAb followed by an RRX-conjugated a-mouse secondary antibody 
(red). LAMP-1 was labelled in all samples to demonstrate permeabilisation of the cell 
membrane. Bacteria labelled by GFP alone were only seen in un-permeablised 
samples where the a-LAMP-1 antibody was also unable to access the cell cytoplasm. 
T X-100, saponin and SLO all successfully permeablised the cells and the SCV resulting 
in double labelled bacteria and which co-localise with LAIVIP-l. Scale bars = 5 jam. 
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Figure 3.7 
The NCV has a low cholesterol content 
A - Calu-3 cells were fixed on cover slips and cholesterol was labelled with filipin. In 
uninfected cells, cholesterol was detected in the membranes of cytoplasmic 
compartments and the plasma membrane. B - Cells were infected with either N. 
meningitidis or S. typhimurium expressing GFP at an MOI of 100 for five hours then 
fixed. Extracellular bacteria were labelled with a-L3,7,9 mAb or a-Salmonella CSA-1 
for N. meningitidis or S. typhimurium respectively, followed by an appropriate RRX-
conjugated secondary antibody (red). Cholesterol accumulated in the SCV membrane 
surrounding intracellular Salmonella, but not in the NCV membrane, surrounding the 
intracellular meningococcus. The length of scale bars is shown on the merged panel 
of images. Inset boxes show enlargements of the intracellular regions containing 
bacteria. 
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4 . GROWTH OF DIFFERENTIATED CELL MONOLAYERS AND 
CHARACTERISTICS OF NEISSERIAL TRAVERSAL 
Work in the previous chapter demonstrates that N. meningitidis is able to adhere to 
and enter into the semi-confluent Calu-3. Here the cells w/ere grown on permeable 
membranes to allow polarisation and the development of a confluent monolayer. 
Growth of cells in this way would allow investigation of the characteristics of 
Neisserial traversal. 
4.1. Monitoring barrier function of monolayers 
Two methods were used to monitor the barrier function of developing monolayers, 
TEER and permeability to a fluorescent tracer. TEER was measured using a TEER 
meter attached to electrodes in the apical and basolateral chambers of a cell culture 
well (Fig. 4.1A). The TEER meter measures the electrical resistance across the layer. 
Dextran (70,000 MW) conjugated to a Texas red fluorophore was used as a tracer and 
added to apical chambers. Samples were taken from the basolateral chamber at 
various timepoints and analysed for fluorescence (Fig. 4.IB). Before use, the level of 
fluorescence of a range of dextran concentrations was measured and a working 
concentration of 0.1-1 [iM gave the optimal sensitivity (Fig. 4.1C). We also checked 
the longevity of tracer in the apical chamber in the presence of infected cells and 
found no loss of fluorescence even after 24 hours (Fig. 4.ID). 
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Figure 4.1 
Techniques to monitor barrier function of the monolayer 
Monitoring barrier function by measuring TEER using EVOIVI chopstick electrodes (A) 
and assessing the permeability of the monolayer to fluorescently labelled tracer (B). 
C - Standard curve for the fluorescently labelled tracer. The Texas Red labelled 
70,000 MW dextran was serially diluted in DMEM:F12 and fluorescence was 
measured. D - Samples were taken from the apical chamber of monolayers 
immediately after the introduction of the tracer and after 24 hours. There was no 
degradation of the tracer in the apical chamber over 24 hours. Error bars show 
standard deviation from at least three separate experiments. 
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4.2. Optimisation of cell culture conditions for growth of Calu-3 
monolayers 
Cell lines such as Chang, that cannot polarise or form tight junctions when grown on 
a cell culture insert, generate little TEER, (<100 Q not shown). The development of 
TEER with Calu-3 cells was affected by a number of factors. Reducing the size of 
pores in the membrane led to higher levels of TEER; however, pores of less than 1 |im 
impeded the passage of bacteria (not shown). Therefore we selected membranes 
with 1 |im pores for all subsequent studies. The density at which cells were seeded 
also affected the development of TEER. Seeding cells at a density of 4 x 10^ per cm^ 
consistently gave the highest TEER, reaching around 1850 0 after five days (Fig. 4.2). 
Further increasing the density of cells did not lead to a further increase in TEER (not 
shown). Coating of culture membranes with different extracellular matrix proteins 
(ECMs) also affected the level of TEER. Indeed some ECMs such as Matrigel™ (not 
shown), laminin and to some extent fibronectin, impaired the development of TEER 
(Fig. 4.2A). The highest levels of TEER were obtained with membranes coated with a 
combination of laminin (10 ng/cm^) and fibronectin (5 ng/cm^) (Fig. 4.2A) although 
the increase was only small (5 -10 %) compared with uncoated membranes. 
Following optimisation of all culture conditions, significant TEER (up to around 2000 
n) was generated reliably and reproducibly five days after seeding (Fig. 4.2B). The 
increasing TEER over time coincided with decreasing permeability of the layer to the 
tracer (Fig. 4.2B), demonstrating that the cells formed an effective cellular barrier. 
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Figure 4.2 
Optimisation of cell culture conditions to generate reproducible levels of TEER 
A - Coating of cell culture membranes with different ECM proteins prior to the 
addition of cells affects the level of TEER across Calu-3 cells. Cells were seeded and 
incubated for five days, the media was changed every other day. TEER was 
monitored on a daily basis. The proteins used to coat culture membranes are shown; 
coating with a mixture of laminin (10 pg/cm^) and fibronectin (5 jig/cm^) gave the 
highest level of TEER. Results shown are representative of two independent 
experiments. B - Development of the Calu-3 monolayer, showing increasing TEER 
and decreasing permeability to Texas red labelled 70,000 MW dextran over time. 
Fluorescent tracer was added to the apical chamber of monolayers. The level of 
fluorescence in the basolateral chamber was measured six hours later. Error bars 
show the standard deviation from at least three separate experiments. 
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4.3. Microscopic analysis of Calu-3 monolayers 
To further characterise the Calu-3 monolayer, TEM was performed to examine cells 
five days after seeding. Calu-3 cells were seen forming confluent monolayers with 
the morphological features of a polarised respiratory epithelium (Figs. 4.3 and 4.4) 
consisting of a continuous monolayer of columnar cells linked by junctional 
structures. There was clear apical-basal polarisation, with the nuclei predominantly 
located towards the basolateral side of cells, the development of tight junctions, and 
the presence of microvilli on the apical surface (Fig. 4.3A). Closer examination of the 
microvilli (Fig. 4.3B) revealed an extensive glycocalyx, which may consist of mucins as 
described previously (Florea etal., 2002). The level of differentiation and polarisation 
of the cell layer was evident from the presence of full junctional complexes between 
cells including tight junctions, adhesion belts and desmosomes (Fig. 4.3C). 
Tight junctions linked the apical boundaries of neighbouring cells in the monolayer to 
each other, so that the membranes of individual cells were barely distinguishable 
(Fig. 4.4A). To examine the extent of tight junctions, immuno-fluorescence 
microscopy was used to detect the tight junction proteins zonula occludens-1 (ZO-1, 
Fig. 4.4B) and occludin (Fig. 4.4C). The layer shows the characteristic chicken-wire 
pattern formed by the presence of contiguous tight junction proteins at the margins 
of all cells. 
We also closely examined the cell layer using TEM for other junctional structures. 
The adhesion belt forms a ring around cells below the tight junctions, linking cells to 
each other, and connecting the actin cytoskeletons of adjacent cells. 
115 
Figure 4.3 
Electron microscopy of the Calu-3 monolayer 
Calu-3 ceils were grown for five days on cell culture membranes then examined by 
TEM. A - Lower magnification view (scale bar = 4 jim) showing cells organised into a 
monolayer of columnar cells joined by tight junctions (TJ), and desmosomes (D). The 
cell culture membrane (CCM) can be seen on the basolateral surface of the cells. 
Apical-basal differentiation is demonstrated by the basal location of nuclei and the 
presence of microvilli (IVIV) on the apical surface. B - Close examination of the MV 
reveals an extensive glycocalyx layer. Scale bar = 1 p.m. C - The cell boundaries show 
extensive junctional structures including full junctional complexes (JC) composed of 
(from apical to basal surface) a tight junction (TJ), an adhesion belt (AB), and a 
desmosome (D). Scale bar = 1 nm. 
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Figure 4.4 
Junctional structures in monolayers of Calu-3 cells 
All major junctional structures were found the monolayers after five days. A - TEM 
image showing close apposition of cell membranes within a tight junction. Scale bar 
= 1 p.m. The integrity of the layer and presence of tight junctions was further 
confirmed using confocal microscopy to visualise the tight junction associated 
proteins, ZO-1 (B) and occludin (C). Scale bars = 5 pim. The classic 'chicken wire' 
pattern of staining can clearly be seen, demonstrating that cells are linked by tight 
junctions. TEM images D and E show high magnification views of an adhesion belt 
and a desmosome respectively. Intercellular and intracellular attachment proteins 
are visible as high density staining in the adhesion belt. Intercellular desmogleins 
(DG), intracellular desmoplakins (DP), and the associated intermediate filaments (IF) 
are present in desmosomes. Scale bars = 0.5 jim. 
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Adhesion belts were present at the majority of cell-cell boundaries (Fig. 4.4D). 
Desmosomes are plate like structures that form on the sides of cells, beneath the 
adhesion belt. They consist of intercellular/membrane proteins known as 
desmogleins and intracellular proteins called desmoplakins. Desmoglein-desmoglein 
interactions link cells to one another and the desmoplakins link the desmogleins to 
the intracellular intermediate filament networks of the cells. Due to their plate-like 
shape, sectioning of desmosomes was not observed at every cell boundary but they 
were present in some sections (Fig. 4.4E). Together, these data confirm that the 
Calu-3 respiratory epithelial cells form a barrier consisting of differentiated, polarised 
columnar cells linked by tight junctions. 
4.4. Features of air interface culture monolayers 
To grow the cells under AlC conditions the apical media was removed from 
monolayers after two days. Although this is a more lengthy process, the cells can 
produce cilia and mucus (Grainger et ol, 2006). AlC monolayers generated only 
about half of the TEER (~1000 Q) of LCC monolayers (~2000 Q) (Fig. 4.5A). However, 
no major morphological differences were apparent in TEM images of five day old AlC 
monolayers (Fig. 4.5B) compared to the LCC monolayers. TJs were still present at the 
margins of cells and the layer was organised into a monolayer. However, cilia and 
mucus build up were not observed. Therefore for the remaining studies, LCC 
monolayers were used unless specified. 
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Figure 4.5 
Growth of AlC Calu-3 monolayers 
AlC monolayers were produced by seeding cells as for LCC monolayers then removing 
all apical media after two days and leaving layers to grow and differentiate for a 
further three days A - Comparison of TEER in five day old AlC and LCC monolayers. 
The TEER across AlC monolayers was approximately half that seen for LCC 
monolayers. Error bars show the standard deviation from at least three experiments. 
Significant differences are indicated: * p < 0.05, * * p < 0.01, * * * p < 0.001 (Unpaired 
T-test). B - TEM images of AlC monolayers at five days. Lower magnification view 
(scale bar = 5 jam) shows cells organised into a monolayer of columnar cells joined by 
tight junctions (TJ), and desmosomes (D). The cell culture membrane (CCM) can be 
seen on the basolateral surface of the cells. Boxed sections are enlarged in i) and ii) 
and show the expected junctional structures between adjacent cells. Scale bars = 1 
|im. 
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4.5. Barrier function of Calu-3 monolayers 
In all subsequent experiments Calu-3 monolayers were used five days after seeding. 
To further characterise the barrier function of these layers at this time, we added 
fluorescently-labelled tracer to the apical chamber and detected its appearance in 
the basolateral chamber over 24 hours. In the absence of cells, there was no TEER 
and the tracer diffused freely into the basolateral chamber (Fig. 4.6A). However, in 
the presence of the Calu-3 cell monolayer TEER was detected and no tracer was 
detected in the basolateral chamber even after 24 hours (Fig. 4.6B). 
In addition, the apical surface of the monolayer was challenged with non-invasive E. 
coli DH5a and its appearance in the basolateral chamber over time was monitored. 
When no cells were present on the cell culture membrane, E. coli was first detected 
in the basolateral chamber two hours after challenge, after which the numbers of 
bacteria increased rapidly (Fig. 4.7A). In contrast, no bacteria were detected in the 
presence of Calu-3 cell monolayers (Fig. 4.7B) even after 8 hours. 
These data confirm that Calu-3 respiratory epithelial cells form a significant barrier 
with high TEER, and are able to prevent the passage of fluorescently labelled dextran 
and non-pathogenic £ coli. 
4.6. Transcellular traversal by N. meningitidis across the epithelial 
cell barrier 
Having demonstrated the barrier function of monolayers five days after seeding, we 
next investigated the ability of N. meningitidis to traverse across cells. There were 
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consistently around 10® cells in the layers at five days post seeding, and the apical 
surfaces were challenged with MC58 at an MO! of 40. This MO! is towards the lower 
end of a large range of MOIs used to study the interaction of N. meningitidis with 
cells which have varied from 10 (Virji et al., 1995) to 500 (Capecchi et a!., 2005; 
Morton et al., 2009). At 8 and 24 hours, the inserts containing infected membranes 
were washed thoroughly in media then transferred into new wells. After one hour 
samples were taken from the basal chambers of the new wells and were plated to 
BHI. Bacteria were occasionally present in the basal chamber prior to 8 hours but 
never earlier than six hours post challenge (not shown). N. meningitidis was 
consistently detected traversing in small numbers (equivalent to 0.0035 % of input) at 
8 hours post challenge (Fig. 4.8A). By 24 hours, the number of bacteria traversing 
over the course of one hour had increased by around four orders of magnitude (Fig. 
4.8A); intermediate levels of traversing bacteria were found at 16 hours (not shown). 
Traversal of the monolayer by N. meningitidis might result from loss of integrity of 
the tight junctions or cell death. To examine these possibilities, the TEER was 
monitored during the course of an infection. Although the TEER across the layer fell 
following bacterial challenge, levels never dropped to below 40 % of the initial 
reading and also fell in the uninfected control wells (Fig. 4.8B). The integrity of the 
layer during infection was also monitored by adding the fluorescent tracer to the 
apical surface of the monolayer at the time of challenge. Although bacteria 
successfully traversed the monolayer, the tracer was not detected in the basolateral 
chamber beneath the infected cells even after 24 hours. 
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Figure 4.6 
Calu-3 monolayers are impermeable to fluorescent tracer 
Texas red labelled 70,000 MW dextran was added to the apical chamber of cell 
culture inserts without (A) or with (B) Calu-3 cell monolayers. Levels of fluorescence 
in the basolateral chamber and TEER were monitored after the addition of the 
fluorescent tracer to the apical chamber. Without cells, the membranes do not 
generate TEER and allow diffusion of tracer into the basolateral chamber. In the 
presence of cells, the monolayer prevented diffusion of the tracer across the 
membrane. Error bars show the standard deviation from at least three separate 
experiments. 
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Figure 4.7 
Calu-3 monolayers do not allow traversal of E. coli DhSa 
E. coli was added at an MOI of 40 to the apical chamber of cell culture inserts without 
(A) or with (B) a Calu-3 cell monolayer. Plating of media from the basolateral 
chamber shows bacteria diffuse across the cell culture membrane within a two hours 
when no cells are present, but do not cross the polarised monolayer. Error bars show 
the standard deviation from at least three separate experiments. 
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Figure 4.7 
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Figure 4.8 
Traversal of N. meningitidis 
A - Polarised monolayers were challenged with MC58 at an MO! of 40. The numbers 
of bacteria traversing the layer was established by transferring inserts to fresh wells 
at 8 and 24 hours and then sampling after one hour from the basolateral chamber of 
the new well. Results are shown as the percentage of bacteria in the input. Dots 
represent individual wells from four separate experiments; horizontal bars represent 
the mean. B -TEER was monitored in the presence and absence of bacteria for 24 
hours following inoculation. Despite bacterial passage, TEER was not lost during the 
experiments. C-Texas red labelled 70,000 MW dextran was added to the apical side 
of cell monolayers which were then challenged with MC58 at an MOI of 40 and 
fluorescence in the basolateral chamber was monitored over the next 24 hours. 
Labelled dextran did not pass through the monolayers despite bacterial passage. 
Diffusion of tracer across inserts with no cells was included as a control. Error bars 
show the standard deviation from at least three experiments. 
129 
Figure 4.8 
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Indeed, there was no significant difference in the level of fluorescence in the 
basolateral chamber of infected and uninfected monolayers (Fig. 4.8C). 
Infected monolayers were also fixed and examined for the presence of the tight 
junction protein ZO-1. The distribution of ZO-1 in infected cells was indistinguishable 
from that in uninfected monolayers (Fig. 4.9A). The protein was present at the 
margins of all cells, with no gaps detected. Additionally, we examined infected 
monolayers by TEM. At 8 hours following inoculation, microcolonies of N. 
meningitidis were present on the apical surface of the monolayer (Fig. 4.9B). These 
bacteria were tightly associated with the apical surface of the cells of the monolayers, 
and were often found atop pedestal-like protrusions of the apical membrane (Fig. 
4.9B and C). After 24 hours, the bacterial colonies had increased in size and covered 
a larger area of the apical surface of the monolayer (Fig. 4.9D). Meningococci were 
still closely adherent to the apical surface (Fig. 4.9E) and examination of the margins 
of cells revealed that the junctional structures were intact (Fig. 4.9F), consistent with 
results obtaining by ZO-1 labelling. Taken together these data demonstrate that 
there is no loss of integrity of the Calu-3 monolayer coincident with traversal of N. 
meningitidis. This is indicates that the meningococcus does not cross the respiratory 
epithelial barrier by a paracellular route or through loss of cells from the layer. 
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Figure 4.9 
Microscopic analysis of infected monolayers 
A - Calu-3 monolayers were inoculated with IVIC58 expressing GFP (green) then fixed 
24 hours later. The tight junction protein ZO-1 was labelled (blue) and the layers 
examined by confocal microscopy. Despite infection, the pattern of ZO-1 labelling 
was unaffected. Scale bars = 5 |im. B, C - For TEM, monolayers were challenged with 
MCSS and fixed 8 or 24 hours later. After 8 hours the monolayer remained intact and 
appeared undamaged despite the presence of bacterial colonies on the apical 
surface. Bacteria adhered tightly to cells and were often atop pedestal-like 
protrusions from the apical membrane. D - After 24 hours, there was no apparent 
disruption to the integrity of the monolayer despite increased numbers of bacteria on 
the apical surface. No gaps in the layer were observed (E). Adherent bacteria 
remained tightly associated with the apical membrane. Enlargement of the region 
between cells (F) revealed the presence of the major junctional structures. Boxed 
regions in D indicate sections enlarged in panels E and F. Sizes of scale bars are 
shown. 
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If N. meningitidis traverses the respiratory monolayer by a transcellular route, the 
cells in the monolayer should harbour a population of intracellular bacteria. 
Therefore monolayers of cells were challenged with MC58, then after 8 or 24 hours 
were exposed to gentamicin for one hour to kill extracellular bacteria. Cells were 
lysed by saponin to release intracellular bacteria, which were recovered by plating 
lysates to solid media. A population of gentamicin-protected bacteria (representing 
approximately 0.1 % of the input) was consistently present in cells at 8 hours post-
challenge, and this number increased by an order of magnitude by 24 hours post 
challenge (Fig. 4.10A). In contrast, no bacteria were recovered from gentamicin-
treated membranes which had been infected with N. meningitidis in the absence of 
cells (not shown). 
It was possible that the recovered bacteria survived gentamicin treatment by 
occupying extracellular sites between cells in the monolayer that were inaccessible to 
the antibiotic. Therefore infected monolayers were disrupted by treatment with 
trypsin for 10 minutes or latrunculin A for 20 minutes prior to incubation with 
gentamicin. Exposure of the monolayer to trypsin for 20 minutes is sufficient to 
remove all cells from the membrane, while treatment with latrunculin A for 15 
minutes leads to a complete loss of TEER (Fig. 5.2A). Treatment with either 
latrunculin or trypsin did not alter the number of CFU recovered from the layer after 
exposure to gentamicin (Fig. 4.10B), consistent with the bacteria being in an 
intracellular compartment. In addition, we performed confocal microscopy of cross 
sections of the monolayer at 24 hours following bacterial challenge. This revealed the 
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presence of N meningitidis within cells, including bacteria located in basal regions of 
cells (Fig. 4.IOC). 
These data demonstrate that there is an intracellular population of meningococci in 
Calu-3 monolayer. This, combined with our results showing the maintenance of 
barrier function during traversal indicate that traversal of N. meningitidis occurs via a 
transcellular route. 
135 
Figure 4.10 
Identification of a population of intracellular bacteria in infected Calu-3 monolayers 
Monolayers of cells were challenged with N. meningitidis at an MOI of 40. A - After 8 
or 24 hours cells were treated with gentamicin to kill extracellular bacteria then lysed 
with saponin to release intracellular bacteria which were enumerated by plating of 
iysates. Each spot represents the result from an individual well from three separate 
experiments. Horizontal bars represent the arithmetic mean. B - Latrunculin A and 
trypsin were used to disrupt the monolayer before treatment with gentamicin. 
Treatment with these chemicals caused no significant reduction in the gentamicin-
protected population of N meningitidis. No bacteria were recovered following 
gentamicin treatment in the absence of Calu-3 cells (not shown). Error bars show the 
standard deviation from at least three separate experiments. C - Representative 
images showing intracellular bacteria present in the monolayer ). Monolayers 
were infected with MC58 expressing GFP at an MOI of 40 and fixed 24 hours later. 
Extracellular bacteria were labelled using an a-L3,7,9 primary antibody and an RRX-
conjugated secondary (red). Actin was stained with Alexa 647 phalloidin (blue). Scale 
bars = 5 \xm. Boxed areas are enlarged in the lower panels of i) and ii). 
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5. HOST AND BACTERIAL DETERMINANTS FOR SUCCESSFUL TRAVERSAL 
Work in the previous chapter shows that the barrier function of Calu-3 monolayers, 
as measured by permeability to fluorescent tracer and TEER, was maintained during 
traversal by the meningococcus. Furthermore bacterial recovery and microscopy 
demonstrate that N. meningitidis is present Inside the cells of the monolayer. Taken 
together, these data provide clear evidence that N. meningitidis crosses the Calu-3 
monolayer via a transcellular route. We hypothesised that further evidence for 
transcellular passage could be gained through better understanding of the 
mechanisms of traversal. Therefore, we attempted to identify the bacterial and host 
factors important for successful traversal. We used inhibitors of host cell pathways 
to define host factors involved, and competitive infections between mutant and wild 
type bacteria to identify important bacterial factors. 
5.1. Investigating host factors required for traversal 
A number of different drugs affecting cellular systems including, the actin network, 
microtubules, endocytosis and energy utilisation/production were selected. All these 
host cell factors are potentially important and have been shown in previous work to 
play roles for pathogens in host cell adhesion, invasion, intracellular movement, or 
traversal. 
Actin has been demonstrated to be required by a number of bacterial species for 
invasion [reviewed in (Cossart and Sansonetti, 2004)] and intracellular locomotion 
[reviewed in (Gouin et ai, 2005)]. A number of drugs disrupt the host cell actin 
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cytoskeleton. Cytochalasin D binds to the barbed end of the actin filament where 
actin polymerisation occurs, irreversibly capping the filament preventing further 
polymerisation or depolymerisation (Flanagan and Lin, 1980; Morris and 
Tannenbaum, 1980; Brown and Spudich, 1981). In contrast, latrunculin A 
depolymerises actin filaments (Kashman et a!., 1980; Coue et a!., 1987) by binding 
monomeric actin (Morton et al., 2000). The actin cytoskeleton is bound by motor 
myosins which allow force generating actin/myosin interactions. Myosin ATPase is 
inhibited by 2,3 butane-dione monoxime (BDM) (Simpson and Armstrong, 1999). 
Microtubules and their associated motor proteins are responsible for the long range 
movement of vesicles within cells, a function which has been hijacked by vacuolated 
pathogens such as Salmonella to facilitate intracellular movement (Ramsden et al., 
2007a). Nocodazoie causes depolymerisation of microtubules by stimulating intrinsic 
GTPase activity of tubulin (De Brabander et al., 1976; Vasquez et ai, 1997). 
Vinblastine also depolymerises microtubules though its mode of action is less clear 
(Wang et al., 2007). Colchicine prevents microtubule polymerisation by binding to 
the tubulin subunits and blocking their polymerisation (Borisy and Taylor, 1967), 
while taxol inhibits the depolymerisation of tubulin subunits (Horwitz, 1992). 
Macropinocytosis refers to the formation of larger scale endocytic vesicles generated 
by outward-directed actin polymerisation near the plasma membrane which creates 
membrane protrusions surrounding target substrates (Swanson and Watts, 1995; 
Amyere et al., 2002; Conner and Schmid, 2003). The entry of a number of 
intracellular pathogens (e.g. Neisseria, Salmonella, Shigella) resembles 
macropinocytosis (Swanson and Watts, 1995; Nassif et al., 2002; Conner and Schmid, 
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2003). Amiloride specifically blocks macropinocytosis though the mode of action is 
not clear (West et al., 1989). 
Clathrin-mediated endocytosis (CME) is responsible for the continuous uptake of 
essential nutrients, antigens, growth factors, and pathogens (Takei and Haucke, 
2001). Mono-dansycadaverine (M-D) blocks the endocytosis of various ligands via 
CIVIE (Davies et al., 1980). 
Sodium azide inhibits mitochondrial respiration by inhibiting the activity of 
respiratory chain complex IV (cytochrome C oxidase) (Bennett et al., 1996). We 
hypothesised that the energy for the movement involved in traversal could be host or 
pathogen derived. This drug differentiates betv^een these possibilities. 
A number of these drugs have been used extensively to identify the host cell factors 
important in the pathogenesis of bacteria. For instance, cytochalasin D has been 
used in polarised epithelial cells to demonstrate that the Influenza virus requires an 
active actin cytoskeleton for internalisation (Sun and Whittaker, 2007). Similarly, 
nocodazole (which disrupts microtubules) has been used to show that intracellular 
movement of the SCV is dependent on an intact microtubule network (Ramsden et 
al., 2007b). 
5.1.1. Analysis of pleiotropic effects of drug treatments 
The major limitation of using drug treatments is potential pleiotropic effects on host 
and bacterial cells. For instance, major side effects of nocodazole treatment include 
disruption of the Golgi apparatus (Turner and Tartakoff, 1989; Dinter and Berger, 
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1998), induction of apoptosis in some cell lines, cell cycle arrest and alteration of cell 
shape (De Brabander et al., 1976). A particular concern was that disruption of 
cytoskeletal components would affect the integrity of the monolayer, intermediate 
filaments and actin are particularly important in the maintenance of epithelial 
structure as they are intimately linked to the adherens belt and desmosomes 
respectively [reviewed in (Koch and Nusrat, 2009)]. Previous work has shown that 
cytochaiasin D significantly alters monolayer permeability (Madara et al., 1986), 
although interestingly, it has still been used in investigations of monolayer traversal 
(Wang et ol., 2007). 
We were also concerned that the drugs could impair the rate of bacterial growth, 
which would have had serious confounding effects on any results. Therefore initially 
the effect of drug treatments on bacterial growth and Calu-3 monolayers was 
investigated. 
5.1.1.1. The effect of chemical Inhibitors on bacterial growth 
The suitability of drugs was initially assessed by monitoring their effects on bacterial 
growth and survival (Fig. 5.1). Wells of cell culture plates containing 1.5 ml of 
DMEM:F12 and the drug under investigation were inoculated with 4 x 10^ bacteria. 
Drugs were used at the concentrations suggested by the manufacturer, and 
according to previous studies (Wang et al., 2007). Cell culture plates were then 
incubated at 37 °C with 5 % CO2. Samples were taken from the wells over 24 hours 
and the OD500 was read using a spectrophotometer. 
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Figure 5.1 
Effect of drugs on bacterial replication 
MC58 was grown in DMEM:F12 with various drugs including those affecting: A - t h e 
microtubule network, B - the actin cytoskeleton, C - endocytic pathways and D -
energy generation and utilisation. Growth was monitored by measuring the ODgoo at 
time points following inoculation of the growth media. 
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We found that treatment with drugs that affected the microtubule network (Fig. 
5.1A) or actin cytoskeleton (Fig. 5.IB) had no effect on bacterial growth, even after 
24 hours. Inhibition of endocytosis using amiloride and monodansylcadaverine had 
no obvious effect on bacterial survival up to 8 hours, but after 24 hours inhibition of 
growth was seen (Fig. 5.1C). Sodium azide caused a general inhibition of growth rate, 
with less bacteria at all timepoints (Fig. 5.ID) while 2,3 butane-dione monoxisome 
(BDIVl) had no effect. 
5.1.1.2. The effect of drug treatments on monolayer integrity 
We were concerned that disruption of important host cell components such as the 
cytoskeleton could have a major impact on the integrity of the monolayers. 
Therefore we next assessed the effect of the selected drugs on the integrity of the 
monolayers by measuring TEER and permeability to fluorescent tracer (Fig. 5.2 and 
5.3). 
Monolayers of Calu-3 cells were established using standard conditions of seeding at a 
density of 4 x 10^ cells per well and culturing for five days in DMEM:F12. Polarised 
monolayers were then incubated with drugs for 24 hours, during which time the TEER 
and tracer permeability were monitored. Drugs which interfere with the microtubule 
network, including taxol (Fig. 5.2A), nocodazole (Fig. 5.2B), colchicine (Fig. 5.2C), and 
vinblastine (Fig. 5.2D) all reduced the TEER of the monolayers gradually, over the 
course of 24 hours. However, at 6 hours TEER remained above 50 % of the starting 
value. Despite a reduction in TEER, there was no detectable increase in the 
permeability of the treated monolayers to tracer even after 24 hours. 
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Figure 5.2 
Effect of microtubule disruption on the barrier function of Calu-3 monolayers 
Calu-3 monolayers were exposed for 24 hours to drugs that modulate the 
microtubule network including taxol (A), nocodazole (B), colchicine (C) and 
vinblastine (D). The effect of these drugs on barrier function was monitored at 
various time points by measuring TEER and checking their permeability to 
fluorescent, Texas red labelled, 70000MW dextran. Untreated layers (E), and layers 
treated with the drug solvent 0.1 % DMSO (F) were included as controls. 
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The effect on TEER appeared to be less marked for taxol and nocodazole than for 
colchicine or vinblastine. After a 24 hour exposure to the drug, TEER fell to -1000 Q 
and ~750 0 for taxol and nocodazole respectively, but fell below 500 Q for colchicine 
and vinblastine. Indeed for the former drugs the effect on TEER was similar to that 
seen for the solvent DMSO alone (Fig. 5.2F). Furthermore TEER fell in untreated 
monolayers to -1000 0 (Fig. 5.2E), indicating that plate movement and handling as 
part of the experimental procedure had an adverse effect on TEER. 
Drugs that disrupted the actin cytoskeleton, including latrunculin A (Fig. 5.3A) and 
cytochalasin D (Fig. 5.3B) had a dramatic effect on the integrity of the monolayer. 
Both of these drugs reduced TEER to less than around 10 % of the start TEER in the 
first hour after treatment. There was also a consistent increase in tracer permeability 
with these treatments, with fluorescence rising to ~0.2 units after 24 hours. Similar 
results were obtained with mono-dansycadaverine (Fig. 5.3C) and amiloride (Fig. 
5.3D), which caused loss of TEER and increased permeability to the tracer. 
Inhibition of mitochondrial respiration with sodium azide (Fig. 5.3E) had no effect on 
levels of TEER or tracer permeability compared to untreated or DMSO treated cells 
even after 24 hours. The same result was obtained with BDM, which inhibits the 
myosin ATPase (Fig. 5.3F). 
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Figure 5.3 
The effect of disrupting actin, endocytosis or energy metabolism on the barrier 
function of Calu-3 monolayers 
Calu-3 monolayers were exposed for 24 hours to drugs and their effect on barrier 
function was monitored at various time points by measuring TEER and permeability 
to fluorescent tracer. Drugs that modulate the actin cytoskeleton, including 
latrunculin A (A) and cytochalasin D (B) were used. Drugs that block endocytosis 
including mono-dansylcadaverine (C) and amiloride (D), were also assessed. ATP 
synthesis and utilisation were also targeted, using sodium azide (E) and BDM (F) 
respectively. 
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Taken together these results indicate that the majority of drug treatments have 
significant effects on the monolayer integrity and/or bacterial replication, and are 
therefore unsuitable for investigating the mechanisms of traversal. Hov/ever, some 
compounds including BDM, nocodazole and taxol had little detectable impact and 
were suitable for experiments. 
5.1.2. Analysis of the effect of taxol and nocodazole on monolayers 
Our data indicated that taxol and nocodazole are suitable for use on monolayers. 
The microtubule network was a good candidate for having a role in traversal because 
it is known that microtubules are required for long range trafficking of vesicles, 
including those containing pathogens such as S. typhimurium (Ramsden et a!., 2007a) 
and N. gonorrhoeae (Wang et al., 2007). 
To confirm the effect of these treatments on Calu-3 cells, monolayers were 
examined by microscopy 24 hours after drug treatment for the presence of 
microtubules and the tight junction protein occludin (Fig. 5.4). In untreated 
monolayers, occludin labelling is visible at the margins of all cells, indicating the 
presence of continuous tight junctions. Microtubule labelling is also distinct and 
organised, with concentrations of microtubules at the margins of cells. In the taxol 
treated monolayers, abnormalities in the microtubule network of cells, including cells 
undergoing abnormal cell division, were seen (Fig. 5.4). 
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Figure 5.4 
The effect of taxol and nocodazole on Calu-3 monolayers 
Monolayers of Calu-3 cells were treated with taxol, nocodazole or mock treated for 
24 hours then fixed. Labelling for ^-tubulin revealed disruption of the microtubule 
network following treatment with taxol and nocodazole. Labelling for the tight 
junction protein occludin demonstrates that these drugs do not cause detectable 
redistribution of tight Junctions. Scale bars = 5 |im. 
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In contrast, 3-tubulin labelling was diffuse throughout cells following nocodazole 
treatment, consistent with microtubule depolymerisation (Fig. 5.4). The distribution 
of occludin was unchanged following treatment with taxol or nocodazole, providing 
further evidence (along with the TEER and tracer data) that the layer remained intact 
despite drug treatment. 
5.1.3. The impact of microtubule disruption on meningococcal traversal 
Next we treated Caiu-3 monolayers with taxol or nocodazole, then infected them 
with MC58 at an MO! of 40. Drug treatment led to a marked and significant decrease 
in traversal of N. meningitidis at 8 and 24 hours post-challenge (p values for taxol or 
nocodazole treated layers, (p< 0.05 and p< 0.01 respectively. Fig. 5.5A). Bacterial 
recovery was also monitored in wells with the drugs but without cells and results are 
shown as the number of bacteria in the basal chamber as a percentage of the number 
of bacteria present in the absence of cells. The drugs had no effect on bacterial 
replication during experiments demonstrating that changes in the recovery of 
bacteria in the basal chamber could not be attributed to any direct effect of the drugs 
on bacterial replication. 
Interestingly, treatment of the layers with taxol or nocodazole did not affect the 
number of intracellular bacteria at 8 or 24 hours (Fig. 5.5B). This suggests that 
microtubules are important for host cell exit and not for entry or replication. Taken 
together, these data show that an intact microtubule network is important for 
successful traversal of the layer by N. meningitidis. 
153 
Figure 5,5 
Disruption of microtubules within the cells of the monolayer reduces traversal of N. 
meningitidis 
A - Monolayers of Calu-3 cells were treated with nocodazole or taxol, then 
challenged with MC58 at an MOI of 40. The number of bacteria in the basolateral 
chamber was established by plating at 8 and 24 hours post challenge. Both 
nocodazole and taxol caused a significant reduction in the number of bacteria in the 
basolateral chamber at both 8 and 24 hours when compared to untreated layers. B -
Recovery of intracellular bacteria following treatment with nocodazole or taxol. 
There was no significant difference in the number of intracellular bacteria at 8 or 24 
hours following treatment with either drug compared to untreated layers. No 
bacteria were recovered following gentamicin treatment in the absence of Calu-3 
cells (not shown). Each spot represents the results from an individual well. 
Horizontal bars represent the arithmetic mean of results. Error bars show the 
standard deviation from at least three separate experiments. Significant differences 
are indicated: * p < 0.05, * * p < 0.01, * * * p < 0.001 (Unpaired T-test). 
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5.2. Bacterial factors involved in traversal 
Transcellular traversal will include adhesion of bacteria to the epithelium, invasion of 
host cells, intracellular replication/survival, apical-basal movement, and basolateral 
escape from cells. We hypothesised that virulence factors of N. meningitidis already 
implicated in these processes could also play a role in traversal. To identify whether 
bacterial factors were involved in traversal, we performed competitive assays 
between the wild-type and mutant strains as described in the Materials and 
Methods. Briefly, the apical surface of Calu-3 monolayers were challenged with a 1:1 
ratio of the wild-type and mutant strains at a final MOI of 40, and the ratio of the 
strains exiting the layer was determined at 8 and 24 hours post-challenge. At these 
times, inserts containing infected membranes were washed thoroughly in media then 
transferred into new wells. Aliquots were taken from the basolateral chambers of 
new wells one hour later, plated to media with and without antibiotics, and the 
competitive index of the mutant calculated (Beuzon and Holden, 2001). 
The advantage of this approach is that it eliminates well-to-well variation in the 
overall level of traversal, allowing direct comparison of the extent of traversal of 
strains. Moving inserts to new wells for one hour allowed detection of the number 
of bacteria traversing over a one hour period limiting the time available for bacterial 
replication in the basolateral chamber. Wells with inserts lacking cells were also 
challenged as a control, and used to monitor the relative growth of different strains 
and their passage through the culture membranes. Rates were comparable for all 
the mutants in the absence of cells so differences in the ratio of bacteria in the basal 
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chamber cannot be attributed to differences in their growth rates in media or their 
ability to traverse membranes without cells. 
5.2.1. The meningococcal lactate permease has no role in traversal 
Previous work has shown that the utilisation of lactate as an energy source is 
important for survival of the meningococcus in nasopharyngeal tissue (Exiey et al., 
2005a). This study used a mutant lacking the gene encoding the lactate permease 
IctP that is required for lactate uptake. We hypothesised that utilisation of lactate 
might also be important for traversal. However, we found that MC58A/cfP has no 
defect for traversal compared to the wild-type strain at 8 or 24 hours (Fig. 5.6A). 
5.2.2. The role of TonB dependent receptors in traversal 
TBDRs are a large family of outer membrane proteins expressed in Gram-negative 
bacteria. They all rely on the inner membrane protein TonB to provide energy for the 
transport of molecules across the outer membrane, and are responsible for the 
uptake of key nutrients such as iron (Wandersman and Delepelaire, 2004). 
Replication of bacteria within host cells requires nutrients. There are a number of 
uncharacterised, putative TBDRs in the MC58 genome. In addition, meningococcal 
mechanisms for intracellular acquisition of nutrients are largely unknown, and we 
hypothesised that TBDRs of unknown function could be important during traversal. 
5.2.2.1. nmbl829 
Previous work demonstrated that an uncharacterised TBDR, NMB1829, has a role in 
colonisation and survival in the organ culture model (ExIey ef o/., 2009). However, we 
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found no defect in traversal for the mutant strain lacking this TBDR {MC58A1S25) 
compared to the complemented strain (Fig. 5.6C). 
5.2.2.2. nmbl882 
Work in our lab has shown that deletion of the gene encoding another TBDR, 
NMB1882, causes a defect in intracellular replication in Chang cells (R. Exiey, 
unpublished). The homologous gene in the gonococcus, tdfF, is also important for 
intracellular replication (Hagen and Cornelissen, 2006). We performed a competitive 
traversal assay, comparing this mutant to wild-type for its ability to cross the model 
epithelium, and found the mutant had a significantly reduced LogCI after 8 hours, 
which increased in magnitude after 24 hours to around -0.75 '(Fig. 5.6A). The 
mechanism for this defect is not clear but it seems likely that NMB1882 is involved in 
acquisition of intracellular nutrients. Iron supplementation restores the intracellular 
replication defect of the TdfF mutant in the gonococcus (Hagen and Cornelissen, 
2006). Interestingly there is also a putative site for Fur binding upstream of 
nmbl882. Fur is an iron regulated transcription factor [reviewed in (Carpenter et al., 
2009)] which suggests that NMB1882 may be involved in iron acquisition. It is also 
noteworthy that a gene, which is known to be important in intracellular survival, is 
implicated in traversal. This is consistent with our finding that the meningococcus 
traverses via a transcellular route. 
5.2.3. Type IV pili are important for traversal 
Tfp are filamentous structures which extend from the surface of bacteria and are 
composed of a number of different protein subunits. In N. meningitidis Tfp are 
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Figure 5.6 
Identifying bacterial factors with a role in traversal 
Competitive infections between MC58 and mutants lacking specific genes. A -
Competitive infections between MC58 and a mutant (MC58A/ctP) lacking the lactate 
permease gene {IctP). The loss of IctP does not affect traversal. B and C -
Competitive infections between MC58 and mutants affected in the genes encoding 
the putative TBDRs nmblSSI (B) or nmbl829 (C). MC58AnmJbl882 has a significant 
defect for traversal while MC58Anmbl829 does not. In C, A denotes a competitive 
index between the wild-type and mutant strains while C denotes a competitive 
infection between the wild-type and the complemented mutant. Each spot 
represents the results from an individual well. Horizontal bars represent the 
arithmetic mean. 
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fundamental for bacterial adhesion (Nassif et al., 1994), although they are also 
required for DNA uptake (Wolfgang et al., 1998), twitching motility (Merz et al., 2000) 
and bacterial aggregation (Helaine etal., 2005). 
Previously, Tfp have also been implicated in meningococcal traversal of a monolayer 
of gastrointestinal epithelial cells (Pujol et al., 1997). Therefore we examined the 
ability of a mutant lacking Tfp (MC58Ap/7f) to cross a respiratory epithelial cell 
barrier. We found that MC58Ap/7f had a significant defect for traversal across the 
Calu-3 monolayer after 24 hours with a mean logCI of approximately -0.7 (Fig. 5.7A). 
To determine at which stage Tfp contribute to traversal, we analysed the adhesion of 
pilus-deficient and wild-type bacteria to the polarised respiratory monolayer. Calu-3 
monolayers were grown for five days and then challenged with bacteria at an MOI of 
40. After three hours, monolayers were washed then treated with 1 % saponin to 
lyse cells and release all cell associated bacteria. The number of bacteria in the lysate 
was enumerated by plating to solid BHI media. Consistent with the CI for MC58Ap//f 
for traversal, the Tfp mutant had a significant defect for adhesion to the monolayer, 
with approximately a 7 fold reduction in adhesion for the pilus deficient mutant (p < 
0.001, Fig. 5.7B). Intracellular bacteria were also recovered from the layer at 8 and 
24 hours by lysis of monolayers with saponin, after a 30 minute gentamicin treatment 
to kill extracellular bacteria. The defect for adhesion was reflected in reduced 
numbers of intracellular bacteria in MC58Ap/7E infected monolayers compared to 
MC58 infected layers (Fig. 5.7C). There was a reduction of approximately one order 
of magnitude in the number of intracellular MC58Ap/7E bacteria compared to MC58. 
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Figure 5.7 
Tfp are important for traversal of the epitlieiial cell barrier 
A - Monolayers of Calu-3 cells were challenged with a 1:1 mixture of MC58 and 
IVICSSAp/VE on the apical surface and the ratio of the strains exiting the basolateral 
surface over one hour was determined 8 and 24 hours later. The mutant lacking Tfp 
had a significant defect for traversal. CI data are shown as the log competitive index 
(logCI). Each spot represents the result from an individual well from three separate 
experiments. Horizontal bars represent the arithmetic mean. B - Monolayers of 
Calu-3 cells were challenged with either MC58 or MC58Ap;7£ After three hours 
monolayers were washed and then lysed with 1 % saponin to release cell associated 
bacteria. There was a statistically significant reduction in the number of cell 
associated bacteria for the pilus deficient strain compared with MC58. C -
Intracellular bacteria were recovered by lysis of cells with saponin after gentamicin 
treatment. MC58Ap//E was present in reduced numbers within the cells of the 
monolayer after 8 and 24 hours compared with MC58. No bacteria were recovered 
following gentamicin treatment in the absence of Calu-3 cells (not shown). Error bars 
show the standard deviation from at least three separate experiments. Significant 
differences are indicated: * p< 0.05, * * p < 0.01, * * * p < 0.001 (Unpaired T-test). 
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5.2.4. The polysaccharide capsule is crucial to traversal 
Recent work using semi-confluent cells has demonstrated that the sialic acid 
polysaccharide capsule of N. meningitidis is important for survival within epithelial 
cells (Spinosa et al., 2007). We hypothesised therefore that the capsule may play a 
role in transcellular traversal of the polarised respiratory epithelia. We compared the 
strain MC58As/aD, which is unable to express a capsule due to loss of SiaD, the 
capsule specific sialyl-transferase (Hammerschmidt et al., 1996a), directly with the 
wild-type strain in a competitive infection. We found that the unencapsulated strain 
had a striking defect in traversal (Fig. 5.8A); after 8 hours the mean logCI of 
MC58As/aD was -1.2, while 24 hours the logCI had fallen to almost -4. 
To understand the stage at which this defect occurred, the adhesion of MC58As;aD to 
monolayers was compared with MC58. Consistent with previous work, we found that 
the capsule deficient strain had a significant increase in adhesion compared to MC58 
(approximately five fold) (p < 0.001, Fig. 5.8B). In addition, intracellular bacteria were 
recovered from MC58 and MC58As/oD infected monolayers after 24 hours. There 
was a significant reduction in the gentamicin-protected intracellular population of 
MC58As/oD compared with the wild-type strain at 24 hours post-inoculation (p < 
0.001, Fig. 5.8C). Previous work has shown that the capsule is not involved in cell 
invasion (Virji et al., 1993; Hammerschmidt et al., 1996b), so this defect is likely to 
reflect reduced intracellular survival as previously described (Nikulin et al., 2006; 
Spinosa et al., 2007). However, this reduction was smaller in magnitude 
(approximately three fold) than the defect for traversal (3 orders of magnitude) 
suggesting that the capsule has a function in basolateral escape from the monolayer. 
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Figure 5.8 
The meningococcal capsule is crucial for traversal 
A - The apical surfaces of Calu-3 cells were infected with a 1:1 mixture of MC58 and 
MC58AsiaD, and the ratio of bacteria exiting the basal surface over one hour at 8 and 
24 hours was determined. The capsule deficient strain had a significant defect for 
traversal. Data are shown as the log competitive index (logCI). Each spot represents 
the result from an individual well from three separate experiments. Horizontal bars 
represent the arithmetic mean. C - Monolayers of Calu-3 cells were challenged with 
either MC58 or MC58As/oD. After three hours monolayers were washed and then 
lysed with 1 % saponin to release cell associated bacteria. There was a significant 
increase in the number of cell associated capsule deficient bacteria compared with 
MC58. C - Despite increased adhesion, the capsule deficient mutant (MC58A5/oD) 
bacteria was present in reduced numbers within the cells of the monolayer after 24 
hours compared with MC58. Error bars show the standard deviation from at least 
three separate experiments. Significant differences are indicated: * p < 0.05, * * p < 
0.01, * * * p < 0.001 (Unpaired T-test). 
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5.2.5. Type IV piii and the polysaccharide capsule are important for 
traversal of AlC monolayers 
CI experiments were also performed using air interface culture (AlC) monolayers. 
Calu-3 monolayers can also be grown under AlC conditions where they have been 
reported to produce cilia and mucus (Grainger et al., 2006), and therefore may 
provide an even more physiologically relevant model (Grainger et al., 2006). Unlike 
in LCC monolayers, we found that bacteria were not present in the basolateral 
chamber after 8 hours (Fig. 5.9). However, bacteria were detected after 24 hours, 
although the total number of traversing bacteria was reduced by at least two orders 
of magnitude compared with LCC monolayers. Consistent with our results from LCC 
monolayers, both Tfp and capsule were necessary for efficient traversal. The defects 
in traversal for both MCSSAp/Vf (Fig. 5.9A) and MC58As/oD (Fig. 5.9B) were similar in 
magnitude to those seen in the LCC monolayers, although more well to well variation 
was observed. 
5.2.6. Comparison of expression of Type IV pili and capsule in apical and 
basolateral populations 
Tfp expression is downregulated after initial adhesion (Deghmane et al., 2002). Cell 
contact induces expression of genes with an upstream CREN sequence (contact 
regulated element of Neisseria) including CrgA. CrgA is then thought to repress 
expression of PilE and PilCl, thus reducing Tfp expression (Deghmane et al., 2002). 
To define whether alterations in pilus expression during adhesion are maintained 
after traversal of the monolayer, we performed slot blot analysis of colonies picked 
167 
from the apical and basolateral chambers of wells infected with MC58 for 24 hours. 
A total of 10 apical and 10 basolateral colonies were isolated and whole cell lysates 
were prepared from each then transferred to a PVDF membrane. Lysates of the Tfp 
mutant MC58ApilE and MC58 were included as controls. Membranes were 
developed with pAb against Tfp (a-Tfp SMI) to detect pilus expression. 
While 10 of 10 colonies in the apical chamber expressed Tfp, we found that only 8 of 
10 colonies were positive for Tfp in the basolateral chamber (Fig. 5.10A). In a repeat 
of the experiment (not shown), 9 of 10 colonies were Tfp positive in the basal 
chamber compared to 10 of 10 in the apical. The Tfp negative colonies are likely to 
be phase variants. Their appearance in the basolateral chamber suggests that there 
is selection against the expression of Tfp at some stage during traversal 
Capsule expression is also down regulated to allow intimate adhesion in a CREN 
dependent manner via CrgA (Deghmane et a!., 2002). To establish whether heritable 
changes in capsule expression also occurred during traversal, colonies in the apical 
and basolateral chamber of wells were examined for the presence of the capsule by 
ELISA 24 hours after infection with MC58. Killed bacteria (1 x 10^) from each colony 
were coated to each well of a 96 well plate and ELISA was performed using a primary 
antibody against the meningococcal serogroup B capsule (a-menB) serially diluted 
from 1:10 to 1:2560 in blocking buffer. All strains were found to be encapsulated; 
MC58As/aD was included as a negative control (Fig. 5.108 and C). 
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Figure 5.9 
Tfp and Capsule play a role in traversal of AlC monolayers 
A - CI experiment comparing traversal of IVIC58 and l\/iC58Ap//£ across AlC 
monolayers. In contrast to LCC monolayers, there was no traversal at 8 hours. 
However by 24 hours some bacteria had traversed the layer. Consistent with results 
from the LCC monolayers, the pilus deficient mutant had a defect for traversal 
compared to the wild-type. B - CI experiment comparing traversal of MC58 and 
IViC58As/oD across AlC monolayers. The capsule minus strain had a marked defect for 
traversal, consistent with results from LCC monolayers. CIs are shown as the log 
competitive index (logCI). Each spot represents the result from an individual well 
from three separate experiments. Horizontal bars represent the arithmetic mean. 
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Figure 5.10 
Comparison of Tfp and capsule expression In Input bacteria and bacteria recovered 
from the basolateral chamber 
A - Monolayers were challenged with MC58 at an MOI of 40. After 24 hours, 10 
colonies were recovered from the apical and basal chambers, and lysates were 
prepared and transferred to PVDF membrane by slot blotting. Membranes were 
probed for Tfp expression with a-Tfp SMI pAb. 8 of 10 colonies expressed pilus in 
the basolateral chamber compared to 10 of 10 in the apical chamber. The expression 
of pilus by MC58 and MC58Ap/7f are also shown. B - ELISA of capsule expression in 
10 colonies isolated from the apical and basolateral chambers of wells after a 24 hour 
incubation with MC58. A suspension of bacteria was made from each colony and 
killed by heating to 56 °C for one hour. Capsule expression was measured by ELISA 
using an anti-serogroup B antibody at a variety of dilutions (shown). MC58 and the 
capsule deficient mutant MC58As;oD were included as controls. All colonies 
expressed capsule except for MC58As/oD. C - Detailed ELISA values at an antibody 
dilution of 1/160. Spots represent the absorbance at 492 nm for individual strains. 
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6. THE ROLES OF CD46 AND TYPE IV PILI IN MENINGOCOCCAL ADHESION 
As discussed in the introduction CD46 has been proposed as the host cell receptor for 
Tfp of N. meningitidis. Briefly, purified Tfp bind to a protein with the same molecular 
mass as CD46, and bacterial adhesion to semi-confluent cervical cells can be inhibited 
by a-CD46 antibodies and purified CD46 (Kallstrom et a!., 1997). Filiated 
meningococci aggregate Staphylococcus aureus coated with a CD46 fusion while un-
piliated meningococci do not (Kallstrom et al., 1997). However, there are several 
lines of evidence against this hypothesis. For instance there is no correlation 
between levels of CD46 expression and meningococcal adhesion (Rahman et al., 
1997; Tobiason and Seifert, 2001; Kirchner et al., 2005). In addition, some results in 
primary human cells are not consistent with the CD46 receptor hypothesis (Edwards 
et al., 2002; Gill et al., 2003). For example, mAbs against CD46 do not inhibit the 
adherence of N. gonorrhoeae to the primary human cervical cells (Edwards et al., 
2002). The aim of the work in this chapter was to use the Calu-3 monolayer to better 
understand the adhesion of the meningococcus to the polarised respiratory 
epithelium and examine the role of CD46 in this initial step of pathogenesis. 
6.1. Expression and localisation of CD46 
There are four major isoforms of CD46 (Fig. 1.4) although the major extracellular 
domains (SCRs 1-4) are identical in all of them (Kim and Song, 2006). The isoforms 
arise from alternative splicing in the STP region and cytoplasmic C-terminal domain 
(Liszewski et al., 1991; Maisner et al., 1996). initial experiments were performed to 
determine whether CD46 was expressed by Calu-3 cells. Whole cell lysates of 1 x 10^ 
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Calu-3 cells were prepared and Western blotting was used to detect CD46 expression. 
Lysates of the same number of COS-7 and HeLa cells, which are known to express 
CD46, were also prepared (Liszewski et oL, 1991). We found Calu-3 cells expressed 
CD46 at similar levels to HeLa and COS-7 cells (Fig. 6.1A). Purified CD46 (SCR domains 
1-4) was also included. CD46 detection (at the size predicted for SCR domains only) 
demonstrates that the antibody is functional in western blots. 
As there are no previous reports of CD46 localisation in polarised respiratory 
monolayers, we next performed immuno-labelling for CD46 in Calu-3 monolayers. 
CD46 was localised at the lateral and basolateral margins of cells in the monolayer 
(Fig. 6.2B). This is consistent with the majority of the literature from a number of 
other cell types and tissue samples (Maisner et o/., 1996; Kinugasa et ol., 1999; 
Teuchert etol., 1999). 
6.2. In vitro interaction of CD46 vwth MC58 
6.2.1. Flow cytometry analysis of the interaction between MC58 and 
CD46 
Next the ability of MC58 to bind to purified CD46 protein (SCR domains) in vitro was 
assessed. To do this, 2 x 10^ fixed MC58 or MC58Ap/7£ were incubated with 0, 0.5, 1 
or 5 ng of purified CD46 for one hour. Bacteria were washed and CD46 binding was 
detected by antibody labelling and flow cytometry (Fig. 6.2). There was no 
detectable CD46 binding to the Tfp mutant, with levels of fluorescence comparable 
to those found in samples in which primary antibody or CD46 were omitted. 
However, there was statistically significant binding of CD46 to the wild-type strain. 
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The geometric mean fluorescence of samples increased from 1.37 to 1.94 as the 
quantity of CD46 protein increased from 0 ng to 5 |ig per 2 x 10^ bacteria (Fig. 6.2). 
6.2.2. Far Western blotting detects CD46 binding 
To further characterise the interaction between CD46 and N. meningitidis, far 
western analysis was used to detect binding of CD46 to bacteria. Briefly, lysates of 
MC58 and the isogenic Tfp deficient mutant MC58Ap/7f were separated by SDS-PAGE 
and transferred to a PVDF membrane. The membrane was then incubated overnight 
with or without purified CD46, washed, then probed for bound CD46 [using a-CD46 
(1.BB.442)], Class I Tfp (using a-SMl) and N. meningitidis (using a-menB pAb) as a 
loading control (Fig. 6.3). In the absence of CD46, no signal was detected when 
membranes were probed with a-CD46 pAb (1.BB.442), indicating that there was no 
non-specific binding of the antibody to bacterial proteins. In the presence of CD46, a 
number of bands were detected indicating binding to several proteins in the bacterial 
lysates. One band, with a predicted molecular mass of 18 kDa, was absent from 
lysates of MC58Ap/7E. This suggests that the protein to which CD46 is bound in this 
band is PilE itself, which is an 18.2 kDa protein. This was confirmed by probing the 
membrane for Tfp which revealed a band at 18 kDa present in MC58 but not 
MC58Ap/7f. Taken together these data show that CD46 binds to a number of MC58 
proteins, one of which is the major pilin, PilE. 
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Figure 6.1 
CD46 expression by different cell lines 
A - Analysis of expression of CD46 in lysates of cell lines by Western blot using the a-
CD46 pAb 1.BB.442. CD46 migrates with its predicted molecular mass of 50-79 kDa. 
The purified SCR domains are detected by the mAb as a band of 40 kDa. B -
Expression of CD46 in polarised monolayers examined by confocal microscopy. Five 
day old monolayers were fixed with 3 % PFA and CD46 was immunolabelled using a-
CD46 pAb (122-2) followed by an appropriate, FITC-conjugated, secondary antibody 
(green). Actin was counterstained with phalloidin conjugated to an Alexa 595 
fluorophore (red). CD46 expression is localised to the lateral and basolateral poles of 
cells in the monolayer. Scale bar = 5 |im. 
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Figure 6.2 
FACS analysis of purified CD46 binding to N. meningitidis 
Fixed bacteria (2 x 10^) were incubated for one hour with purified SCR 1 - 4 domains 
of CD46. Binding was analysed by FACS after bacteria had been labelled with a-CD46 
pAb (1.BB.442) and an appropriate, FITC-conjugated, secondary antibody. A -
Representative FACS plots of CD46 binding to MC58 and MC58Ap/7f showing dose 
dependent binding of CD46 to wild-type MC58. B - Average of geometric mean 
fluorescence from three separate experiments. Statistically significant binding of 
CD46 to MC58 was observed, although it was at the limit of detection. No binding of 
CD46 to the pilus deficient mutant was apparent. Error bars show the standard 
deviation from three separate experiments. Significant differences are indicated: * = 
* p < 0.05, ** p < 0.01, * * * p < 0.001 (Unpaired T-test). 
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Figure 6.3 
Far Western analysis of CD46 binding to wild-type and pilus deficient N. 
meningitidis 
Whole cell lysates of MC58 and MC58Ap//E were prepared then separated by SDS 
PAGE and transferred to a PVDF membrane. Membranes were incubated with or 
without purified CD46 overnight and probed for the presence of CD46 (with a-CD46 
pAb 1.BB.442), Class 1 Tfp (with a-TFP pAb SMI) and N. meningitidis B proteins (with 
a-menB pAb). Probing for bacterial proteins shows that samples were loaded 
equally. Probing for Tfp shows that the major pilin (PilE) ( a- ) migrates at the 
predicted size of 18 kDa and is absent from MC58Ap/7E. Probing for CD46 reveals that 
a number of proteins in bacterial lysates bind to purified CD46 including PilE, as this 
band (a- ) is absent from the MC58Ap/7f lysate. Sizes of a molecular weight marker 
are shown in kDa. 
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6.3. Physiological relevance of CD46 binding to adhesion of N. 
meningitidis. 
Our data showed that purified CD46 binds to fixed IViC58. However, binding was 
close to the detection limit by FACS and required large quantities of CD46 protein (up 
to 5 ng per 2 x 10^ bacteria). HeLa cells have been shown to express -100,000 CD46 
molecules per cell (Seya et oL, 1990; Cho et a!., 1991) which is the equivalent of just 
~1 ng of CD46 protein per 1 x 10^ host cells. Therefore we next investigated whether 
binding had a role during attachment of bacteria to polarised monolayers. 
6.3.1. CD46 does not co-localise with adherent bacteria 
The apical surfaces of Calu-3 monolayers were infected with MC58 at an MOI of 40 
for 8 hours then fixed and immuno-labeiled. Representative images (Fig. 6.4) show 
that, as in uninfected monolayers, CD46 remains localised to the lateral and 
basolateral margins of cells in the monolayer. Adherent bacteria are present on the 
apical surface of cells and do not co-localise with CD46. No re-distribution of CD46 to 
the site of bacterial attachment was detected. 
6.3.2. Purified CD46 does not interfere with meningococcal adhesion 
We hypothesised that if CD46 was indeed the receptor for Tfp, then purified CD46 
would compete with cells for binding to bacteria and would therefore interfere with 
adhesion. To test this, MC58 was incubated with purified CD46 for 30 minutes prior 
to infection of Calu-3 monolayers (6.25 ng CD46/1 x 10^ bacteria). At three hours 
post inoculation adherent bacteria were recovered. There was no significant 
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difference in the level of adhesion of CD46 bound bacteria compared to bacteria that 
w/ere not pre-incubated vjith CD46 (Fig. 6.5). These data are consistent with CD46 
binding playing no role in the adhesion of MC58 to the polarised respiratory epithelia. 
6.4. Construction of a stably transfected CD46" cell line 
To gain further insights into the role of CD46 in meningococcal adhesion and 
traversal, we decided to knock down CD46 expression in polarised monolayers of 
Calu-3 cells. Previous work showed that transient transfection of polarised 
monolayers of Calu-3 cells is inefficient compared with transfection of COS-7 cells 
(Florea et al., 2002). This is probably due to Calu-3 cell differentiation and mucin 
production which can inhibit access of transfection reagents to the cell surface 
(Florea et al., 2002). Transfection rates of unpolarised Calu-3 cells, however, are 
comparable to COS-7 cells. Therefore we decided to generate a stably transfected 
line of Calu-3 cells using a retroviral transfection system. This cell line would carry a 
stably integrated DNA construct encoding an shRNA targeted to knock down CD46 
expression. This stable cell line could then be used to grow CD46" monolayers. 
The strategy for developing the stable cell line is detailed in the Materials and 
Methods. Briefly, oligonucleotides encoding shRNAs against target sequences in 
CD46 are cloned into a packaging vector, pReSI - Puro. Constructs are then 
transfected into the amphitropic retroviral packaging cell line, Phoenix, using 
lipofectamine. 
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Figure 6.4 
Localisation of CD46 in infected monolayers 
Monolayers of Calu-3 cells were infected with MC58 expressing eGFP (green) at an 
MO! of 40 for 8 hours, then fixed with 3 % PFA. CD46 was immunolabelled using a-
CD46 pAb (122-2) followed by a RRX (red) secondary antibody; actin was stained 
using phailoidin conjugated to Alexa 647 (blue). Representative images are shown. 
There was no redistribution of CD46 in the monolayer following infection with N. 
meningitidis, with the pattern of CD46 labelling indistinguishable from that seen in 
uninfected layers. Scale bars = 5 [im. 
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Figure 6.5 
Purified CD46 does not compete with MC58 for binding to Calu-3 cells 
IVIonoiayers of Calu-3 cells were inoculated at an MOI of 40 with MC58 mixed with 25 
|ig of purified CD46 per well (1 x 10^ cells). MC58 and purified CD46 were pre-
incubated for 30 minutes prior to challenge. Monolayers were also infected with 
MC58 pre-incubated with DMEM:F12 as a control. Cell-associated bacteria were 
recovered after three hours and enumerated by plating to solid media. Pre-
incubation with CD46 had no significant effect on association of MC58 with the Calu-
3 monolayer. Error bars show the standard deviation from at least three separate 
experiments. 
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Phoenix cells are based on 293T cells, but express the Gag, Pol and Env proteins of 
Moloney Murine Leukemia Virus (MMULV). The pReSI - Puro vector encodes the 
viral long terminal repeats (LTRs) and packaging signal so sequences cloned into the 
vector are packaged into pseudoviral particles when the construct is transfected into 
the Phoenix cells. 
At 48 hours after transfection supernatants containing pseudovirus are harvested 
from Phoenix cells, filtered, and used to infect semi-confluent Calu-3 cells. In 
principal, integration of the pseudovirus into the genome of cells should introduce 
the shRNA producing sequence, as well as a puromycin resistance gene. Long term 
growth in the presence of puromycin would then allow the selection of a polyclonal, 
CD46" stable cell line. 
6.4.1. Design of shRNA constructs to knockdown CD46 expression 
Criteria for the selection of shRNA target sequences have been proposed by Scott 
Frank (Frank et a!., 2006, Scott Frank (personal communication)) and are detailed in 
Fig. 6.6A. The sequence of CD46 was scanned for potential shRNA target sequences. 
Four target sequences fulfilling the criteria were found and named shCD46 1 - 4 (Fig. 
6.68). Target sequences were used to design oligonucleotides that would form 
shRNAs against CD46 when transcribed. To do this, the target sequence was linked 
to the antisense sequence by a 15 base, stem loop forming linker, and a DNA Pollll 
terminator sequence was added to the 3' end. Restriction sites were also added to 
the ends of oligonucleotides to facilitate cloning, and a C/ol site was included to allow 
identification of successful recombinants following transformation (Fig. 6.6C). 
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Complementary oligonucleotides were annealed and ligated into the pReSI - Puro 
vector (Fig. 6.6D), then transformed into E. coli. Successful ligation was identified by 
performing a C/ol digest on plasmids isolated from transformants. Cla\ digestion of 
pReSI - Puro yields the linearised 6.5 kB plasmid. In successful transformants, the 
Cla\ site introduced in the insert results in two bands, of 1.5 kB and 5 kB following 
digestion. Constructs encoding all 4 different shRNA sequences were successfully 
generated (Fig. 6.6E). 
6.4.2. Optimisation of lipofectamine transfection 
Next the shCD46 constructs were tested for their ability to silence CD46 expression. 
This required transient transfection of Calu-3 cells with the constructs. To achieve 
this, Lipofectamine 2000 was used and to maximise the chances of observing an 
effect, the protocol to give the highest possible level of Calu-3 cell transfection was 
optimised in both 6 and 24 well plate formats. Initial experiments were performed 
with a GFP encoding plasmid, pEGFP-Nl. Cells were harvested 48 hours post 
transfection and the transfection efficiency was assessed by FACS analysis. 
Transfected cells are fluorescent due to GFP expression. 
The transfection efficiency was determined at a range of DNA concentrations and cell 
densities in both 6 and 24 well plate formats. DNA was also omitted from 
transfection of some samples as a control (Fig. 6.7A and Fig. 6.8A). For each set of 
conditions, the fluorescence index (Fl) (% of cells transfected x geometric mean 
fluorescence) (Fig. 6.7B and Fig. 6.8B) was calculated and the percentage of cells 
transfected (Fig. 6.7C and Fig. 6.8C) was recorded. 
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In the 24 well plate format we obtained the highest Fl (20973 units) when 2 x 10^ 
cells were seeded/well and transfected with 1 ng of DNA (Fig. 6.7). However, in this 
case, although expression was high in transfected cells, only 56 % of cells were 
transfected. For all further transfections we decided to use 1 ng of DNA and a 
seeding density of 1 x 10^ cells/well as this gave the second highest Fl (16660 units) 
and also a high percentage of transfected cells (68 %) (Fig. 6.7). 
In the 6 well format, the highest Fl (27375 units) was obtained with a seeding density 
of 8 X 10^ cells and 4 |ig of DNA per well. However, just 62 % of cells were 
transfected under these conditions. Therefore we opted to use a seeding density of 4 
X 10^ cells per well, and transfect with 4 |ig of DNA. This gave a higher level of 
transfection (75.63 %) with slightly reduced Fl (18154 units). 
6.4.3. Testing the efficiency of shCD46 constructs 
6.4.3.1. Western blot analysis of CD46 knockdown by shCD46 
The ability of the four shCD46 constructs to reduce CD46 expression was determined 
by transfecting them into Calu-3 cells and monitoring CD46 expression by Western 
blotting. Cells were seeded at a density of 4 x 10^ cells per well in 6 well plates, 
grown overnight, then transfected with one of the shCD46 constructs 1-4, an shRNA 
construct containing scrambled sequence (shRNA-Mock), or PBS alone. 
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Figure 6.6 
Generating shRNA constructs to target CD46 
A - Selection criteria for the 21 base shRNA target sequences: i) Essential nucleotide 
positions are indicated and other nucleotides are represented by X. ii) 7 to 9 
guanines (G) or cytosines (C) at positions 1 to 19 (underlined), iii) 4 to 7 G or C bases 
at positions 1 to 11 (blue), iv) Five or more adenines (A) or thymines (T) at positions 
13 to 19 (red), v) Poly-C or poly-G stretches should be avoided, vi) Runs of more 
than three Ts should be avoided. B - Coding sequence of the human CD46 gene. 
Exons are show/n in blue, introns in black. Four potential shRNA target sequences 
(highlighted in yellow) were selected and named shCD46 1-4. C - Structure of shRNA 
oligonucleotides. Sense sequence was linked to antisense sequence by a 15 base 
stem loop forming sequence and a PolllI terminator sequence was added to the 3' 
end. 6amHI and HinDlW sites were added to the 5' and 3' ends respectively, and a 
C/al site was introduced close to the 3' end to allow identification of recombinants. 
Complementary DNA oligonucleotides were annealed and ligated into pReSI - Puro 
(D) and transformed into E. coli. E - DNA fragments resulting from C/ol digestion of 
plasmids isolated from transformants. C/ol digestion of pReSI - Puro produces a 6.5 
kB linear plasmid. Following successful ligation a further C/ol site is introduced into 
the vector yielding two bands of 1.5 kB and 5 kB after digestion. 
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Figure 6.7 
Optimisation of transfection with Lipofectamine in 24 well plates 
Calu-3 cells were seeded at different densities in 24 well plates. The following day 
pEGFP-Nl (encoding GPP) was transfected into cells using lipofectamine. DNA was 
diluted in Optimem then combined with 2 |al of Lipofectamine. After 20 minutes the 
Lipofectamine/DNA mixture was added to a well in Optimem. After five hours the 
media was removed and replaced with normal culture media. Levels of transfection 
were assessed using flow cytometry. Fluorescence of 10,000 cells was measured. A 
- Histogram of representative flow cytometry results showing levels of GFP 
fluorescence (FLl-H) in untransfected cells. B - The mean Fl following transfection 
using different DNA concentrations and cell densities are shown. The Fl was 
calculated by multiplying the geometric mean of fluorescence by the percentage of 
transfected cells. C - Representative histograms showing the percentage of 
transfected cells when different DNA concentrations and cell densities were used. 
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Figure 6.8 
Optimisation of Lipofectamine transfection protocol for 6 well plates 
Calu-3 cells were seeded at different densities in 6 well plates. The following day the 
GFP encoding plasmid pEGFP-Nl was introduced into cells at two concentrations 
using 6 |al of lipofectamine per well. Levels of transfection were assessed by flow 
cytometry. Fluorescence of 10,000 cells was measured. A - Representative 
histogram FACS results showing levels of GFP fluorescence (FLl-H) in untransfected 
cells. B - The Fi for transfection at different DNA concentrations and cell densities 
are shown. The FI was calculated by multiplying the geometric mean of fluorescence 
by the percentage of transfected cells. C - Representative histograms showing the 
percentage of transfected cells when different DNA concentrations and cell densities 
were used. 
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At 48 hours after transfection, cells were lysed and CD46 expression was analysed by 
Western blotting (Fig. 6.9). Equal loading of samples was assessed by probing blots 
for tubulin. The level of CD46 expression for all four shCD46 constructs was 
indistinguishable from levels seen in shRNA-Mock transfected, PBS transfected, or 
untransfected cells. This suggests that the constructs were ineffective at knocking 
down CD46 expression. However, with a transfection efficiency of ~75 % in tests 
with pEGFP-Nl, we were concerned that Western blotting might not be sufficiently 
sensitive to detect a reduction in CD46 levels. It was possible that reduction of CD46 
expression in transfected cells was masked by the presence of untransfected cells, 
still expressing CD46. 
6.4.3.2. Flow cytometry analysis of CD46 knockdown by shCD46 
Therefore, to establish whether the constructs were capable of reducing expression 
of CD46 we next assessed CD46 expression using flow cytometry (Fig. 6.10). Calu-3 
cells were seeded at a density of 1 x 10^ per well in a 24 well plate and transfected 
with 1 [ig of DNA per well. As above, cells were transfected with one of the shCD46 
constructs, the shRNA-Mock construct or PBS. After 48 hours the cells were 
harvested, labelled for CD46 expression and analysed by flow cytometry. The 
geometric mean fluorescence of shCD46 construct transfected cells was compared to 
that from shRNA-Mock transfected cells. 
There was no significant difference for shCD46 2 or shCD46 3 transfected cells, but a 
small significant reduction in CD46 expression was observed in cells transfected with 
shCD46 1 where the geometric mean fluorescence was 85 % of that in cells 
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transfected with shRNA-Mock (Fig. 6.10A). The most marked reduction was detected 
in shCD46 4 transfected cells, with expression at approximately 80 % of shRNA-Mock 
transfected cells. This construct was selected for making a stable cell line. 
6.5. Attempts to create a CD46 knockdown cell line 
Phoenix cells were transfected with either the shCD46 4 construct or the shRNA-
Mock construct. After 48 hours the supernatants (potentially containing pseudoviral 
particles) were removed from transfected cells and used to infect dishes of semi-
confluent Calu-3 cells. At 24 hours after infection, the culture medium was replaced 
with media containing puromycin to select cells infected with the retrovirus. Cells 
were maintained in puromycin to select for stably transfected cells expressing the 
shRNA constructs. However, despite attempts using several concentrations of 
puromycin (2.5 |ig/ml - 25 |ig/ml) no Calu-3 cells were viable after 7 to 14 days. 
Uninfected cells exposed to puromycin died after the same length of time. Further 
work is needed to optimise this protocol and establish the cell line. Understanding 
the role of CD46 in adhesion and traversal of a polarised respiratory cell model 
should help clarify the role of CD46 in a human infection setting. 
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Figure 6.9 
Western blot analysis of the effect of shRNA constructs 
Western blot analysis of CD46 expression in Calu-3 cells 48 hours after transfection. 
Calu-3 cells were transfected with shRNA constructs shCD46 1-4, and then harvested 
48 hours later. Untransfected cells, mock transfected cells, and cells transfected with 
shRNA-Mock (containing a scrambled shRNA sequence) were included as controls. 
Levels of CD46 were detected with a-CD46 pAb (1.BB.442). No reduction in 
expression was detected using the shCD46 constructs compared to the controls. 
Membranes were also probed for tubulin to demonstrate equal loading of lanes. This 
experiment was repeated four times. 
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Figure 6.10 
Flow cytometry analysis of the effect of shRNA constructs 
Calu-3 cells were transfected with shRNA constructs shCD46 1-4, then after 48 hours 
harvested and processed for FACS analysis using a-CD46 (1.BB.442) pAb. 
Untransfected cells, mock transfected cells, and cells transfected with shRNA-Mock 
were included as controls. A - Average level of CD46 expression at 48 hours after 
transfection relative to shRNA-Mock transfected cells. Expression did not fall below 
80% of control for any of the constructs. shCD46 4 gave the most significant 
knockdown. Error bars show the standard deviation from three separate 
experiments. B - Representative histograms showing levels of CD46 expression 
obtained with each of the shCD46 constructs compared to controls. 10,000 cells 
were analysed per sample. Significant differences are indicated: * p < 0.05, ** p < 
0.01, * * * p < 0.001 (Unpaired T-test). 
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7. DISCUSSION 
7.1. N. meningitidis interactions with semi-confluent Calu-3 cells 
Previous work has established that the Calu-3 cell line reproduces the features of a 
differentiated, functional human airway epithelium when grown on permeable cell 
culture inserts (Shen et al., 1994; Grainger et ai, 2006). Indeed Calu-3 cells are the 
principal cell line employed in research into tracheobronchial epithelial permeability 
and have been used extensively in studies of drug delivery and toxicology (Cavet et 
al., 1997; Ehrhardt et al., 2002; Pezron et oi, 2002; Fiegel et ol., 2003; Cooney et ai., 
2004; Li et al., 2006a). Furthermore expression of the CFTR has enabled its use in CF 
research (Li et al., 2006b). 
No studies have previously reported N. meningitidis challenge of Calu-3 cells. We 
have demonstrated that semi-confluent Calu-3 cells grown on impermeable 
substrates exhibit similar patterns of adhesion and uptake of N. meningitidis as Chang 
cells, which have been widely used for studying this bacterium (Merz et al., 1999; 
Capecchi et al., 2005; Exiey et al., 2005a; Exiey et al., 2009). We also found that 
adhesion of the meningococcus to Calu-3 cells was dependent on Tfp, consistent with 
work with other cell lines (Virji et al., 1992; Pujol et al., 1997; Nassif et al., 1999), and 
that invasion occurs at low, but appreciable levels. 
We performed TEM studies of infected, semi-confluent Calu-3 cells. A striking level 
of interaction between host cells and adherent bacteria was detected. The 
morphology of the host cell plasma membrane was altered at the point of contact 
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with bacteria. In many cases the bacteria were atop pedestal like structures, 
reminiscent of changes seen on epithelial cells infected with enteropathogenic E. coli 
(EPEC) [reviewed in (Campellone and Leong, 2003)]. Tight adhesion of N. 
meningitidis to cells has been reported elsewhere but the level of re-modelling in the 
Calu-3 cells is particularly extensive, and is similar in appearance to the changes seen 
in infected tissues in the organ culture model (Stephens et ol., 1993). We were also 
able to detect intracellular bacteria within semi-confluent Calu-3 cells by TEM and 
immunofluoresence microscopy. These bacteria appeared to be within vacuoles. 
Following infection of Calu-3 cells with N. meningitidis, we noted that 
permeabilisation with 0.1 % saponin did not allow labelling of intracellular bacteria 
whereas permeabilisation with 0.2 % T X-100 did. This was also seen in Chang and 
HeLa cells. Infection with eGFP expressing MC58 revealed that intracellular 
meningococci were still protected from a-LPS antibodies after permeabilisation with 
0.1 % saponin or SLO but not after treatment with T X-100. Both saponin and SLO 
target cholesterol (Bhakdi et al., 1985; Jacob et al., 1991; Ohno-lwashita et at., 1991; 
Sekiya et al., 1993) where as T X-100 permeabilisation is cholesterol-independent. 
The resistance of the NCV to cholesterol dependent permeabilisation suggests that it 
has a low cholesterol content. Filipin staining of cholesterol confirms this. Our 
permeabilisation and labelling protocols were validated using Solmonello, which is 
enclosed in a cholesterol rich vacuole (Catron etol., 2002) as a positive control. 
Cholesterol alters the physiochemical properties of phospholipid membranes (Yeagle 
PL In: Finegold L, 1993). In biological membranes, cholesterol increases order of the 
membrane (Yeagle, 1985; Ohvo-Rekila et al., 2002) rendering it stable yet flexible 
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(Yeagle, 1985; Needham and Nunn, 1990). Because cholesterol affects membrane 
properties, it can also influence the behaviour and functions of proteins residing in 
the membrane, as w/ell as partition subsets of proteins to sections of membrane with 
differing cholesterol contents (Yeagle, 1991). 
Lipid rafts are areas of the plasma membrane with increased cholesterol and 
sphingomyelin content (Simons and Ikonen, 1997). As a result, specific subsets of 
proteins are partitioned into rafts, allowing them to serve as organising centres for 
signalling molecules and second messenger effectors (Golub et al., 2004). Lipid raft 
domains are often sites for the initiation of cellular processes such as caveolae 
formation and clathrin mediated endocytosis (Incardona and Eaton, 2000; Ohvo-
Rekila et al., 2002). Interestingly, rafts are known to function as sorting devices to 
distribute proteins to the apical side of epithelial cells (Fullekrug and Simons, 2004) 
and perhaps because of this spatial availability, interaction with host rafts is a 
common strategy used by bacteria to enter cells. For example CD55, which is 
localised to the apical surface of epithelia by partitioning into to raft domains is the 
receptor for several E. coll strains (Peiffer et al., 1998; Selvarangan et a!., 2000). 
Vesicles consisting of lipid rafts, and hence with a high cholesterol content, are also 
prevented from entering the degredative compartments (Simons and Gruenberg, 
2000). Therefore accumulation of lipid raft domains (and hence cholesterol) either 
during invasion [e.g. M. tuberculosis (Gatfield and Pieters, 2000)] or post entry [e.g. 
Chlamydia spp. (Norkin et al., 2001)], assists intracellular survival. S. typhimurium 
extensively modulates the cholesterol levels in the cell (Catron et al., 2002; Parwez et 
al., 2008). During the late stages of S. typhimurium infection it has been shown that 
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as much as 30 % of total cellular cholesterol is recruited to the SCV (Catron et a!., 
2002). It also appears that cholesterol esterification by the Salmonella secreted 
protein effector SseJ is functionally important for intracellular bacterial survival 
(Parwez et ai, 2008). 
The low cholesterol content of the NCV may reflect either a raft independent route of 
entry, or the ability of as yet unknown bacterial effectors to remove cholesterol from 
the NCV. It also suggests that the mechanisms of intracellular survival may be 
significantly different from that of pathogens that hijack high cholesterol content 
rafts for intracellular survival such as Legionella pneumophila (Watarai et al., 2001), 
P. aeruginosa (Grassme et al., 2003), S. typhimurium (Catron et al., 2002; Garner et 
al., 2002), S. flexineri (Lafont et al., 2002), Chlamydia spp (Norkin et al., 2001) and M. 
tuberculosis (Gatfield and Pieters, 2000). 
There is considerable heterogeneity in the cholesterol content of eukaryotic 
phospholipid membranes. Most unesterified cholesterol can be found in the plasma 
membrane. Depending on the cell type and the assay used, plasma membranes have 
been reported to contain between 40 and 90 % of the total cellular unesterified 
cholesterol (Lange et al., 1989; Lange, 1991; Liscum and Munn, 1999; van Meer and 
Sprong, 2004). The nuclear envelope, mitochondria and endoplasmic reticulum have 
a low cholesterol content (Yeagle and Finegold, 1993; Liscum and Munn, 1999) and it 
is possible that the low cholesterol content of the NCV mimics one of these 
compartments to avoid degradation. It is also interesting that depleting cellular 
cholesterol levels increases the rate of apical to basal transcytosis of dimeric IgA 
across a polarised monolayer of MDCK cells (Leyt et al., 2007). Therefore the low 
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cholesterol content of the NCV may represent evolution of the pathogen for a rapid 
transit, to avoid intracellular degradation. 
Characterisation of the lipid composition of the NCV could be informative as 
attempts to identify endocytic markers with which it associates have thus far yielded 
little information. No markers of intracellular compartments have been found to 
consistently co-localise with intracellular meningococci (Virji et al., 1991; Pujol et al., 
1997; Nikulin et al., 2006) although there is some evidence that in HBMEC cells NCVs 
acquire TfR and LAMP-1 (Nikulin et al., 2006). Tala and co-workers attribute the lack 
consistent co-localisation of intracellular N. meningitidis with protein markers to the 
fact that the NCV does not exist, suggesting instead, that the intracellular 
meningococcus is free in the cytoplasm (Tala et al., 2008). However, our TEM data 
and permeabilisation studies suggest that this is not the case. Likewise TEM images 
of encapsulated meningococci within cells of the nasopharyngeal OCM clearly show 
them enclosed within vacuoles (Stephens et al., 1993). 
A new FRET-based CCF2/B-lactamase reporter assay, used to assess the time after 
infection that Shigella escapes its intracellular vacuole (Ray, in press), may make it 
possible to demonstrate conclusively whether the meningococcal surface comes into 
contact with the cytoplasm (Ziokarnik et al., 1998; Charpentier and Oswald, 2004). 
Briefly, bacteria are biochemically linked to a ^-lactamase enzyme and host cells are 
pre-loaded with a CCF2 substrate. The substrate consists of two fluorphores linked 
by a cephalosporin core. The core is susceptible to cleavage by ^-lactamases, 
therefore the presence of this enzyme linked to bacteria in the cytosol causes 
fluorophore cleavage and a detectable shift the fluorescence emission wavelength. 
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This method should make it possible to say definitively whether the meningococcus 
escapes the NCV. 
7.2. Developing a model of the respiratory epithelial barrier 
Understanding the interactions of pathogens with host cells is of vital importance to 
our understanding of disease progression. Infection of semi-confluent cells, cultured 
on impermeable substrates, is a simple and convenient way to study certain aspects 
of these interactions such as adhesion and invasion. However, results from cells 
grown to semi-confluency cannot always be directly extrapolated to the in vivo 
situation. The use of confluent, polarised, monolayers of cells grown on permeable 
supports mimics better the physiologically relevant situation and can provide insights 
that cannot be found by any other methodology. This is demonstrated by work on S. 
flexneri where confluent polarised monolayers of Caco-2 intestinal epithelial cells 
were used to show that entry of the bacteria into epithelial cells is restricted to the 
basolateral surface. This indicates that Shigella penetrates the intestinal epithelial 
barrier through M-cells rather than through epithelial cells as previously supposed 
(Mounier et ai, 1992). Other work using polarised monolayers of MDCK cells 
identified a novel adhesin in Salmonella which is specifically involved in adhesion to 
polarised cells (Gerlach et ai, 2008). 
The ability of bacteria to cross cellular barriers is critical during colonisation and 
disease. These barriers can be formed in the host by a variety of cell types including 
epithelial and endothelial cells, and at mucosal surfaces they form a key component 
of innate immunity against infectious agents. The first cell barrier encountered by 
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bacteria in the nasopharynx is the pseudostratified columnar epithelium of the upper 
respiratory tract. In this work we used the Calu-3 monolayer to investigate epithelial 
traversal by N. meningitidis. 
When propagated on semi-permeable membranes under LCC, Calu-3 cells polarise 
and form monolayers (Shen et al., 1994; Grainger et al., 2006). Two techniques were 
used to monitor the development of monolayers, measurement of TEER and 
permeability to a fluorescent tracer. TEER is a measure of the electrical resistance 
across the layer and represents to some extent the integrity of tight junctions (Balda 
et al., 1996). We also used Texas red labelled 70,000 MW dextran as a fluorescent 
tracer. We established a working concentration at which small changes in 
concentration of the tracer gave the largest changes in fluorescence and confirmed 
that there was no degradation of the tracer in the presence of cells over 24 hours. 
We could therefore be confident that significant increases in the permeability of the 
layer to macromolecules would be easily detectable, by the concomitant increase in 
fluorescence of media in the basolateral chamber. In general we found that the 
permeability of the layer to the tracer was less sensitive than the TEER. Indeed even 
in instances where TEER was reduced by 40 % we did not detect diffusion of the 
tracer across the layer. The correlation between these two methods was 
demonstrated by monitoring TEER and tracer permeability for six days after seeding. 
The decreasing permeability of developing layers to tracer correlates with increasing 
TEER. 
We optimised several parameters for growing Calu-3 monolayers, including the 
seeding density (4 x 10^ per cm^), membrane pore size (1 jam) and the use of 
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monolayers five days post seeding. Furthermore we found that pre-coating 
membranes with a mixture of laminin and fibronectin gave approximately a 10 % 
increase the TEER of the monolayer at five days post seeding. However, this protocol 
was not used in experiments because it was time consuming and in our hands, Calu-3 
cell monolayers produced upwards of 1850 Q of TEER without coating. This is higher 
than previous studies using this cell line (Ehrhardt et al., 2002; Patel et ai, 2002; 
Florea et ol., 2003; Cooney et al., 2004), perhaps due to the different membrane pore 
size used; other studies used 0.4 |im pore size membranes. In addition, the 
distribution of the tight junction proteins ZO-1 and occludin, as well as electron 
microscopy of monolayers, demonstrated that the cells displayed all the 
characteristics of polarised epithelial cells linked by a full range of junctional 
structures. These data, combined with the finding that the layers were impermeable 
to fluorescently labelled tracers and non-pathogenic E. coli, show that the LCC 
monolayers provide a good model of the upper respiratory epithelium. 
Calu-3 monolayers can also be grown under AlC conditions (Forbes and Ehrhardt, 
2005; Grainger et al., 2006). This is a more lengthy process, and cells can be used up 
to 18 days post seeding (Borchard et al., 2002). Grown in this way the cells can 
produce cilia and mucus (Grainger et al., 2006) and may therefore produce an even 
more physiologically relevant model of the nasopharyngeal epithelium for use in the 
future. We found that the AlC monolayers generate about half the TEER of LCC 
monolayers. This is consistent with previous work (Grainger et al., 2006), but the 
reasons are not clear. TEM examination of the AlC layers showed that they 
resembled LCC monolayers morphologically, without developing cilia or evidence of 
210 
mucus production. In the future it would be possible to extend the time for 
differentiation of the AlC layer to see if these features develop. Consistent growth of 
differentiated, cilliated, epithelia may be a useful extension to the relevance of the 
model in studying the pathogenesis of N. meningitidis, and could be used to validate 
reports that the meningococcus binds only to non-cilliated cells in the 
nasopharyngeal epithelium (Stephens et al., 1983). 
7.3. N. meningitidis traverses the monolayer by a transcellular 
route 
We detected passage of N. meningitidis across Calu-3 monolayers within 8 hours of 
challenge, but by 24 hrs the number of bacteria traversing over one hour had 
increased by approximately four orders of magnitude. N. meningitidis still traversed 
the AlC monolayers but this occurred significantly slower than through LCC 
monolayers for unknown reasons. Potential explanations for this include increased 
or altered production of mucus, or changes in receptor expression or distribution; 
these possibilities could be investigated in the future. 
There is a distinction between pathogens such as S. typhimurium which utilise a 
transcellular route to cross epithelial cell monolayers (Finlay et al., 1988), and those 
pathogens (including bacterial, fungal and viral) which cross by a paracellular route. 
In all reported cases paracellular traversal requires destruction of cells or disruption 
of tight junctions (Lee et al., 1999; Katz et al., 2000; Cywes and Wessels, 2001; Katz et 
al., 2002; Kim et al., 2005; Lytton et al., 2005; Soriani et al., 2006; Figueiredo et al., 
2007; Vermeer et al., 2007; Attali et al., 2008; Sajjan et al., 2008). The only previous 
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studies of bacterial traversal of Calu-3 monolayers (by P. aeruginosa and B. cepacia) 
found monolayer disruption and paracellular passage (Lee et al., 1999; Kim et al., 
2005). 
Until this study, knowledge of epithelial traversal by N. meningitidis was limited to 
three studies which proposed both paracellular and transcellular routes and did not 
focus specifically on the route of traversal. The cell lines used were not 
physiologically relevant with two studies performed in monolayers of T84 intestinal 
epithelial cells (Merz et al., 1996; Pujol et al., 1997) and one study utilising a bi-layer 
of endometrial epithelial cells and microvascular endothelial cells (Birkness et al., 
1995). The bilayer study found long columns of bacteria between cells, as well as 
some traversing in vacuoles through cells (Birkness et al., 1995). However, the 
epithelial cells in this model do not polarise, which may affect the distribution of 
surface receptors and therefore bacterial adherence and traversal. Studies with T84 
intestinal epithelial cells show that barrier function is maintained during traversal, 
and on this basis alone suggest a transcellular route is more likely (Merz et al., 1996; 
Pujol et al., 1997). 
We found that Calu-3 monolayers also continued to display barrier function during 
traversal of N. meningitidis. There was a minor reduction in TEER across the 
monolayers following bacterial challenge, including challenge with non invasive E. 
coli. However, levels of TEER never fell to less than 40 % of the initial readings, in 
contrast to the complete loss of resistance seen when paracellular traversing 
pathogens infect monolayers (Lee et al., 1999; Katz et al., 2000; Cywes and Wessels, 
2001; Katz et al., 2002; Kim et al., 2005; Lytton et al., 2005; Soriani et al., 2006; 
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Figueiredo et al., 2007; Vermeer et al., 2007; Attali et al., 2008; Sajjan et ai, 2008) or 
following drug treatments [this study; (Madara et al., 1986)]. For instance 
cytochalasin D or latrunculin, which disrupt tight junctions (Shen and Turner, 2005), 
reduce TEER to less than 100 Q within 30 minutes (not shown). We found that TEER 
highly sensitive, fluctuating in response numerous factors including handling of cell 
culture plates. This resulted in a reduction of TEER even in uninfected control wells. 
In light of these observations, it is unlikely that the drop in TEER seen during infection 
represented a significant disruption to the integrity of the layer. This is supported by 
the monolayers remaining impermeable to fluorescent tracer and there being no 
change in the distribution of ZO-1 following infection. Additionally we were unable 
to detect any cell destruction or alteration of junctional structures by TEM. We also 
found that the monolayers allowed the selective passage of strains during mixed 
infection experiments, confirming that traversal does not result from loss of integrity 
of the barrier. Finally, an intracellular population of bacteria was detected in Calu-3 
monolayers by recovery of viable organisms following treatment with gentamicin, 
and by confocal microscopy. Thus several independent lines of evidence indicate 
that N. meningitidis crosses the respiratory epithelial barrier by a transcellular route. 
Meningococcal traversal of the epithelium by the transcellular route consists of a 
number of steps including: i) adhesion to the apical surface, ii) invasion of epithelial 
cells, iii) survival within cells, iv) movement to the basolateral surface, and v) 
basolateral escape of bacteria. We next investigated the host and bacterial cell 
factors involved in traversal and attempted to identify the specific stages of traversal 
to which they contributed 
213 
7,4. Host determinants for successful traversal 
Initially we used chemical inhibitors to identify host cell pathways involved in 
meningococcal traversal of the Calu-3 monolayer. However, many drugs either 
disrupted the integrity of the monolayer or impaired the viability of N. meningitidis. 
We selected a variety of inhibitors which target different cellular pathways. The 
effect of the drugs on bacterial replication was assessed over a 24 hour period. In 
general the drugs had little effect on replication. Exceptions were sodium azide, 
which inhibits ATP synthesis and caused reduction in growth rate, and the inhibitors 
of endocytosis (amiloride and M-D) which reduced replication at later timepoints. 
These drugs were excluded from further studies on infected monolayers, inhibitors 
of endocytosis also reduced monolayer integrity making them entirely unsuitable for 
further studies. 
We analysed the effect of the drugs on monolayer integrity by measuring TEER and 
permeability to fluorescent tracer for 24 hours after treatment. Interestingly, a 
previous study used a number of the chemicals and reported no adverse effects on 
TEER (Wang et al., 2007). However, in our hands several of these drugs had drastic 
effects on TEER. For instance cytochalasin D and latrunculin A reduced TEER to less 
than 10% of the initial value in under 30 minutes. These differences might be due to 
the different cell lines used as the other study involved T84 intestinal epithelial cells. 
All drugs which disrupt the actin cytoskeleton rapidly and comprehensively reduced 
TEER. This is consistent with other studies (IVIadara et a!., 1986), and understandable 
given the integral role of actin in cell shape and tight junction formation. We also 
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found that treatment with these drugs led to a small but consistent increase in tracer 
permeability. Therefore the role of actin in meningococcal traversal of respiratory 
epithelial cells could not be investigated with these agents. However, another drug, 
BDM, had no effect on TEER. This drug inhibits the myosin ATPase preventing force 
generating actin/myosin interactions without affecting cell morphology (Simpson and 
Armstrong, 1999). Therefore BDIVl may allow assessment of the role of actin in 
epithelial traversal, though the specificity of this drug for the myosin ATPase is 
uncertain (Titus, 2003). 
The effects of drugs that disrupt the microtubule network were less severe. TEER 
was maintained until 8 hours after treatment and never fell below 600 Q even after 
24 hours. In addition the layers remained impermeable to tracer. We selected 
nocodazole and taxol for further studies because they had the least effect on 
integrity, and distinct mechanisms of disrupting the microtubule network. Immuno-
fiuoresence labelling showed that treatment did not affect the occludin labelling of 
tight junctions and had the predicted effects on microtubules: nocodazole caused 
depolymerisation of microtubules and taxol froze the existing network preventing 
depolymerisation. 
Traversal of the meningococcus was impaired by interfering with the microtubule 
network with either taxol or nocodazole. Microtubule disruption specifically blocks 
transcellular but not the paracellular traversal. The only example of apical to basal 
traversal of epithelia, using a paracellular route, without disrupting tight junctions is 
the passage of leucocytes. However, this pathway is not affected by inhibiting the 
microtubule network with taxol or nocodazole (Hofman et a!., 1996). Therefore, the 
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impact of microtubule disruption on the passage of bacteria provides further 
evidence for a transcellular route of meningococcal traversal. 
These data also indicate that traversal by N. meningitidis does not occur by the same 
mechanism as transcytosis of polymeric immunoglobulins, which is initiated by 
receptor-mediated, clathrin-dependent endocytosis (Mostov and Deitcher, 1986) and 
does not require intact microtubules (Hunziker et al., 1990). We also found that the 
number of intracellular bacteria at 8 and 24 hours was not affected by microtubule 
disruption, suggesting that microtubules are involved in basolateral escape of 
meningococci from cells rather than entry. 
The microtubule network has a major role in the sub-cellular trafficking of vesicles 
[reviewed in (Caviston and Holzbaur, 2006)]. This is achieved by the molecular 
motors kinesin and dynein which bind microtubules at one end and cargo at the 
other, then through the hydrolysis of ATP move in a unidirectional manner along the 
microtubule network [reviewed in (Caviston and Holzbaur, 2006)]. Other pathogens, 
such as Salmonella, are able to exploit the microtubule network and its associated 
motor proteins to allow intracellular movement of the SCV (Ramsden et al., 2007a). 
It would be interesting to see if the microtubule motors are involved in the traversal 
of N. meningitidis, though specific disruption of the motors in the monolayer could 
prove problematic. Chemical disruption is hampered by pleiotropic effects and siRNA 
or the use of dominant negative constructs is hampered by the low rates of 
transfection for polarised Calu-3 cells (Florea et al., 2002). 
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7.5. Meningococcal determinants for successful traversal 
To identify bacterial factors involved in traversal, vje performed competitive assays 
between the wild-type and mutant strains. The advantage of this approach is that it 
eliminates well-to-well variation in overall levels of traversal, and allows direct 
comparison of the extent of traversal of strains. 
Work in our laboratory has shown that the putative TBDR NMB1882 is important for 
intracellular replication (R. ExIey, unpublished), as is the gonococcal homologue TdfF 
(Hagen and Cornelissen, 2006). We found that MC58Anmbl882 had a defect for 
traversal of the Calu-3 monolayer. The biochemical function of this receptor is not 
known but it is noteworthy that this gene, which is known to be important in 
intracellular survival, is also implicated in traversal. The result is consistent with our 
finding that the meningococcus traverses via a transcellular route. The reason 
underlying the intracellular replication defect is not yet clear but it is likely, that 
NMB1882 is involved in nutrient acquisition as other TBDRs. TdfF is involved in iron 
acquisition and it is likely that NMB1882 has a similar function in the meningococcus. 
This hypothesis is strengthened by the identification of a regulatory sequence 
upstream of the coding region of the gene (R. ExIey, unpublished) which is predicted 
to be bound by the iron responsive transcription factor. Fur. 
Another mutant lacking putative TBDR deficient, nmbl829, had no defect for 
traversal of the Calu-3 monolayer. This gene had been identified as important for 
survival in the organ culture model (OCM) (ExIey et al., 2009). The Anmbl829 mutant 
also has enhanced levels of adhesion (ExIey et al., 2009) and displays no defect for 
217 
intracellular replication in semi-confluent Chang cells (R. Exiey unpublished). The 
defect in survival in the OCM therefore is hypothesised to occur early in infection, 
perhaps even before the interaction with host cells (ExIey et al., 2009). Given that it 
is a TBDR, NMB1829 may be involved in acquisition of nutrients such as iron from 
secretions in the nasopharynx. This might explain why the mutant did not have a 
traversal defect in the Calu-3 monolayer. Host components and cells that are present 
in complex explanted tissue (such as sub-epithelial cells, immune cells, mucosal 
antibodies and nutrients) are not present in the Calu-3 model. 
Lactate permease (LctP) is responsible for uptake of lactate by N. meningitidis and is 
required for both nasopharyngeal colonisation and disseminated infection (ExIey et 
al., 2005a; ExIey et al., 2005b). It has also been shown that the acquisition of lactate 
does not impede adhesion of N. meningitidis to epithelial cells (ExIey et al., 2005a), 
but nothing is known about its contribution to intracellular survival or epithelial 
traversal. We have shown that IctP plays no role in traversal of the Calu-3 
monolayer. The intracellular carbon energy source of N meningitidis, and the genes 
required for its utilisation remain unknown. 
We found that Tfp mediate attachment of the meningococcus to the monolayer, as 
well as to semi-confluent cells, demonstrating that the mechanism of initial adhesion 
is similar in non-polarised and polarised cells. Consistent with previous results (Pujol 
et al., 1997), the Tfp-minus mutant had a significant defect for traversal across both 
LCC and AlC monolayers compared with the wild-type strain. The defect for adhesion 
of the pilus deficient strain to polarised monolayers was similar in magnitude to the 
reduction in number of intracellular bacteria, and the overall defect of MC58Ap/7f for 
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traversal. These data suggest that Tfp contribute to traversal during the attachment 
of the bacterium to the apical surface of cells, after which they are dispensable. This 
is supported by the finding that two out of ten strains were pilus-negative following 
traversal of the monolayer, which is likely to result from phase variation In pilus 
expression. This raises the possibility that the pilus is actually detrimental for the 
meningococcus during traversal subsequent to host cell adhesion. 
Recent work has shown that the polysaccharide capsule plays an important role in 
the survival of N. meningitidis in epithelial and endothelial cells, perhaps by 
mediating resistance against CAMPs (Nikulin et a!., 2006; Spinosa et a!., 2007). In 
keeping with this, we found that there was a reduction in the recovery of the capsule 
deficient mutant (MC58As/oD) from within polarised Calu-3 monolayers in spite of a 
five-fold increase in adhesion. This indicates that the capsule is required for survival 
within cells. The MC58As/oD exhibited a dramatically reduced rate of epithelial 
traversal of both LCC and AlC monolayers, far in excess of its defect for intracellular 
survival, suggesting that the capsule has further roles during exit of the bacteria from 
the basolateral pole of cells. 
The meningococcal capsule plays a major role at various stages of pathogenesis. 
Within the nasopharynx, the capsule is thought to inhibit the association between 
bacteria and epithelial cells (Hammerschmidt et al., 1996a; Virji et a!., 1996), with 
capsule expression down-regulated during intimate adhesion (Deghmane et ol., 
2002). Subsequently the capsule is necessary for the avoidance of phagocytosis and 
resistance against complement mediated lysis once the bacterium has entered the 
systemic circulation, with the overwhelming majority of bloodstream isolates 
219 
expressing a capsule (Vogel and Frosch, 1999). Our data shows that the capsule is 
virtually indispensable for passage across the respiratory epithelial barrier (during 
intracellular survival and escape from the basolateral surface), another stage that is 
critical for meningococcal colonisation and disease. 
7.6. The roles of CD46 and Type IV pili in meningococcal adhesion 
Previous work has suggested that CD46 is the host cell receptor for the 
meningococcal Tfp (Kallstrom et a!., 1997). However, other work contradicts this 
(Rahman et al., 1997; Tobiason and Seifert, 2001; Edwards et a!., 2002; Gill et al., 
2003; Kirchner et al., 2005). Previous investigations have used organ cultures or 
semi-confluent cells. We examined the role of CD46 in the adhesion of the 
meningococcus to a polarised respiratory epithelial monolayer. 
The level of expression of CD46 in Calu-3 and HeLa cells was examined by Western 
blot analysis. Interestingly, we observed that expression of CD46 was confined to the 
basolateral surfaces of cells in the monolayer, with no expression detectable on the 
apical surface. This is consistent with the majority of reports which show that CD46 
localisation in epithelia is basolateral in both tissue samples [e.g. hepatic cord 
(Kinugasa et al., 1999)] and cell culture models [e.g. MDCK cells (Maisner et al., 1996; 
Teuchert et al., 1999)]. However, there are a limited number of studies which show 
some apical presentation [e.g. the female genital tract (Oglesby et al., 1996)]. There 
was no previous information about CD46 localisation in polarised respiratory 
monolayers. 
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There was evidence of a Tfp dependent interaction between fixed meningococci and 
purified CD46 by FACS, although the level of binding appeared to be low and close to 
the limit of detection. The interaction was confirmed by Far Western blotting which 
indicated that a number of bacterial proteins, including PilE bound to purified CD46. 
A direct interaction between CD46 with PilE has not been shown before, although 
binding to a secreted form of PilE (S-pilin) has been reported in the gonococcus 
(Rytkonen et a!., 2001). We also detected interaction of CD46 with a ~100 kDa 
protein that may be PilC. This interaction has been previously reported in the 
gonococcus (Albiger, 2000), however, analysis of PilC mutant bacteria is required to 
confirm this finding. Mass spectrometry of other bands could be used to identify the 
other interacting proteins. 
Expression levels of CD46 by Calu-3 cells were similar to HeLa cells, previously 
determined as 100,000 molecules/cell (Seya et al., 1990; Cho et a!., 1991). At a MW 
of ""68 kDa, this is equivalent to just ~1 ng of CD46 per well of a 24 well plate 
(containing 1 x 10^ host cells). We did see an in vitro interaction between purified 
CD46 and N. meningitidis, however the binding was close to the limit of detection by 
FACS despite the large quantities of CD46 protein used (up to 2.5 ^g per 1 x 10^ 
bacteria). This suggests that the level of binding is very low, although actual 
quantification of the binding affinity would require methods such as surface plasmon 
resonance (SPR), using purified Tfp and purified CD46. 
In the absence of binding data the physiological relevance of this weak interaction 
was investigated. We saw no evidence that CD46 contributes to the adhesion of A/. 
meningitidis. Bacterial adhesion was not inhibited when meningococci were 
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incubated with 25 ng/ml of CD46 protein, prior to infection of cells. This contradicts 
previous work that showed a dose dependent inhibition of meningococcal adhesion 
when bacteria were pre-incubated with 2, 5 or 10 pg/ml of full length CD46 (BCl 
isoform) (Kallstrom et al., 1997). This difference could be because we used only the 
four extracellular, complement regulatory, SCR domains of CD46 rather than the full 
length molecule. However, the regions omitted in our experiments are 
predominantly intracellular or transmembrane. Another possible explanation is that 
the previous work was also carried out with a different cell line (ME180). 
Basolateral localisation of CD46 has been noted before (Teuchert et al., 1999; 
Johansson et al., 2003), and is dependent on a tetrapeptide (FTSL) motif at the c-
terminus of the protein (Teuchert et al., 1999). Our work has shown for the first time 
that there is no re-localisation of CD46 to the apical surface or sites of adhesion with 
bacteria. CD46 expression remained confined to the basolateral surfaces of infected 
monolayers making it difficult to envisage how CD46 could act as a receptor for Tfp. 
We also intended to investigate whether CD46 is important for traversal of the 
respiratory epithelium. Transient transfection of polarised monolayers of Calu-3 cells 
is very inefficient (Florea et al., 2002) so we attempted to generate a stable CD46" cell 
line, which could be grown into a CD46 monolayer. We designed and synthesised 
four shRNA constructs to inhibit CD46 expression. Transient transfection conditions 
for Calu-3 cells were optimised in experiments using transfection with a GFP 
construct, followed by assessment of fluorescence by FACS. All four shRNA 
constructs were tested, and the most effective (shCD46 4) was selected for further 
work. Unfortunately, none of the constructs provided efficient CD46 knock down. 
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Despite this, we attempted to use a retroviral transfection system which would allow 
genomic integration of shCD46 4 into the Calu-3 cells, giving stable expression, and 
therefore stable knockdown. However, despite several attempts we failed to 
generate a puromycin resistant stable cell line. It is not clear if this was due to i) 
inefficient synthesis of pseudoviral particles from the packaging Phoenix cell line, ii) 
low infectivity of the pseudoviral particles, iii) inefficient integration, or low 
expression levels in the integrated construct. Further work is needed to establish the 
nature of the problem. For instance analysis of pseudoviral titres in the Phoenix cell 
supernatant, or analysis of pseudovirus infectivity could be preformed. A positive 
control construct, would also be helpful, and allow optimisation of viral production 
and infection. However, given the inefficient knockdown of CD46 by the constructs 
in the first instance, it may be easier to purchase commercially available retroviral 
particles, carrying shRNA constructs against CD46. 
Taken together these data indicate that although there is some in vitro binding of 
purified CD46 to N. meningitidis and PilE, CD46 does not seem to be important in 
adhesion bacteria to the respiratory epithelial cells. The weak interaction between 
CD46 and PilE may go some way to explaining why confusion has arisen in the field 
surrounding this issue. 
7.7. Future work 
Investigating the compartment utilised for traversal is problematic in Calu-3 
monolayers as imaging through the supporting membrane is difficult, and the 
intracellular population of bacteria is relatively low. However, further work could be 
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undertaken in semi-confluent cells to determine the nature of the NCV. Further 
characterisation of the intracellular niche occupied by the meningococcus should 
help to understand the mechanisms of transcellular passage. 
The physiological relevance and polarised nature of the Calu-3 cell monolayers should 
allow the identification of further bacterial and host factors responsible for 
meningococcal interactions with epithelia during early colonisation and pathogenesis. 
It should also be possible to perform a screen of meningococcal mutants and define 
further bacterial factors involved in traversal. A screen has already been performed 
to isolate mutants of N. gonorrhoeae that show enhanced trafficking across T84 
monolayers (Hopper et ol., 2000a; Hopper et a!., 2000b). A similar screen, but 
isolating both enhanced and reduced trafficking mutants would be informative. In 
addition, as N. meningitidis is predominantly commensal it would be interesting to 
compare pathogenic strains to carrier/commensal strains and see if they differ in 
their ability to traverse the epithelia. 
It would also be interesting to understand whether the first bacteria to traverse the 
monolayer in an experiment are a subpopulation with specific characteristics that 
promote their passage or are the same as all the other bacteria in the apical 
chamber. Repeatedly passaging the first bacteria to traverse the monolayer and 
using them to infect further monolayers might select a hyperinvasive population. 
This could then be studied to reveal the basis for the hyperinvasivity. Alternatively, 
the failure to select a hyperinvasive strain would indicate that traversal is a stochastic 
process, with earlier traversal occurring by chance, when the number of bacteria in 
the apical chamber reaches a level where it becomes statistically probable. 
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Calu-3 cells could also be used to study the epithelial traversal of other pathogens 
present in the respiratory tract including Streptococcus pneumoniae and H. 
influenzae. The results should provide valuable information about the pathogenesis 
of these important human pathogens, while defining the factors necessary for 
migration across the epithelium could lead to the development of novel interventions 
to prevent the diseases they cause. 
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